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Abstract
This thesis describes the development of diastereotopic group selective processes 
allowing the desymmetrisation of 1,4-cyclohexadiene derivatives and their 
application to target synthesis.
Chapter 1 discusses some of the benefits that may be derived by the use of 
desymmetrisation, and demonstrates some of the ways in which it has recently been 
applied in compounds based on 1,4-cyclohexadiene.
Chapter 2 describes a novel use of the Prins reaction to desymmetrise 
cyclohexadiene derivatives with high diastereoselectivity, and the optimisation of 
this resulting in an effective, practical and straightforward procedure.
Chapter 3 details the investigation into desymmetrisation through diastereoselective 
iodocyclisation reactions, much higher stereoselectivity is observed than found 
previously in cyclohexadiene based substrates and an explanation is suggested by 
examination of structural differences.
Chapter 4 reviews some of the previous synthetic approaches to members of the 
fawcettimine group of Lycopodium alkaloids. This is followed by the results of our 
first approach to the core tetracyclic ring system of lycoposerramine A, based on the 
discovery of a novel base induced diastereotoselective cyclisation reaction.
Chapter 5 describes our revised approach, leading to the construction of a closely 
related tetracycle, although not permitting the construction of the target.
Chapter 6 discusses the synthesis of the core tricyclic system of lycoposerramine S by 
a different strategy. NMR spectra obtained from the final product are found to 
closely match those obtained from the natural product.
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Chapter 1
Introduction
1.1 Symmetry in Synthetic Chemistry
The potential for many organic compounds to be assembled simply and efficiently by 
consideration of their symmetry was recognised, and applied to remarkable effect, 
by Robinson over 90 years ago. Disconnecting tropinone 1 at the bonds indicated, 
and appropriately functionalising both termini of the four carbon fragment, he 
suggested its synthesis by simply combining the three symmetrical synthons shown 
in Scheme l . 1
Scheme 1. Reagents and Conditions: (a) i) MeNH2/ H20, 72 h; ii) H+.
This was, indeed, found to be the case, and by use of a more readily enolised 
acetone surrogate the cascade of reactions was found to be so effective under such 
mild conditions that he proposed that it may also be the mechanism of its 
biosynthesis.2
This example illustrates some of the benefits that may be derived by maintaining an 
element of symmetry through a sequence; firstly, the starting materials are relatively 
simple, and also, therefore, generally cheap and easy to obtain. Also, there are fewer 
selectivity issues, due to the equivalence of the two pairs of functional groups. This 
allows the simultaneous homologation of both in a single step, and can be an 
extremely effective means of constructing long, acyclic, chains.3
Although there are a great number of symmetrical target molecules there are, by 
necessity, many more that are asymmetrical.4 These generally have at least some 
symmetry, however, and their synthesis can be facilitated by the same benefits 
described above if selected symmetry elements can be broken at a later stage. The 
various methods through which this can be achieved have received extensive 
reviews.3'7 This process of desymmetrisation alone can offer certain advantages, 
illustrated by the example in Scheme 2. The Birch reduction /  alkylation sequence 
readily affords 1,1-disubstituted 2,5-cyclohexadienes such as 3, containing a
2
prochiral quaternary centre. Transformation of one of the enantiotopic double 
bonds, often in a cyclisation reaction, results in a loss of symmetry, thus determining 
the configuration of the quaternary centre in a process separate from its bond 
formation. This may, in many cases, provide higher selectivity than the more 
conventional direct approach, and can be even more effective when applied to a 
substrate containing several prochiral centres.
Scheme 2. Desymmetrisation of a l,l-disubstituted-2,5-cyclohexadiene.
Such an enantioselective transformation, of course requires the use of a chiral 
catalyst or reagent. It is also relatively difficult to determine the success, or 
otherwise, of the reaction. By incorporating a stereogenic centre prior to 
desymmetrisation, as in compound 5, Scheme 3, for instance, the substrate is able to 
control which of the, now diastereotopic, groups is involved in the reaction. Since 
the products of the reaction are diastereoisomers, they are easily differentiated, and 
often separable simply by flash column chromatography. The success of the 
transformation is, therefore, straightforward to determine with a racemic substrate, 
while still allowing for asymmetric synthesis by use of a chiral alkylating reagent 
following the Birch reduction.
C02H
HO 2C
2 3 4 ent-4
R R
C02H
HO 2C R H 02C,,. , sC02H
2 5 6 7
Scheme 3. Desymmetrisation by diastereotopic group selectivity.
3
1.2 Desymmetrisation of Achiral Cyclohexadienes
While enantiotopic group selectivity requires the use of a chiral reagent or catalyst, 
desymmetrisation can still be achieved by the same processes used on chiral 
substrates, although resulting in racemic products.
1.2.1 Non-Group Selective Desymmetrisation
A novel alternative to the more common entry into these substrates, the Birch 
reduction, was reported recently by Crich to allow the preparation of 
l-aryl-2,5-cyclohexadienes. The addition of aryl radicals to benzene was shown to 
occur when benzeneselenol or diphenyl diselenide was added as a catalyst. Over a 
series of publications, a wide range of aryl iodides were shown to undergo this 
addition, and the products were then desymmetrised by a variety of reactions.8
Dihydroxylation of 9, for example, with strictly 1 equiv. of NMNO in aqueous 
acetone, gave diol 10. This could be further oxidised, allowing access to various 
cyclitols.9 The preference observed for dihydroxylation anti to the substituent was 
also found by Landais in similar cases.10
(a) r H C r ^ p  (b)
, 52 % 65 %
OH
8 9 10
Scheme 4. Reagents and Conditions: (a) Bu3SnH, AIBN, (PhSe)2, PhH, reflux;
(b) 0s04, NMNO (1 equiv.), acetone, water, 2:1.
The preparation of benzoic acid derivative 12 in this manner allowed the preparation 
of Danishefsky's pancratistatin precursor 13, shown in Scheme 5. This route required 
3 fewer steps than the original procedure and provided a slight increase in overall 
yield.11
An interesting epoxycyclisation was also reported, effected by treatment of epoxides 
15a and 15b, shown in Scheme 6, with BF3.OEt2.
4
11 12 13
Scheme 5. Reagents and Conditions: (a) l2/ NaHC03, THF.
R R R
R
NBoc
'OH
R
NHBoc
R
NHBoc
14a, R = H 15a, R = H ,67%  16a, R = H, 86%
14b, R = -0CH20 - 15b, R = -0CH20-, 16b, R = -0CH20-,
60 % 68 %
Scheme 6. Reagents and Conditions: (a) mCPBA, CH2CI2/ 0 °C; (b) BF3.Et20,
0°C.
A major disadvantage of this approach is that it cannot easily be applied to the 
preparation of 1,1-disubstituted cyclohexadienes. Landais realised that many targets, 
those shown in Scheme 7 for example, may be accessible by the desymmetrisation of 
such substrates, and initiated a study into their synthesis by the Birch reduction /  
alkylation of biaryl compounds.12
Ac
Me
Buchi ketone 17a
Crinine 18a
Aspidospermidine 19
Scheme 7. Targets potentially accessible through Birch reduction of biaryls.
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The rate of reduction of each ring was found to be influenced by the substituents in 
the same order found in simple mono-aryl systems, where ArOMe > ArH > ArOH. In 
many cases, this allowed the highly regioselective reduction of a series of substrates 
20a-h, shown in Table 1, affording the corresponding 2-aryl-2-(3,5-dimethoxy-2,5- 
cyclohexadienyl)acetonitriles 21a-h in high yield.
R3
(a) or (b)
MeO ^  OMe 
20a-h
MeO OMe
21a-h
r ■<
OMe
(l ll
V CN
II Ij
v OMe
22
Entry Substrate Ri *2 *3 r4 Conditions Yield 21 (%)
1 20a H H H H (a) 88%
2 20b OH H H H (b) 82%
3 20c H OH H H (b) 75%
4 20d OH OMe H H (b) 82%
5 20e H OMe OH H (b) 86%
6 2 Of H OMe OMe H (a) 0% a
7 20g H OMe H OMe (a) 91%
8 20h NHBoc H H H (b) 50%
Table 1. Reagents and Conditions: (a) i) Li, NH3, THF, -78 °C; ii) CICH2CN; (b) i)
n-BuLi; ii) Li, NH3, THF, -78 °C; iii) CICH2C N .a A mixture of 22 and 20f (approx. 
1:1) was obtained in 78 % yield.
The unsubstituted aryl group of compound 23, shown in Scheme 8, was found to be 
reduced preferentially, allowing the preparation of simple 1,1-disubstituted 
cyclohexa-2,5-dienes by this method.
6
MeO. OH
48%
23
MeO CN
24
Scheme 8. Reagents and Conditions: (a) i) n-BuLi; ii) Li, NH3/ THF; iii) CICH2CN,
-33 #C.
The product 24 was used in an very concise synthesis of crinine analog 18b, shown in 
Scheme 9. Alkylation of phenol 24, followed by reduction of the nitrile, gave 
compound 25. This was desymmetrised in an LDA catalysed hydroamination 
reaction, allowing formation of the remaining ring by a Pictet-Spengler reaction.
OH OMe OMe
NHCN 69 % MeO 73 % MeOMeO'
NH
24 25 26
(c)
82%
MeO. OMe
18b
Scheme 9. Reagents and Conditions: (a) i) M e2S04/ K2C03, acetone, reflux, 20 
h; ii) LiAIH4, AICI3, Et20 , room temp., 4 h.; (b) LDA (0.4 equiv.), THF, 20 °C, 4 h;
(c) CH2=NH2rr, THF, 40 °C, 60 h.
Prior deprotonation of the sulfonamide group by treatment with n-BuLi also allowed 
the selective reduction of the unsubstituted aryl group of compound 27. The 
alkylated product 28 was then desymmetrised in an oxidative amination reaction, 
catalysed by Pd(ll), as shown in Scheme 10. The optimum conditions were found to
7
use NaOAc as the base and activated carbon as a support to facilitate the re­
oxidation of precipitated Pd(0).13
70%
27
(b) NC^ >
91 %
29
NC H N -S 0 2Et
28
Scheme 10. Reagents and Conditions: (a) i) n-BuLi ii) Li, NH3/ THF, -78 °C; ii) 
CICH2CN; (b) Pd(OAc)2 (10 mol %), Carbon, NaOAc (2 equiv.), 0 2, DMSO, 55 °C,
24 h.
Reduction of the nitrile group of 28, followed by protection of the resulting amine, 
allowed the synthesis of the protected Buchi ketone 17b in a cascade-type sequence, 
as shown in Scheme 11. This was proposed to occur by oxidation of 30 at the allylic 
position, followed by conjugate addition of both the amide and sulfonamide.
EtQ2S -N NAc
17b O
NHAc 54 %
30
Scheme 11. Reagents and Conditions: (a) i) Pd(0), t-BuOOH, CH2CI2; ii) DBU,
CH2CI2, reflux.
1.2.2 Enantioselective Desymmetrisation of Cyclohexadienes
There are also several examples of the enantiotopic group selective 
desymmetrisation of cyclohexadienes. Landais has conducted extensive investigation 
into the dihydroxylation and aminohydroxylation of silylated cyclohexadienes, for 
example,10 and also recently reviewed the area.7
Studer recently reported the development of a catalytic system capable of mediating 
the selective addition of a cyclohexadienyl species, generated in situ from treatment 
of silane 31 with TBAF, to a range of aldehydes.14 Out of the range of metal sources
8
and ligands screened, a combination of copper(l) or (II) triflate and the 
DIFLUORPHOS ligand 33 provided the highest diastereo- and enantioselectivity, 
although in less than 40 % yield.
The conditions shown in Scheme 12 were found to be optimal, the addition of 3 
equivalents of CF3CH2OH resulted in a substantial increase in yield without any loss 
of selectivity. Application of these conditions to a range of aromatic and 
heteroaromatic aldehydes provided compounds 32 in good yield and with 
comparable enantioselectivity to that previously reported to be obtained from the 
use of a stoichiometric amount of a chiral titanium complex.15 Diastereoselectivity, 
favouring the formation of syn-32, was also good, although lower, in many cases, 
than that found in the corresponding reactions with the titanium complex.
Si(Oi-Pr)3
(a)
17 examples
31 syn- 32
44-91 % yield
d.e. 43 - 93 %
e.e. 83 - 94 %
anti-32
33 - (R)-DIFLUORPHOS
Scheme 12. Reagents and Conditions: 31 (3 equiv.), Cu(OTf)2 (10 mol %), 33 
(10 mol %), CF3CH2OH (3 equiv.), TBAF (1 equiv.), ArCHO (1 equiv.), THF, - 
25 °C, 20 h.
Nakada recently reported a catalytic asymmetric intramolecular cyclopropanation of 
a cyclohexadiene derived a-diazo-P-ketosulfone,16 later also applying the procedure 
to the analagous p-ketoesters. Diazo compound 35, prepared by a rather lengthy, 
although straightforward and efficient sequence, was cyclised in excellent yield and 
enantioselectivity with a catalyst based on chiral bisoxazoline 37, as shown in 
Scheme 13.17
9
OTBDPS TBDPSO / — ^  TBDPSO
6 steps y-COzf-Bu (a)
84 % yield
c r
84%  
95 % e.e.
34 35
H * :°H C 02t-Bu 
36
O ^ ^ O  
\ ^ n N ^y  
i-Pr 37 1-Pr
Scheme 13. Reagents and Conditions: (a) Cu(OTf)2 (10 mol %), 37 (15 mol %), 
toluene, room temp., 4 h.
The potential application of this approach to the natural product hyperforin 42, 
shown in Scheme 14, was then demonstrated, although with an achiral bisoxazoline 
ligand. Diazo compound 38, derived via the Birch reduction of 2,6-dimethoxybenzoic 
acid, was cyclised to intermediate 39.18 Treatment with ZnCI2 then allowed 
fragmentation to the bicyclo[3.3.1]nonane ring system found in 42.
O
TBDPSO J L x O z E t
M e O y > L  N2
l ^ M e O  ,
38
(a)
70%
O
I
N N 
41
OTBDPS'
MeO
H COzEt J
HO.
MeO — OTBDPS
Scheme 14. Reagents and Conditions: (a) i) Cu(OTf)2.C6H6 (5 mol %), 41 (15 
mol %), toluene, 80 °C, 1.5 h; ii) ZnCI2 (1.5 equiv.), room temp., 3.5 h.
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1.3 Diastereoselective Desymmetrisation of Cyclohexadienes
A novel diastereoselective desymmetrisation was reported recently by Landais.19 
Attempted base catalysed hydroamination of amine 43, shown in Scheme 15, 
generated a cyclised product in high yield and diastereoselectivity. On closer 
inspection of the data, however, the product was determined to be the allylic amine 
44, which is unlikely to result from the expected process. The mechanism proposed 
to explain this finding involves an initial diastereoselective protonation of 
cyclohexadienyl anion 45, favouring the formation of intermediate 48. Addition of 
the amide anion to this diene, followed by protonation of the allylic anion 49 at the 
less hindered position, yields the product 44.
pV NH^ <Ph <a>, pV NCkPh
(  I  1  95% yield (  H' T  J
OMe > 95 % d.e. OMe
43 44
Me
46
Ph PhNH
OMe
45
Ph
OMe
49
O— Li
Me
48
Me
47
Scheme 15. Reagents and Conditions: (a) BuLi (20 mol %), THF, 20 °C, 4 h.
Fujioka and Kita reported the diastereoselective desymmetrisation of aminal 50 in a 
bromocyclisation reaction. Further oxidation of the initial product resulted in the 
isolation of dihydroimidazole 51 in good yield, as shown in Scheme 16.20 This allowed 
an efficient synthesis of (-)-y-lycorane 52.
11
PMP
HN
PMP
PMP
5 7 % 6 steps
50 51 52
Scheme 16. Reagents and Conditions: (a) NBS (2.1 equiv.), CH2CI2. PMP = 4- 
MeO-C6H4.
Recent examples from our group include the conjugate addition reaction shown in 
Scheme 17, the chiral sulfoxide exerting moderate diastereocontrol over the 
cyclisation of compound 53.21
Me.
Ph
O
,MeMe,.
Ph Ph
53 54 ,35% 55,11%
Scheme 17. Reagents and Conditions: (a) t-BuOK, THF, room temp.
The radical cyclisation reactions shown in Scheme 18 were more successful. The 
chiral secondary alcohol of compound 56a directing addition of the generated aryl 
radical with good diastereocontrol. This was further improved by the addition of the 
bulky silyl ether of 56b, while protection as an acetonide in 58 resulted in formation 
of the other diastereoisomer, also with fairly good stereocontrol.22
12
56a, R = H 
56b, R = TBS
Mev Me \ /
0  0  Br
57a, 53 %, 60 % d.e. 
57b, 52 %, 82 % d.e.
58 59, 77 %, 67 % d.e.
Scheme 18. Reagents and Conditions: (a) Bu3SnH, AIBN, PhH; reflux.
Also, the first reported group selective Prins reaction, as shown in Scheme 19, finally 
demonstrated excellent diastereoselectivity, with no minor diastereoisomers of 
either aldehyde 61a or tetrahydropyran 62a apparent by NMR analysis.23 The yields 
were poor, however, and the optimisation of this reaction is discussed in the 
following chapter.
60a 61a, 14% 62a, 3 %
Scheme 19. Reagents and Conditions: (a) TiCI4, CH2CI2, -78 °C, 2 h.
1.4 Objectives
The aim of the project was to investigate possible alternative and /  or improved 
methods of desymmetrising cyclohexadiene based compounds, and also to 
demonstrate the value of such methods by their application to synthesis of 
appropriate targets.
13
Chapter 2
Prins Cyclisation Reactions of 1,4- 
Cyclohexadienes
2.1 Introduction
The Prins reaction of cyclic acetal derivatives permits an extremely versatile entry 
into highly functionalised tetrahydropyrans,24 and has been widely used in total 
synthesis.25 Previous work within the Elliott group had established that the Prins 
reaction could be used to effect a novel and highly diastereoselective 
desymmetrisation of chiral cyclohexa-l,4-diene derived acetals.26 For example, 
treatment of acetal 60a with TiCU resulted in the formation of three compounds, 
61a, 62a and 63a, shown in Scheme 20.
Me (a)
60a
HO
Me
Cl
MeJ
63a
H H 
JH
Me"/ OT^Me
62a, 3 %
61a, 14 %
Scheme 20. Reagents and Conditions: (a) TiCI4, CH2CI2, -78 °C, 2 h.
The 1H NMR spectrum obtained from the crude reaction mixture showed it to consist 
predominantly of alcohol 63a. This product was found to be relatively unstable, 
however, and only pyran 62a and aldehyde 61a were isolated by chromatography.
The mechanism shown in Scheme 21 was proposed by El Sayed to explain this result. 
The stereochemistry of the products is determined by the Prins cyclisation of the 
oxocarbenium ion generated from acetal 60. Of the two chair conformers, 64 and 65, 
from which a transition state is accessible, 64 is the least destabilised by A1,3 strain 
generated between the Ri and R2 groups. Cyclisation therefore favours the 
formation of carbocation 66 with the stereochemistry indicated.
15
60 64 65
6-endo
©
OH
66 67
Cl', H20
-HCI
HO.
Scheme 21- Mechanism of the Prins cyclisation and subsequent reactions.
The final products suggest that two pathways of similar importance are available to 
this intermediate. Addition of a chloride ion affords the stable tetrahydropyran 62. 
This depends, however, on the availability of a chloride ion, if there are none in the 
vicinity a lesser degree of stabilisation can be attained by an intramolecular 
carbocation rearrangement, for which the Prins reaction is well known. A Wagner- 
Meerwein shift results in the formation of tetrahydrofuran 67, where the cation now 
occupies a position where it is both tertiary and allylic. This is far less unstable, and, 
although it will still readily trap a chloride ion, it will also release it again more easily, 
thereby allowing equilibration to the thermodynamically favoured enal 61.
Suprisingly, there was only one report that could be found in the literature at the 
time where the Prins reaction had been employed in a desymmetrisation. 
Rychnovsky, during his synthesis of 17-deoxyroflamycoin 71, reported the
16
preparation of tetrahydropyran intermediate 70 by a diastereoselective Prins 
cyclisation of diene 6 8 , shown in Scheme 22 .27 While this is a desymmetrisation, it is 
simply a result of monofunctionalisation, the possibility of group selectivity between 
the enantiotopic double bonds was not investigated.
(a), (b)
OAc O
42 - 51 % © i
f3boBnO. OBn OBn
OH OH OH OH OH OH OH
71
Scheme 22. Reagents and Conditions: (a) BF3.OEt2/ HOAc, cyclohexane; (b)
Ac20, Et3N, DMAP.
The novel results found by El Sayed were thus felt to potentially be very useful, 
however, significant optimisation would be required. As this work was begun 
towards the end of her project there was insufficient time for this to be investigated. 
I took over the project with this aim, beginning by attempting to optimise the 
reaction conditions and purification procedure.
2.2 Results and Discussion
A range of substrates were prepared by the procedure reported by El Sayed,26 as 
shown in Scheme 23. These were obtained as single diastereoisomers, presumably 
the syn isomers which allow both substituents to occupy equatorial positions. As the 
acetal stereocentre is lost on oxocarbenium ion formation, this aspect was not 
investigated further. The 2-bromophenyl substituent of diol 74b was maintained for 
consistency with the results and data obtained by El Sayed.21
17
72
Me
73a
(b) (c)
67%  
2 steps
OH OH
74a 60a, R = Me, 85 %
60c, R = /-Bu, 87 % 
60e, R = Ph, 90 %
O Br OH OH BrCO2M6
(a) MeQ2C.
86%
72 73b 74b 60f, R = Me, 91 %
60g, R = /-Bu, 47 % 
60h, R = Ph, 55 %
Scheme 23. Reagents and Conditions: (a) i) LDA, THF, -78 °C; ii) CH3COCI or 
2-BrC6H4COCI; -78 °C to r.t.; (b) LiAIH4/ THF; (c) RCHO, PPTS, CH2CI2 or RCHO,
H2S04/ DMF.
2.2.1 TiCU Mediated Prins Reactions
Before looking into the use of other catalysts the reactions were first repeated by 
the originally reported procedure. As the *H NMR spectra of the crude product 
mixtures previously obtained appeared to be relatively clean it was suspected that 
reasonable yields could be achieved simply by careful repetition of the reactions and 
chromatography. Frequent monitoring by tic, for example, showed that much less 
time was sometimes required for complete consumption of the substrate.
The simplest of the substrates, acetal 60a, was chosen for the first attempt. Analysis 
by tic showed the complete consumption of the starting acetal after only one hour 
and the reaction was promptly quenched. Only two compounds were observed in 
the *H NMR spectrum of the crude product, allylic alcohol 63a, and pyran 62a, in an 
approximate ratio of 2.6:1, as shown in Scheme 24. The formation of aldehyde 61a, 
noted to be present in the crude material obtained by El Sayed, would appear 
avoidable by allowing the reaction to proceed only for the minimum time required.
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The crude product was chromatographed immediately and the time spent in contact 
with the silica gel stationary phase kept as brief as possible in an attempt to 
minimise the decomposition of aldehyde 63a. The two fractions that were eleuted 
were, nonetheless, found to contain the same products isolated by El Sayed, 
although the yield was greatly improved, approaching 50 % in total.
(<0
63a:62a
approx. 2.6:1 MeJ
60a 63a 62a, 20 %
- nOe
61a, 28 %
Scheme 24. Reagents and Conditions: (a) TiCI4 (2 equiv.), CH2CI2; -78 °C, 1 h.
The stereochemistry of these products was unable to be assigned by El Sayed, only 
pyran 62a showing a useful nOe between one, or both, of the protons indicated, 
lending tentative support to the structure as shown.
Although the combined isolated yield was reasonable, the isolated yields of 
individual compounds were still poor, limiting the utility of the reaction. The 
estimated yield of alcohol 63a that could be expected, were it stable enough to be 
isolated, was a much more acceptable 52 %. This value is unlikely to be particularly 
accurate, though the discrepancy between this and the yield of aldehyde 61a 
isolated is large enough to suggest that a significant improvement may be realised by 
prevention of this transformation.
The silica gel used for chromatography was thought to be the most likely culprit, and 
the reaction repeated and chromatographed on silica neutralised by washing with 
triethylamine in petroleum ether. This was unsuccessful, as were attempts with
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alumina, in both neutral and basic forms; the same two products being found in each 
case.
We next considered the possibility that derivatisation of alcohol 63a may increase its 
stability. Treatment of the crude reaction mixture with AcCI, Et3N and DMAP, 
however, resulted only in decomposition to aldehyde 61a, as did attempted silyl 
ether formation with TBDMSCI and imidazole. Although derivatisation may be 
possible under acidic conditions, we did not invesitgate this matter any further.
Isobutyl acetal 60c was then cyclised, as shown in Scheme 25. This required a slightly 
longer reaction time, possibly due to the more crowded acetal ring. The XH NMR 
spectrum of the crude material showed it to consist of alcohol 63c and pyran 62c, in 
approximately the same ratio found in the previous example. In this case, however, 
aldehyde 61c was isolated in a yield more in line with that expected from this ratio.
A small amount of a third compound, proposed as being diene 75c, was also isolated. 
Although this could not be fully characterised, the 1H NMR spectrum obtained from 
this material corresponded closely to the spectra given by related compounds of this 
structure. This is presumably formed by the elimination of Hb from alcohol 63c.
The stereochemistry of aldehyde 61c and pyran 62c was assigned by El Sayed based 
on the results of nOe experiments. Aldehyde 61c showed nOe's between all four 
protons of the tetrahydrofuran ring, these must, therefore, all lie on the same side of 
this ring. In compound 62c, it was determined that the three protons shown were in 
close proximity, and therefore all axial on the tetrahydropyran ring.
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'Me <a>
63c:62c
approx. 2.7:1
HO^ M
60c
Hb H '-Bui 
63c 62c, 14 %
- nOe
HO
Me
Me
7-Bu
/-Buo n
61c, 37 %
Scheme 25. Reagents and Conditions: (a) TiCI4 (2 equiv.), CH2CI2, -78 °C, 2 h.
Cyclisation of acetal 60e also required 2 hours for completion, yielding a crude 
material composed of alcohol 63e and pyran 62e, as shown in Scheme 26. In this 
case, however, the pyran 62e was found to be the major product, suggesting that 
rearrangement following the Prins cyclisation is less favourable. A similar preference 
was also observed on cyclisation of benzaldehyde derived acetal 60h, shown in 
Scheme 30, Page 24, although the reason for this is not clear.
Ph
HO
Me
''Me
63e:62e
approx. 1:1.3 c r" ' Ph J
63e60e 62e, 38 %
61 e, 20  %
Scheme 26. Reagents and Conditions: (a) TiCI4 (2 equiv.), CH2CI2, -78 °C, 2 h.
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Although no diagnostic nOe's w ere observed by El Sayed in the spectra obtained  
from these products, the tetrahydropyran 62e was crystalline and its structure 
determined by X-ray crystallography to be as shown in Fig. 1, consistent with  
previous results and predictions.
62e
Fig. 1. ORTEP plot of the crystal structure of compound 62e. Thermal
ellipsoids drawn at the 50 % probability level. 26
The first of the 2-bromophenyl substituted series, acetal 60f, required even longer to  
reach completion. The ratio of the tw o  products was determ ined from the 1H NMR  
spectrum of the crude material to lie significantly in favour of the tetrahydrofuran  
63f, as shown in Scheme 27.
Me
HO
Ar
63f:62f
approx. 6.5:1 c r ° ‘
63f60f 62f, 10 %
- nOe
HO.
Me
61 f, 44 % 75f, 17 %
Scheme 27. Reagents and Conditions: (a) TiCU (2 equiv.), CH2CI2, -78 °C, 4 h. 
Ar = 2-Br-C6H4.
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This may be due to stabilisation of transition state 76f, shown in Scheme 28, by 
delocalisation of the positive charge around the aromatic ring, thereby increasing the 
contribution from the rearrangement pathway.
Scheme 28. Possible stabilisation of cation during rearrangem ent.
Three products were isolated by chromatography in 71 % total yield, and individual 
yields were in close agreement with the ratio observed in the crude material. The 
formation of diene 75f was again observed, this time in a significant amount. A 
possible explanation is the increased steric hindrance of proton Ha caused by the 
bulky aryl substituent, increasing the proportion of elimination by loss of Hb.
With the exception of diene 75f, the stereochemistry of the products was 
determined by El Sayed based on the observation of the indicated nOe's.
Cyclisation of acetal 60g appeared to be complete after 2 hours, although significant 
decomposition was evident in the 1H NMR spectrum of the crude product. The 
presence of a relatively large amount of 2 -bromobenzaldehyde was also apparent, as 
was the absence of the expected pyran. The total isolated yield, of aldehyde 61g and 
diene 75g, was less than 30 %, as shown in Scheme 29. There is no obvious reason 
why this substrate should give such a low yield, while comparatively high yields were 
obtained from acetals 60c and 60f where these substituents were each present 
separately.
The stereochemistry of the products could not be determined by nOe experiments, 
but is expected to be as indicated by analogy with previous results.
66f 76f 67f
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/-Bu
HO
63h:77
approx. 2:1 /-Bu
Br
OHCX)
60g 63g 77
HO
/-Bu /'-Bu
61 g, 21 % 75g, 6 %
Scheme 29. Reagents and Conditions: (a) TiCI4 (2 equiv.), CH2CI2, -78 °C, 2 h.
Ar = 2-Br-C6H4.
Cyclisation of the final substrate, acetal 60h, as shown in Scheme 30, gave several 
unique results. Firstly, the reaction was complete within only 15 minutes, in contrast 
to the relatively slow cyclisation of the mono-aryl substituted acetals 60e and 60f.
HO^ ^H
(a)
63h:62h:78 CP'
1.5:2.1:1 H
H H
60h 63h, 24 %
Ph
+
OH
62h, 28 %
HO Ph
+
78, 9 %
Scheme 30. Reagents and Conditions: (a) TiCI4 (2 equiv.), CH2CI2, -78 °C, 15 
min. Ar = 2-Br-C6H4.
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Secondly, the allylic alcohol 63h was, in this case, sufficiently stable for isolation by 
chromatography. The reason for this is not clear, although access to both positions 
required for elimination does appear to be somewhat hindered.
Finally, compound 78, the product of Prins cyclisation via a 5-endo pathway, was also 
isolated. A similar trend where increasing substituent bulk leads to preferential 
formation of the smaller ring size was later observed in iodocyclisation reactions, as 
shown in Scheme 31. Although the reason for this is not clear, it may be partly due to 
a gem-dimethyl type effect on bond angles.
The stereochemistry of allylic alcohol 63h and the 5-endo cyclisation product 78 
could not be determined by nOe experiments, the tetrahydropyran 62h, however, 
was a crystalline solid and the X-ray crystal structure shown in Fig. 2 was obtained by 
El Sayed.
113a, R = Me, < 30 min 114a, 66 % 115a, 6 %
113c, R = f-Bu, < 1min 114c, 89 % 115c, not observed
l2, NaHCOs, 
MeCN
Scheme 31. Effect of steric bulk on regioisomer ratios.
Fig. 2. ORTEP plot of the crystal structure of compound 62h. Thermal 
ellipsoids drawn at the 50 % probability level.26
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In summary, the Prins reaction was applied as a means of desymmetrising 
cyclohexadienes with high diastereoselectivity. The stereochemistry of the products 
appears to correspond to cyclisation through the more stable of the two possible 
transition states. Total yields were improved significantly over those found initially, 
mostly by the minimisation of reaction times and prompt purification following 
work-up. Low selectivity between several possible reaction pathways remained a 
problem, however, and no single compound could be obtained in greater than 50 % 
yield.28
2.2.2 Triflic Acid Mediated Prins Reactions
A possible solution to the selectivity problem may be to employ an acid catalyst with 
a less nucleophilic counter-ion. The cationic Prins cyclisation product 80, shown in 
Scheme 32, would then be forced to undergo rearrangement, ultimately leading to 
the tetrahydrofuran derivative 81. Alternatively, the addition of a nucleophile to 
serve as a cation trap may, by suppressing the rearrangement pathway, allow 
selective access to tetrahydropyran derivatives 83.
v r ^CFjS O jH R2,  ^ o ^ r , .
60
Nu'
83
-H+
Scheme 32. Possible Prins Reactions with Triflic Acid.
Triflic acid seemed ideally suited to this task, given the low nucleophilicity of the 
triflate anion. An ice-cold solution of acetal 60a in CH2CI2 was, therefore, treated 
with 1.5 equivalents of triflic acid, as shown in Scheme 33. Examination of the XH
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NMR spectrum of the crude product confirmed this hypothesis, showing aldehyde 
61a to be the dominant product and no evidence of the presence of pyran 62a.
Aldehyde 61a was obtained in good yield following chromatography, as well as a 
small amount of ketone 84a, presumably due to the reduced regioselectivity of 
acetal opening. As this constituted less than 10 % of the total product, the selectivity 
was deemed more than adequate, and the yield of 61a was more than double that 
obtained from the use of TiCI4.
Me
+
Me
84a
Scheme 33. Reagents and Conditions: (a) TfOH (1.6 equiv.), CH2CI2, 0 °C, 15 
min.
The possibility of favouring tetrahydropyran formation was tested by performing the 
reaction in a solution of acetonitrile, as shown in Scheme 34. This proved ineffective 
at suppressing rearrangement, as the major product evident in the 1H NMR spectrum 
obtained from the crude material was still aldehyde 61a. A minor product was 
apparent, however, in a ratio of 1:3 to aldehyde 61a, that appeared to fit the 
structure of pyran 79, although this was not isolated and characterised further due 
to the poor selectivity.
58a:80,
approx. 3:1
60a 61a 79
Scheme 34. Reagents and Conditions: (a) TfOH (2 equiv.), MeCN, 0 °C.
Pleased with the outcome of the first example, we synthesised two series of 
substrates in order to investigate further. Two additional acetals were added to the
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series derived from methyl substituted diol 74a, shown in Scheme 35, in order to 
obtain a more complete picture of the scope and limitations of the reaction.
OH OH
(a)
74a 60b, R = n-Bu, 88 % 
60d, R = f-Bu, 75 %
Scheme 35. Reagents and Conditions: (a) RCHO, PPTS, CH2CI2.
Rather than prepare a series of aryl substituted acetals from diol 74b, we chose to 
use diol 74c instead for simplicity. Acetal formation with the same five aldehydes 
provided all but the t-Bu substituted member of series 85a-e, shown in Scheme 36.
75%
72 73c
OH OH
(b)
8 4 %
74c 85a, R = Me, 71 % 
85b, R = n-Bu, 66 % 
85c, R = /-Bu, 66 % 
85d, R = f-Bu, 0 % 
85e, R = Ph, 42 %
Scheme 36. Reagents and Conditions: (a) i) LDA, THF, PhCOCI, -78 °C to r.t.;
(b) LiAIH4, THF; (c) RCHO, PTSA, CH2CI2/D M F (approx 10:1).
The remaining methyl substituted acetals, 60b-e, cyclised similarly to 60a, giving the 
results summarised in Table 2. Yields were reasonably good in most cases, with the 
exception of Entries 4 and 5. Acetal 60d was simply very slow to cyclise, this could 
likely be overcome by the use of a larger excess of triflic acid, which can be seen in 
Entries 1-3 to result in a large increase in rate. The aryl substituted acetal, 60e, on 
the other hand, cyclised extremely rapidly, the comparatively low yield apparently a 
result of product decomposition.
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R0 ^ 0  (a)
''Me
Me
+
60a-e 61a-e 84a-e
Entry Acetal R = TfOH (equiv.) Time (min) Yield 61 (%) Yield 84 (%)
1 60a Me 1.6 15 66 6
2 60b n-Bu 1.2 90 60 8
3 60c /'-Bu 1.1 90 53 7
4 60d t-Bu 1.1 240 l l a 5
5 60e Ph 1.5 5 42 trace
Table 2. Reagents and Conditions: (a) TfOH, CH2CI2, 0 °C to r.t. a25 % of 
starting material was recovered.
Cyclisation of the phenyl substituted acetals was also quite successful, the results are 
summarised in Table 3. Although the formation of minor by-products was observed 
in this series also, these were found to be the epimeric aldehydes 87. 
Regioselectivity of the initial acetal opening appears to be higher in this series, as 
none of the ketones found in the previous series were detected. This is perhaps due 
to increased steric hindrance from the larger phenyl substituent.
H+
85a-e 86a-e 87a-e
Entry Acetal R = TfOH (equiv.) Time (min) Yield 86 (%) Yield 87 (%)
1 85a Me 5 15 64 0
2 85a Me 1.1 60 50 8
3 85a Me 1.5 90 0 61
4 85b n-Bu 1.1 60 51 4
5 85c /-Bu 5 15 58 0
6 85e Ph 5 15 61 0
Table 3. Reagents and Conditions: TfOH, CH2CI2, 0 °C to r.t.
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Epimerisation was also noted to occur by El Sayed when Prins cyclisations of aryl 
substituted substrates with TiCU were allowed to warm to room temperature for 
extended periods of time. Isomerisation of aldehyde 61f to 8 8 f, shown in Scheme 37, 
for example, presumably occurs via ring opening of the heterocycle to give the 
stabilised benzylic carbocation 89.26 This was easily avoided in cyclisations catalysed 
by triflic acid by employing a fairly large excess of acid. Cyclisation then proceeded 
extremely rapidly allowing isolation of the kinetic products in good yield, as in Entries 
1,5  and 6 , for example.
Alternatively, the extended reaction time of Entry 3 allowed complete epimerisation 
of aldehyde 8 6 a, affording aldehyde 87a in good yield. This would presumably also 
be successful with the other alkyl substituted substrates, though this was not 
investigated. Acetal 85e was best cyclised under the conditions of Entry 6 , longer 
reaction times allowing decomposition of the product to occur.
(a)
60f
Me
61f
OTiCI
89
Me
88f, 25 %
Scheme 37. Reagents and Conditions: (a) TiCU, CH2CI2, -78 °C to r.t., 24 h.
2.3 Conclusion
The Prins desymmetrisation of chiral 2 ,5 -cyclohexadiene based acetals with TiCU was 
shown to allow access to several complex products with essentially complete 
diastereocontrol. Though such compounds may be valuable synthetic intermediates,
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the lack of control over reactivity resulted to low yields, limiting the utility of the 
method.
The cause of the low selectivity was determined to be due to competing 
rearrangement and quenching of the carbenium ion produced by the Prins 
cyclisation. By employing triflic acid instead, the carbenium ion is forced to undergo 
rearrangement resulting in the selective formation of tetrahydrofuran derivatives. 
The procedure developed was shown to be applicable to a range of substrates and is 
likely to be of use in the synthesis of complex molecules. Investigations into the 
synthesis of the cladiellin diterpene 7-deacetoxyalcyonin acetate 90, for example, 
have since been undertaken by our group.29
HO° Me
90
Fig. 3. 7-deacetoxyalcyonin acetate.
Although this requires that the two pairs of ring junction protons be onti, in contrast 
to the syn relationship obtained thus far, it was thought that this be achieved by 
incorportation of a tethering chain, such as in acetal 91, shown in Scheme 38. The 
resulting oxocarbenium ion would favour the near-attack conformation 92 over the 
alternative eclipsed conformation, thus generating the desired stereochemistry.
H CHO 
H
Scheme 38.
This was recently shown by a colleague to be the case, simply treating bis-silyl 
protected aldehyde 9 4  with triflic acid effected concomitant deprotection,
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oxocarbenium ion formation and Prins cyclisation, followed by rearrangement to 
aldehyde 93, as shown in Scheme 39.
OHC
HOTBDMSO
TBDMSO
32%
9294
H ..CHO
9395
Scheme 39. Reagents and Conditions: (a) TfOH (1 equiv.), CH2CI2, 0 °C to room 
temp.
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Chapter 3
lodocyclisation Reactions of 1,4- 
Cyclohexadienes
3.1 Introduction
The selective desymmetrisation of a diene in an iodocyclisation reaction was first 
reported by Kurth over 20 years ago. Cyclisation onto the y-position of substrate 96 
was found to be favoured by a factor of almost 150:1 over cyclisation onto the y'- 
position, as shown in Scheme 40. This group selectivity presumably results from  
repulsion between the methyl and iso-butene substituents in the transition state 
leading to compound 99 .30
Scheme 40. Reagents and Conditions: (a) l2/ CH2CI2/ sat. aq. NaHC03, 20 min.
Hart attempted a similar desymmetrisation of a cyclohexa-2,5-diene, as shown in 
Scheme 41, in an effort to prepare intermediate 102 enantioselectively, thereby 
achieving an asymmetric synthesis of pleurotin.31 The model substrates, 100a and 
100b, were found to cyclise with insufficient selectivity, however, and this aspect of 
the work was abandoned.
99
H
101a, 47 %, 30 % e.e. 
101b, 78%, 42% e.e.
O
100a, R1f R2 -  Me 
100b, R1 = H,
r 2 = c h 2oh
H
102
Scheme 41. Reagents and Conditions: (a) l2, THF, H20.
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PMP
50 112 51
19 % over
6 steps
52
O
Scheme 46. Reagents and Conditions: (a) NBS (2.1 equiv.), CH2CI2. PMP = 4- 
MeO-C6H4.
The acyclic diene 96 is the only substrate reported where the stereodirecting 
element is actually within the ring formed by cyclisation, as shown in Fig. 4. This 
clearly exerts far greater stereocontrol and suggests that iodocyclisation of 
cyclohexadienes such as 74, 116, and 121, shown in Scheme 47, may also occur with 
very high group selectivity.
Ph
100a, 1.9:1 100b, 2.5:1 107, approx. 4:1 103, 13:1
Fig. 4. Features of iodocyclisation substrates.
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Such substrates would be readily accessible by alkylation of ester 72 with acyl 
chlorides, epoxides or epoxide equivalents, allowing a detailed investigation into 
several modes of cyclisation.
74 C 02Me
n  H
113
72
R
s o 2i *
O
HO OH
118
Scheme 47. Examples of substrates accessible from ester 72.
3.2 Results and Discussion
Substrates 113 were studied in most detail, the products expected by competing 5- 
exo and 6 -endo processes are shown in Scheme 48.
,RiHO
OH
113
O  + 
7H
HO
H
114
Scheme 48. 5-exo /  6-endo iodocyclisations.
Diols 74 were available from the work on the Prins reactions discussed in Chapter 2, 
and would allow investigation into 5-endo cyclisations, as shown in Scheme 49.
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74a, R = Me 
74b, R = 2-Br-C6H4
Scheme 49. 5-endo iodocyclisations.
116a
116b
117a
117b
Another possibility is the alkylation of ester 72 with a cyclic sulfate, allowing 
cyclisation by 6 -exo and 1-endo pathways to be investigated, as shown in Scheme 50.
R R
HO
119118
Scheme 50. 6-exo /  7-endo cyclisations 
3.2.15-exo /  6-endo  Cyclisation Reactions
In order to test our hypothesis a suitable substrate was required, the n-Bu 
substituted diol 113b was chosen as a starting point. Alkylation of methyl 2,5- 
cyclohexadiene carboxylate with hexene oxide gave lactone 121b, as was reported to 
result from a similar alkylation by Kraus.38 This was easily reduced to the required 
substrate with LiAIH4, as shown in Scheme 51.
n-Bu
n-Bu
CO2M6
(a)
,m-Bu
86% 
2 steps
72 121b 113b
Scheme 51. Reagents and Conditions: (a) i) LDA, THF, -78 °C; ii) hexene oxide,
-78 °C to room temp.; (b) LiAIH4, THF.
Reaction of 113b with iodine and NaHC03 in acetonitrile for 1 h gave a crude 
material composed primarily of one compound. The purity of this was sufficient to
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allow the structure to be determined as that of 114b, shown in Scheme 52, by XH - 1H 
and *H - 13C correlation NMR spectroscopy. The stereochemistry of this product 
could not be determined from the NMR data generated, however, it was expected to 
be as shown based on examination of models of diol 113b. The minor product was 
not isolated due to the small quantity present, the structure and stereochemistry 
were assigned as that of 115b by analogy with later results.
n-Bu
65%
114b:115b
approx. 20:1
Scheme 52. Reagents and Conditions: (a) l2, NaHC03, MeCN, 1 h.
This regioselectivity can be explained by the model shown in Scheme 53; as 
suggested by Baldwin, the angle of attack required of the alcohol nucleophile for a 5- 
exo ring closure would appear to require a much less strained geometry than the 
competing 6-endo ring closure.39 The basis for the predicted stereochemistry can 
also be seen, as cyclisation onto one of the double bonds results in a destabilising 
interaction between the substituent and the cyclohexadiene ring. This is avoided by 
cyclisation onto the other double bond, which allows the substituent to occupy a 
pseudo-equatorial position in the new ring.
5-exo6-endo
tOH OH
113
OH
+
115
OH
Scheme 53. Origin of stereo- and regioselectivity.
As high diastereoselectivity is obviously possible by this method, with no minor 
diastereoisomers being observed, a series of related substrates were prepared in 
order to determine the scope and limitations of the reaction. Most of these 
additional substrates were prepared in the same manner, simply by varying the 
epoxide used in the alkylation step, as shown in Table 4.
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Alkylation of ester 72 with just 0.5 equivalents of unprotected glycidol gave a 
reasonable yield of lactone 121e (Entry 3), which was then reduced to triol 113e. 
Alkylation with vinylcyclohexane oxide and cyclohexene oxide (Entries 4 and 6 ) 
provided acceptable yields of diols 113f and 113i, respectively. The lactone isolated 
following alkylation with styrene oxide (Entry 5) was 121h, the product of epoxide 
opening at the benzylic position. Reduction to diol 113h therefore allowed the 
possibility of stereocontrol by a more distant stereogenic centre to be studied.
Ri
c ° 2Me /°  \  ? 2
A  *  ^ < ?  <a> ° A v R2 (b) h o A ' ' 1
( j  +    ( M )     | M )  o h
72 121a-i 113a' i
Entry Diol Ri = r 2 = Yield 121 (%) Yield 113 (%)
1 113a Me H - 87a
2 113b n-Bu H - 00 CD 01
3 113e CH2OH H 23 56
4 113f c-C6Hh H 55 91
5 113h H Ph 40 84
6 113i -(c h 2 4 “ 34 92
Table 4. Reagents and Conditions: (a) LDA, THF, -78 °C to room temp.; (b)
LiAIH4, THF.a Yield over 2 steps.
Diol 113a (Entry 1) was the unexpected product of reduction of lactone 121d with 
UAIH4, as shown in Scheme 54. Prevention of dehalogenation by the use of the 
minimum required amount of hydride and ice cooling was only moderately 
successful, and chromatographic separation of the products was fairly tedious. A 
method based on that reported by Chaveriat, with NaBH4 as the reductant, was 
eventually found to be much simpler.40
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H O ^ X ^ l  ^ 6  , (a)' (b) ? ° 2Me (a), (c^ H O ^ X >  'xCH2CI
(M| 0H 87% ( f j )  68% (M) OH
113a 72 113d
Scheme 54. Reagents and Conditions: (a) LDA, epichlorohydrin, THF, -78 °C to 
room temp.; (b) LiAIH4, THF; (c) NaBH4, EtOH.
Substrates 113c and 113g, shown in Scheme 55, were felt likely to be useful 
additions to the series, but were found to be difficult to obtain in the same manner. 
Alkylation with styrene oxide formed mostly lactone 121h rather than 121g, while 
the epoxide required to prepare lactone 121c was not commercially available and its 
synthesis was difficult due to its volatility.
Both diols were found to be very conveniently prepared by alkylation of ester 72 
with a-bromoketones, followed by reduction of keto-esters 122c and 122g as shown 
in Scheme 55. The apparent low yield obtained by reduction of keto-ester 122g was 
at least partly due to a spillage during its isolation.
Scheme 55. Reagents and Conditions: (a) LDA, THF, -78 °C to room temp.; (b)
LiAIH4, THF.
With a selection of substrates now in hand, we were pleased to find that all cyclised 
readily, with results similar to that obtained with diol 113b, as shown in Table 5. 
Isolated yields of the 5-exo cyclisation products were good to excellent; except in the 
case of Entry 3, the only significant byproducts observed in the *H NMR spectra of 
the crude material were the corresponding 6 -endo cyclisation products. 
Diastereoselectivity is, therefore, at least greater than the regioselectivity shown.
C02Me
Br
72 122c, R = f-Bu, 90 % 
122g, R = Ph, 87 %
113c, 57%  
113g, 35%
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Rc
HO'
OH
113a-i
(a) HO
114a-i
HO
+
115a-i
Entry Diol Ri = R2 = Base Time
(min)
Ratio
114:115
Yield 114 
(%)
Yield 115 
(%)
1 113a Me H NaHC03 30 11:1 66 6
2 113b n-Bu H Na2C03 60 20:1 65 -
3 113c t-Bu H NaHC03 1 >99:1 89 -
4 113d CH2CI H Na2C03 30 17 1 87 -
5 113e c h 2o h H NaHCOa 1 19 1 91 -
6 113f C-CgHn H Na2C03 30 30 1 44 -
7 113g Ph H Na2C 03 30 10 1 59 4
8 113h H Ph Na2C03 30 19 1 79 3
9 113i -(CH2)4- Na2C03 30 10 1 62 -
Table 5. Reagents and Conditions: (a) l2/ Base (see table), MeCN.
It should be noted that while the base used was mostly Na2C0 3 , NaHC03 was used in 
some cases to similar effect. Also, the reaction times given are not necessarily the 
minimum required, two cases (Entries 3 and 5) were analysed by tic after just one 
minute and found to already be complete.
As was found initially in the cyclisation of diol 113b (Entry 2), the stereochemistry of 
these additional 5-exo products was often also difficult to determine by NMR 
spectroscopy. Diagnostic cross-peaks were observed in the NOESY spectra of only 
two compounds, 114i and 114h, shown in Fig. 5, and a further two compounds, 114c 
and 114g, were crystalline solids suitable for stereochemical determination by X-ray 
diffraction, the results of which are shown in Fig. 6 .
OH
*1141
H OH
114h
Fig. 5. Stereochemical determination of 5-exo products.
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114g
C9 02
ce
C2 C l 2
C14
04 C13.Ol
03
Fig. 6. ORTEP plots of the crystal structures of compounds 114c and 114g. 
Thermal ellipsoids are drawn at the 50 % probability level.
All four compounds have the stereochemistry predicted by the model shown 
previously in Scheme 53; cyclisation occurs onto the alkene which allows the least 
hindered approach and results in the substituents occupying the pseuc/o-equatorial 
positions on the tetrahydrofuran ring. Since these four compounds cover the range 
of substitution patterns found in the remaining examples it is likely that these will 
also be of this stereochemistry.
It was a great relief to find that the stereochemistry of the minor products was 
comparatively straightforward to ascertain by NMR. Compound 115a, shown in Fig. 
7, showed a large trons-diaxial coupling from the proton indicated, therefore the 
methyl substituent must be equatorial. Compounds 115g, 115h and 115i gave 
diagnostic nOe's as indicated, all in support of the stereochemistry predicted.
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OH OH LOH
PhPhMe
'ax
115a 115g 115h 115i
- nOe
Fig. 7. Stereochemical determination of 6-endo products.
The regioselectivity of the cyclisations shown in Table 5 appears to correlate with the 
steric bulk of the substituents. Entries 1-3, for example, where Ri ranges from Me, 
through n-Bu to t-Bu, show the selectivity for 5-exo cyclisation to increase from 10:1 
to 20:1 to greater than 99:1. A possible explanation for this may be that by 
increasing the R-CHOH-C bond angle, strain between the substituent and the 
adjacent CH2 group can be reduced, as shown in Fig. 8 . This would simultaneously 
place the alcohol in closer proximity to the nearer end of the double bond, increasing 
both the relative probability and rate of the 5-exo cyclisation. Semi-empirical 
geometry optimisation at the MNDO level of theory gave the bond angles shown, 
supporting this theory, however, more definitive proof was not obtained.
OH OH
113a 113c
Fig. 8 . Effect of substituent size on computed bond angles.
The addition of a weak base prevents equilibration to the thermodynamic product, 
shown by Knight to occur via protonation of the ring heteroatom, as shown in 
Scheme 56.41
•"Bu
Ts
123 Kinetically
favouredThermodynamicallyfavoured
K2C 03
with base: 124:125, 7:93 
without base: 124:125, 100:0 Me
"Bu
i
Ts
124 125
Ts
Scheme 56.
We thought that, in our case, omission of the base and extenstion of the reaction 
time may affect the regiochemical outcome of the reaction. With most substrates a 
small shift in the product distribution was, indeed, observed, although this was often 
not to a useful extent. Cyclisation of diol 113a (Ri = Me, R2 = H) in this manner, for 
example, gave the two products 114a and 115a in a ratio of approximately 5:1 after 
20 hours.
Diol 1131, however, did show selectivity for formation of the 6 -endo product under 
these conditions, the ratio after 24 hours being approximately 8:1 in favour of 115i, 
as shown in Scheme 57. In this case, presumably, significant stabilisation can result 
from isomerisation to the trons-decalin system.
1131
H
1151, 57% 114i, not isolated
Scheme 57. Reagents and Conditions: (a) l2, MeCN, room temp., 24 h.
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3.2.2 5-endo Cyclisation Reactions
Cyclisation of alcohols 74a and 74b also yielded mixtures of two compounds, these 
were identified as the products of 5-endo cyclisation of both the primary and 
secondary alcohols, as shown in Scheme 58. While this was not unexpected, we were 
suprised to find that both products were formed as essentially single 
diastereoisomers.
Me. H
OH 72 %
116a:117a
7:1
O +
H H
74a 116a 117a
116b, 40% 117b, 32%
Scheme 58. Reagents and Conditions: l2, NaHC03, MeCN, room temp, 1 h.
The mechanism responsible for stereocontrol in the cyclisation of the primary 
alcohol is not clear, it seems highly unlikely to be due to direct interaction with the 
distant stereogenic centre. An indirect mechanism of transmission may be possible, 
for example, by group selective intramolecular iodonium ion formation followed by 
cyclisation of the primary alcohol, as shown in Scheme 59. A similar mechanism 
involving the intramolecular delivery of 'l+/ from an acyl hypoiodite was proposed by 
Bartlett42 to explain the unusual selectivity for formation of the 3,4-c/s isomer on 
iodocyclisation of some 3-substituted 4-pentenoic acids under kinetic conditions, a 
phenomena also noted by Kurth in the opening example of the chapter.30
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Scheme 59. Plausible mechanism of stereocontrol in 5-endo cyclisations.
The stereochemistry of compounds 116a and 116b was confirmed to be as predicted 
in Scheme 59 by the observation of the nOe's shown in Fig. 9. The XH NMR spectrum 
obtained from compound 116b also showed a relatively low chemical shift (6  4.63 
ppm) for one of the alkene protons, suggesting its close proximity to the aromatic 
ring. Assignment of the predicted stereochemistry of compounds 117a and 117b was 
not possible by NMR experiments due to the free rotation of the chiral side-chain.
Fig. 9. Determination of stereochemistry of 116a and 116b.
Regioselectivity in these examples appears to support the hypothesis proposed in 
the previous section, as the bulky aryl substituents reduced the extent of cyclisation 
through the secondary alcohol. Rather than cyclise in a 4-exo manner, however, 5- 
endo cyclisation of the primary alcohol appears to be preferable.
- nOe
116a 116b
3.2.3 6-endo /  7-exo  Cyclisation Reactions
Ester 72 was also alkylated with the cyclic sulfate ester 126, as shown in Scheme 60, 
allowing 6-exo /  1-endo cyclisations to be investigated.
Scheme 60. Reagents and Conditions: (a) LDA, THF, -78 °C to room temp.; (b)
LiAIH4, THF.
Cyclisation of diol 118 under the same conditions gave the 6 -exo and 7-endo 
products, 119 and 120, both as single diastereoisomers as shown in Scheme 61. The 
selectivity between the two pathways was lower than in the 5-exo /  6 -endo 
examples, as might be expected.
Scheme 61. Reagents and Conditions: l2, NaHC03, MeCN, room temp.
The stereochemistry of the tetrahydropyran 119 can be understood as arising from 
cyclisation onto the double bond that allows the methyl substituent to lie equatorial 
in the transition state. This was confirmed by observation of an n.O.e. between the 
CH next to iodine and one of the CH's next to oxygen on the tetrahydropyran ring. As 
this gave a large axial coupling to the CH with the attached methyl group, the methyl 
group must be equatorial. The stereochemistry of the 1-endo isomer 120 could not 
be proven but is presumably the same as the 6 -exo isomer.
Me Me
C02Me
48%
HO OH
72 126 127 118
Me Me
Me
118 119,41 %
H
120, 10%
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3.3 Conclusion
lodocyclisation reactions of cyclohexadienes containing one or more stereogenic 
centres in the tethering chain have been found to proceed with excellent 
diastereotopic group selectivity in all cyclisation modes investigated. The synthesis of 
these substrates is highly versatile and this reaction should, therefore, be useful in 
synthesis.43
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Chapter 4
Synthesis of Lycoposerramine Alkaloids
4.1 Introduction
The Lycopodium genus has revealed an abundance of alkaloids of wide functional 
variety yet based principally on one of the 16 carbon scaffolds shown in Fig. 10.44
NH
Me Me'T
15 HO
Me
Phlegmarine 128 Lycodine 129 Lycopodine 130 Fawcettimine 131
(Miscellaneous)
Fig. 10. Sub-groups of the Lycopodium alkaloids.
Lycopodine 130 was the first of the Lycopodium alkaloids to be isolated and identified. 
The class which takes its name is the most populous, containing just over a third of the 
currently known alkaloids.
The Lycodine class contains just over ten percent of Lycopodium alkaloids, some of 
which are active as acetylcholinesterase inhibitors. This is the only class currently 
known to contain such inhibitors.45
Fawcettimine 131 is the prototype of the second most abundant class, possibly derived 
from the Lycopodine class by migration of C4 from Ci3 to Ci2. It has been proposed that 
all of these alkaloids could be derived from phlegmarine 128, which could in turn be 
the product of coupling two 2 -propylpiperidine moieties, indicated by the dashed lines 
in Fig. 10.
4.2 Synthesis of Fawcettimine Class Compounds
We were most interested in synthesis of fawcettimine derivatives such as those shown 
in Fig. 11, as these compounds should be accessible through a Birch reduction, 
alkylation, desymmetrisation (BRAD) strategy.
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Me
NMe
lycoposerramine A 
132
lycoposerramine S
133
lycoposerramine B 
134
Me
pp— NMe Pl'— NMe
magellanine
135
paniculatine
136
serratinine
137
Fig. 11. Examples of fawcettimine type alkaloids.
4.2.1 Fawcettimine
Fawcettimine and 8 -deoxyserratinine were the first of the class to be synthesised, by 
Inubushi and coworkers, in 1980.46 The key step was a Diels-Alder reaction between 
the racemic cyclohexenone 138 and 1,3-butadiene, giving the [6 ,6 ]-bicyclic 
intermediate 139 with the correct stereochemistry, as shown in Scheme 62. A further 
19 steps were required in order to transform this into a mixture of epoxide 
diastereoisomers a-140 and P-140.
Epoxide a-140 was rearranged to the allylic alcohol and oxidised to enone 142. 
Hydrogenation and hydrolysis of the trifluoroacetamide group gave racemic 
fawcettimine in a total of 24 steps with 0.26 % overall yield. This was found to be 
identical to a authentic sample, proving the structure, although the stereochemistry at 
C4 remained uncertain since it is not clear which face of the enone would be preferred 
for hydrogenation.
Amide hydrolysis of p-140 allowed cyclisation of the free amine onto the epoxide. 
Oxidation to the diketone and selective reduction of the six membered ring ketone 
gave 8-deoxyserratinine 141 in a total of 23 steps with 0.28 % overall yield.
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Me
^  29% yield 
55%  
conversion
NCOCF
H H
Me
131
Fawcettimine
142
141
8-Deoxyserratinine
Scheme 62. Reagents and Conditions: (a) 140, butadiene, BF3.OEt2.
In 1986 Heathcock and coworkers reported a much more practical and elegant 
synthesis from a similar 2-alkyl-5-methylcyclohexeneone precursor, again allowing the 
methyl substituent to control the stereochemistry of the subsequent 
transformations.47 Fawcettimine was obtained in 10 steps and 9 % overall yield from 
enone 143. This was later optimised further, the sequence described below giving 17 % 
overall yield though also in 10  steps.
The methyl substituent of enone 143 allowed a stereoselective Sakurai reaction with 
allylsilane 144, as shown in Scheme 63, oxidation of the product providing aldehyde 
145 in near-quantitative yield. A Horner-Wadsworth-Emmons reaction then allowed 
formation of the bicyclic hydrindanone core by an intramolecular Michael reaction. 
The 1,4-addition product 147 is favoured under Baldwin's rules, being a 5-exo-trig 
cyclisation. The alternative 1,6-addition would be a 5-endo-trig cyclisation.
Saponification of ester 147 followed by Arndt-Eistert homologation of the resulting 
acid provided the remaining carbon atom of the nine-membered ring. Reduction with 
LiAIH4 in ether at -110 °C gave amino-diol 149 as the major diastereoisomer of a 9:1 
mixture of alcohol isomers. Selective tosylation of both the amine and primary alcohol 
then allowed cyclisation of 6 /s-tosylate 150, forming the nine-membered ring in good 
yield, as shown in Scheme 64.
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Me
CN
143
(a), (b)
CHO
94 - 97 %
CN
145
(c)
90%
CQ2Et
CN
146
Me3Si
Me3SiO
144
Me,,
C 0 2Et
147
Scheme 63. Reagents and Conditions: (a) 144, TiCI4, CH2CI2; (b) Cr03, pyridine;
(c) ethyl trimethylphosphonoacetate, NaOEt, EtOH, DMF.
Sodium naphthalenide effected deprotection of sulfonamide 151 without reduction of 
the double bond, as shown in Scheme 65. Oxidation of the secondary alcohol with 
chromium trioxide in 80 % aqueous acetic acid gave compound 152, which was found 
to exist almost entirely in the keto-amine form.
Me/,
(a), (b) 
5 3 %
Me/,
C 0 2Et
(c)
Me,,
95%
C 02Me
OH
151 Ts
6 9%
OH
TsHN OTs
150
Scheme 64. Reagents and Conditions: (a) NaOH, EtOH, H20; (b) i) (COCI)2, 
benzene; ii) CH2N2; iii) PhC02Ag, Et3N, MeOH; (c) LiAIH4, ether; (d) Ts20, DMAP, 
CH2CI2; (e) Bu4NOH, benzene.
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Fawcettimine exists mostly in the hemi-aminal form, suggesting this intermediate to 
be the C4 epimer of fawcettimine. Ozonolysis of the perchlorate salt of 152 allowed 
spontaneous isomerisation at the C4 position, and the synthetic fawcettimine thus 
obtained was found to be identical to the natural material. Further confiramtion of the 
Q-stereochemistry was provided by x-ray crystallography.
(a), (b) Me''-
82%
OH
151 Ts 152
HO
Me90%
131
Scheme 65. Reagents and Conditions: (a) Na, naphthalene, DME; (b) Cr03,
HOAc; (c) i) HCI04; ii) 0 3; iii) NaHC03.
The first asymmetric synthesis was recently published by Toste, starting from the same 
enone precursor 138 used by Inubushi. This was prepared as a single enantiomer by a 
Robinson annulation catalysed by the chiral proline derived base 155, as shown in 
Scheme 6 6 .48
OC(CH3)3
OTMS
155
Scheme 66. Reagents and Conditions: (a) i) 10 mol % 155, neat, 60 h, 0 °C; ii)
TsOH, toluene, reflux. Ar = 3,5-(CF3)2C6H3.
Conjugate addition of allenyltributylstannane gave the trans-silyl enol ether 156 with 
high selectivity (> 95:5 d.r.). lodination of the alkyne then set the stage for the key 
gold(l) catalysed 5 -endo-dig cyclisation of the silyl enol ether onto the alkyne, 
completing the [6,5]-bicyclic core, as shown in Scheme 67.
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Me,,
(a), (b)
H
(c) Me/'.
69%
157
Me,,
OTBDMS 
156
Scheme 67. Reagents and Conditions: (a) allenyltributylstannane, TBDMSOTf,
CH2CI2; (b) NIS, AgN03/ DMF; (c) 10 mol % (PPh3)AuCI; AgBF4; CH2CI2 /  MeOH.
Following protection of the ketone, the remaining three carbon atoms and nitrogen 
atom of the nine-membered ring were introduced by a palladium catalysed cross­
coupling of 157 with the product of hydroboration of N-Boc allylamine. Hydroboration 
/  oxidation of the terminal alkene then gave alcohol 158, which was converted to the 
iodide allowing closure of the nine-membered ring with potassium tert-butoxide, 
shown in Scheme 68.
157
(d), (e)
74% 60%
158 NH2 NHBoc
Scheme 68. Reagents and Conditions: (a) (CH2OH)2, TsOH, benzene, reflux; (b) 
i) CH2=CHCH2NHBoc, 9-BBN; ii) [PdCI2(dppf)], AsPh3, Cs2C03, DMF; (c) BH3; (d)
PPh3, l2, imidazole, CH2CI2; (e) t-BuOK, THF.
To complete the synthesis, the ketal protecting group of 159 was removed and the 
remaining ketone introduced by hydroboration and a two step oxidation. Removal of 
the Boc protecting group then gave (+)-fawcettimine ((+)-131).
A formal asymmetric synthesis was published shortly after by Liu and Chau.49 They 
synthesised (/?)-2 -iodo-5 -methylcyclohexenone 161 as a single enantiomer from (/?)- 
pulegone, as shown in Scheme 70. This was converted into Heathcock's cyano-enone 
143 by an intermolecular radical conjugate addition to acrylonitrile.
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Me,, (a ) - (c )
8 4 %  
10:1 d.r.
(d)
8 3%
(+V131« 9  Boc
X = -0 (C H 2)20 -
Scheme 69. Reagents and Conditions: (a) PPTS; acetone /  water; (b) i) BH3.THF,
THF; ii) NaOH, H20 2; (c) Dess-Martin periodinane, DCM; (d) TFA; CH2CI2.
Conjugate addition of a protected acetylenic Grignard reagent to 143 followed by 
enolate iodination gave compound 162, allowing formation of the five-membered ring 
by an intramolecular 5-exo-dig radical cyclisation onto the alkyne. Removal of the silyl 
group and a two step allylic oxidation of 163 enabled the conjugate addition of the silyl 
enol ether of methyl acetate to give 164. Presumably this could be converted into (+)- 
fawcettimine in a similar manner to Heathcock's intermediate.
TMS
(b), (c)
I 70 % CN 78 % CN
O
(R)-143 162
(d), (e) 
50%
CNCN
164
O
Scheme 70. Reagents and Conditions: (a) acrylonitrile, Bu3SnH, AIBN, PhH; (b) 
4-trimethylsilylbut-3-ynyl chloride, Mg, Cul, TMSCI, HMPA, THF; (c) Nal, 
mCPBA, THF; (d) Bu3SnH, AIBN, PhH, slow addition; (e) TFA, CH2CI2.
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4.2.2 Magellanine
Magellanine 135 is probably the only other alkaloid in this class to have received so 
much synthetic attention. The first total synthesis by Overman yielded magellanine 
and magellaninone 165 in 25 and 26 steps, respectively, from the single enantiomer 
cyclobutanone 166 shown in Scheme 71.50
Protected keto-alcohol 168 was prepared from 166 by a five step sequence involving a 
Baeyer-Villiger reaction to open the four membered ring. Iodide 167 was prepared 
from the same precursor in 27 % yield over three rather lengthy steps. Addition of the 
vinyllithium generated from 167 to ketone 168, followed by deprotection gave diol 
169. This was protected as the bis-silyl ether, the primary protected alcohol oxidised by 
a Swern reaction and the resulting aldehyde converted into the dimethyl acetal 170 in 
preparation for the key Prins-Pinacol sequence.
H H
r K  3sleps. 1-^dS
27%
°  H H
166 167
5 steps
PH
(a), (b)
71 %
OTBDPS HO
168 169
PTES H(c), (d)
72%
MeO
Scheme 71. Reagents and Conditions: (a) i) 167, t-BuLi, Et20 , -110 °C; ii) 168; (b)
TBAF, THF; (c) Et3SiCI, DMAP, imidazole, CH2CI2; (d) i) Swern oxidation; ii) 
(MeO)3CH, PPTS, CH2CI2.
Prins cyclisation of acetal 170 by treatment with TiC^ in CH2CI2 gave compound 171, 
with the stereochemistry predicted to result from attack on the oxonium ion by the 
outer face of the bicyclic alkene, as shown in Scheme 72. The product was, however,
Me
NMe
magellaninone
165
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found to consist of a 2:1 mixture of epimers of the adjacent ether. This mixture was 
taken through a further 12  steps to give magellanine 135 at which point the minor 
epimer was separated and oxidised to magellaninone 165.
pTES H
MeO
OMe
(a)
57%
170 171
H
OMe
""" 
I
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^
I
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v \  H MeO I ) < / MeO
"V jH
H V H v  _
Scheme 72. Reagents and Conditions: (a) TiCI4, CH2CI2, -78 °C to -20 °C.
There have since been a number of other synthetic approaches to magellanine and the 
structurally-related natural product paniculatine.51
4.2.3 Lycoposerramine A
Synthetic studies on Lycoposerramine A 132 have so far not been reported. This 
compound contains a novel oxadiazolidinone ring system and is so far the only natural 
product found to contain this motif. We decided to first concentrate on this ring 
system, choosing compound 172, shown in Scheme 73, as an initial target. The 
quaternary stereocenter and 6,5-bicyclic system make a desymmetrisation an ideal 
strategy for its synthesis.
Me
OTBDMS OTBDMSNMe
132 172
Scheme 73. Retrosynthesis of Lycoposerramine A.
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4.3 Initial Approach to Key Fragment 172
We had planned to construct the the hydrindanone core of 172 by a radical cyclisation 
of chloride 173, reported by El Sayed to afford compound 174 in moderate yield and 
with good diastereocontrol.26
TBDMSQ
.OTBDMSTBDMSO OTBDMS
46%  
83 % d.e.
173
Scheme 74. Reagents and Conditions: (a) Bu3SnH, AIBN, PhH, reflux, 30 h.
While attempting to optimise this reaction, however, we discovered that 173 could 
also be cyclised under strongly basic conditions. Treatment with n-BuLi, as shown in 
Scheme 75, afforded 1,3-diene 175 as a single diastereoisomer in almost quantitative 
yield. This was proposed to occur by cyclisation of an intermediate cyclohexadienyl 
anion onto the alkyl chloride, comparable to the initial diastereoselective protonation 
step of Landais' protonation-hydroamination sequence described in Chapter 1, Page 
11. We were unable to determine the configuration of the secondary silyl ether, 
although it was expected to be as indicated, based on modelling of the transition state.
H TBDMSO i  TBDMSQ 
TBDMSO r L d  C l X / x H  /
OTBDMS OTBDMS
OTBDMS
173 175
Scheme 75. Reagents and Conditions: (a) n-BuLi (1.1 equiv.), THF, -78 °C to 
room temp., 1 h.
Given the many advantages of this method over the radical cyclisation, we began to 
consider possible routes to target 172 through this intermediate instead. While the 
additional double-bond was expected to complicate matters, a sequence involving 
cycloaddition onto a similar 1,3-diene, reported by Shibasaki, suggested it may, in fact, 
prove beneficial.
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Reaction of diene 176, shown in Scheme 76, with photochemically-generated singlet 
oxygen, provided endoperoxide 177 as a single diastereoisomer. Treatment with base 
initiated rearrangement to two regioisomeric y-hydroxyenones, 178 and 179, the 
former being favoured by a factor of 4.3:1 .52
176 177 178 179
Scheme 76. Reagents and Conditions: (a) 0 2, hv, Rose Bengal, /'-PrOH; (b) Et3N, 
CH2CI2.
A similar outcome from application of this sequence to diene 175 would also, 
therefore, allow rapid access to the cores of the serratinine type alkaloids, while 
alcohol deoxygenation and conjugate addition would furnish our initial target, ketone 
172.
Irradiation of a solution of 175 and a catalytic amount of Rose Bengal in isopropanol, 
bubbled with a stream of dry oxygen, afforded a 2:1  mixture of endoperoxide 
diastereoisomers in high yield. The major isomer 180 was presumed to result from 
cycloaddition to the outer face of the bicyclic system, although the stereochemistry 
was not proven.
,OTBDMS
+
OTBDMSOTBDMS
180, 53 %
OTBDMS
175
Scheme 77. Reagents and Conditions: (a) 0 2, Rose Bengal, hv, /'-PrOH.
While the selectivity of cycloaddition with 175 was lower than in Shibasaki's example, 
Kornblum-DeLaMare rearrangement of the crude endoperoxide mixture showed no 
evidence of minor regioisomers. Unfortunately, however, the products were found to 
be the undesired isomers 182 and 183, shown in Scheme 78. It seems that the large,
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though more distant, CH2OBn group of endoperoxide 177 is more effective in 
obstructing the approach of the base than the quaternary center.
.OTBDMS
OTBDMS
175
(a)
OTBDMS
OHOTBDMSHO
182,37%  183,25%
Scheme 78. Reagents and Conditions: (a) i) 0 2/ Rose Bengal, hv, /-PrOH; ii) Et3N,
/-PrOH, room temp., 48 h.
As we now required the complete reduction of the ketone, we began investigating the 
various methods known to achieve this. The Huang-Minlon modification of the Wolff- 
Kishner reaction failed to yield any product, as did the milder tosylhydrazone reduction 
with both NaBH4 and LiAIH4.53 Many attempted thioketal formations with various acid 
catalysts and dithiol derivatives, such as b/s-trimethylsilylethanedithiol,54 also failed, 
presumably due to the acid sensitivity of the silyl protecting groups. Many of these 
attempts were also performed with the saturated ketone 184, obtained by the 
hydrogenation of enone 182 as shown in Scheme 79, although also without success.
OTBDMS
91 % HO
OTBDMS
184
H O H OTBDMS 
182
Scheme 79. Reagents and Conditions: (a) NH4C02H, Pd/C, EtOH, reflux, 1 h.
It was finally found that reaction of enone 182 and ethanedithiol with Me2AICI, at 0 °C, 
with frequent monitoring by tic, gave a material that appeared to be a thioacetal of 
some form. The complicated NMR spectrum obtained may be due to the formation of 
a mixture of monomeric and dimeric conjugate addition products, although this was 
not investigated and the material simply treated with freshly prepared Raney nickel in 
EtOH and heated to reflux overnight. Chromatography of the crude product resulted in 
the isolation of a substance tentatively assigned as 186, shown in Scheme 80, based 
the limited data obtained. As this result could not be reproduced, however, we chose 
to abandon this approach.
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,OTBDMS
OTBDMSHO
182
OTBDMS
OTBDMS
185
(b)
20% HO
OTBDMS
186
Scheme 80. Reagents and Conditions: (a) HS(CH2)2SH, M e2AICI, CH2CI2, 0 °C, 1 h;
(b) Raney Ni, EtOH, reflux, 18 h.
Another option would be to oxidise to the dienone and then attempt the selective 
reduction of the less hindered carbonyl group, although this was not investigated. We 
turned our attention instead to alternative reactions of the endoperoxides. Reaction 
with a good nucleophile, for instance, is reported to occur by attack on the weak 0 - 0  
bond, and should, therefore, result in alkylation of the less hindered oxygen atom, 
leaving the other free for oxidation to the enone.55 Reaction of peroxide 180 with BnLi 
or simply n-BuLi, as shown in Scheme 81, however, was extremely slow and no 
identifiable products could be observed.
(a) or (b)
BnO
OH OTBDMS
187
OTBDMS
180
Scheme 81. Reagents and Conditions: (a) i) BnBr, BuLi, THF, -78 °C, 30 min; ii)
180, THF, -78 °C to r.t., 24 h; (b) BuLi, THF, -78 °C to room temp., 24 h.
Attack on the peroxide by LiAIH4, on the other hand, was extremely rapid, as shown in 
Scheme 82, and the prospects for selective formation of a tosylate or xanthate from 
the expected product, diol 188, seemed reasonable. This plan was scuppered when the 
product was found to be the triol 189 resulting from deprotection of the primary silyl 
ether. This was not considered a useful intermediate due to the number of additional 
steps expected to be required.
Attempts to circumvent this side-reaction by the use of milder reducing agents were 
unsuccessful; sodium borohydride was unreactive towards endoperoxide 180, while 
the use of lithium triethylborohydride resulted in its complete destruction. The use of
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a bulkier/more robust protecting group for the primary alcohol would provide a likely 
solution, and may also aid in discrimination between the two alcohols.
Scheme 82. Reagents and Conditions: (a) LiAIH4, THF, room temp., 1 h 30.
4.4 Conclusion
The Lycopodium group of alkaloids is comprised of many widely varied, complex 
structures, with high potential medicinal value yet limited natural availability. As such, 
they present important and challenging targets for total synthesis.
Following a review of the synthesis of the fawcettimine group of alkaloids, we outline 
our strategy for accessing a key bicyclic intermediate to the tetracyclic core of 
lycoposerramine A by a desymmetrising radical cyclisation.
A novel alternative cyclisation was discovered, however, allowing access to a similar 
intermediate, though with far greater efficiency and simplicity. Many unsuccessful 
attempts were made to employ this intermediate, and we eventually chose to 
abandon this approach and return to the original plan, the results of which are 
discussed in the following chapter.
^OTBDMS %nOTBDMS xNOTBDMS
OTBDMS OH OTBDMS OH OTBDMS
180 188 189
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Chapter 5
Revised Approach to the Synthesis of 
Lycoposerramine A
5.1 Radical Cyclisation Approach
Finding ourselves unable to derive any of the benefits from the anionic cyclisation we 
chose to return to the radical cyclisation, expecting the product to be more amenable 
to appropriate functionalisation. Compound 174, shown in Scheme 83, was obtained 
by El Sayed in reasonable yield and with good d.e., presumably favouring the 
diastereoisomer indicated, although this was not proven.26
TBDMSQ
OTBDMSTBDMSO OTBDMS
46%  
83 % d.e.
174
Scheme 83. Reagents and Conditions: (a) Bu3SnH, AIBN, PhH, reflux, 30 h.
After establishing conditions for completion of the sequence from 174 to the key 
intermediate 172, we determined that protection of the secondary alcohol should be 
unnecessary, as this removes the need for differential protection and a deprotection 
step, mono-silyl ether 190 was prepared and cyclised as shown in Scheme 84. While 
the diastereoselectivity was slightly reduced in the absence of the bulky protecting 
group, the two isomers were now separable by chromatography, and the major isomer 
191 was obtained in good yield.
HQOTBDMS OHOH OTBDMS TBDMSO
OHOH
76%
113d 190 191,48% 192,19%
Scheme 84. Reagents and Conditions: (a) TBDMSCI, imidazole, DCM; (b) 
Bu3SnH, AIBN, PhH, 16 h.
5.2 Functionalisation of the Cyclohexene Ring
Conversion of 191 into the required enone was now straightforward by the three step 
sequence shown in Scheme 85. Reaction with mCPBA provided a mixture of epoxide 
diastereoisomers 193 and 194, in an approximate ratio of 7:1. As these stereocentres
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are lost in the following steps, separation of these isomers was not attempted.56 
Epoxide opening with the phenylselenyl anion, followed by selenoxide elimination 
gave allylic alcohol 195 in good yield.57 Finally, selective oxidation of the allylic alcohol 
with Mn02 afforded enone 196.58
PH
OTBDMS
191
96 % H 
193:194
approx. 7:1
OTBDMS OTBDMS
193 194
77%
PH
HO OTBDMS
195
PH
97%
OTBDMS
196
Scheme 85. Reagents and Conditions: (a) mCPBA, NaHC03, CH2CI2, (b) i) PhSeNa 
EtOH, ii) H20 2/ THF, (c) M n 0 2, CH2CI2.
Introduction of the methyl substituent by conjugate addition to enone 196 was 
attempted firstly with MeLi/CuCN at -78 °C, as shown in Scheme 86. As no reaction 
was observed even on warming to room temperature, the mixture was re-cooled to 
0 °C and treated with BF3.OEt2.59 The *H NMR spectrum of the resulting crude material 
showed it to consist of a mixture of diastereoisomeric addition products, later proven 
to be 197 and 198, in an approximate ratio of 2:3.
jT \ 197:198
O OTBDMS approx. 2:3 OTBDMSOTBDMS
196 197 198
Scheme 86. Reagents and Conditions: (a) i) MeLi (2.4 equiv.), CuCN (1.2 equiv.),
THF, -78 8C, 5 min; ii) 196, -78 °C to room temp., 1 h; iii) BF3.OEt2, 0 °C, 30 min.
Use of Me3AI/Cu(OTf)2 in toluene, however, favoured the formation of compound 197 
over 198 by a factor of approximately 3:1, as shown in Scheme 87. While the major
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product of this reaction was thought to be the desired diastereoisomer, due to the 
large axial coupling observed between the CHMe and one of the CH2C=0 protons 
indicated, this was later realised to be inconclusive as the minor isomer could also 
adopt a conformation that would show a similar coupling. Only by proceeding with this 
mixture of isomers could the stereochemical assignments of 197 and 198 be confirmed 
to be as indicated.
,OH
(a)
81 %
OTBDMS 197:198 
approx. 3:1
Me
Me
OTBDMS OTBDMS
196 197 198
OH
Me
OTBDMS
Scheme 87. Reagents and Conditions: (a) Me3AI (3 equiv.), Cu(OTf)2 (0.1 equiv.), 
toluene, 0 °C to room temp., 8 h.
Although we did not attempt further optimisation of this result, a similar system has 
recently been reported by Mukai to undergo a highly diastereoselective conjugate 
addition reaction, as shown in Scheme 88.60
jOMOM.OMOM
200:ep/-200
97:3
NMeNMe
200199
Scheme 88. Reagents and Conditions: (a) i) MeLi, CuCN, Et20, 0 °C, 15 min; ii)
199, TMEDA, -40 °C, 12 h.
The formation of compound 200, an intermediate in the synthesis of magellanine and 
paniculatine, was found to be favoured by a factor of 97:3 over its C25-epimer under
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these conditions. The addition of TMEDA presumably serves to activate the mixed 
cuprate, a strategy which may also prove more successful in our case, as the use of 
BF3.0 Et2 or MesSiCI can affect the stereoselectivity of the reaction.
5.3 Attempted Construction of the Oxadiazolidinone Ring
With key intermediate 197 now in hand we turned our attention to construction of the 
oxadiazolidinone ring system. It was initially envisaged that a Mitsunobu reaction with 
a suitably protected hydroxylamine derivative, followed by deprotection, would allow 
cyclisation onto the ketone to give nitrone 201, as shown in Scheme 89. 1,3-Dipolar 
cycloaddition of a suitable isocyanate would then allow access to a derivative of the 
target compound 202.
RN,
Me Me Me
OTBDMS OTBDMS OTBDMS197 201
Me
OTBDMS
202
Scheme 89. Proposed route to oxadiazolidinone ring.
Construction of a model, however, suggested that nitrone 201 would experience 
significant strain as a result of the bridgehead alkene, and that it was, therefore, 
unlikely to be a suitable intermediate. As the cycloaddition of an isocyanate to a 
nitrone is the only reported means of accessing this heterocyclic system, we faced 
quite a challenge in devising an alternative.
Nevertheless, we conceived of a plausible solution involving a hydroxylamine with 
orthogonal carbamate and carbonate protecting groups. Following formation of an 
imine from ketone 203 for instance, deprotection of the base-labile carbamate would 
allow cyclisation of the free hydroxylamine nitrogen onto the imine, which could, in
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turn, cyclise onto the carbonate protecting group with loss of an alcohol, as shown in 
Scheme 90.
R02C0
FmocN*^ FmocN:
r o 2c o
-'Fmoc'
OTBDMS OTBDMS
Me
RO ) OTBDMS203
-ROH
Me
R OTBDMS
Scheme 90. Proposed alternative cyclisation mechanism.
A range of suitably protected hydroxylamines were prepared in order to test this 
hypothesis.61 Schotten-Baumen reaction of A/-Fmoc hydroxylamine 20462 with methyl 
chloroformate, Boc anhydride and phenylchloroformate, as shown in Scheme 91, 
furnished hydroxylamines 206, 207 and 208 in good yields. Also prepared was the Boc 
carbamate 209, by reaction of N-Boc hydroxylamine 205 with Boc anhydride.
HN-OH
(a)
204 206, R = Me, 73 %
207, R = f-Bu, 94 %
208, R = Ph, 63 %
205
O
209, R = Me, 82 %
Scheme 91. Reagents and Conditions: (a) ROCOCI (1.0 equiv.), 1:1 THF /  EtOAc : 
saturated aqueous NaHC03, 0 °C to room temp., 16 h.
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Mitsunobu reaction of 197 with just 1.1 equivalents each of hydroxylamine 206, DIAD 
and PPh3 gave the deired product 210, although in only low yield and with 26 % 
recovered starting material. By use of 1.7 equivalents each of 208, DIAD and PPh3 the 
yield of 211 was marginally improved, while the Boc carbamate 212 was obtained in 
high yield by reaction with 2.0 equivalents of 209 and 1.5 equivalents each of DIAD and 
PPh3. The low yields of Fmoc carbamates may be due to the slightly basic nature of the 
reaction mixture.
Scheme 92. Reagents and Conditions: (a) 206, 208 or 209, DIAD, PPh3, DCM,
30 - 60 min.
The NMR spectra obtained from these compounds showed very broad signals, 
presumably due to restricted carbamate bond rotation, and could not be assigned; as 
such, the spectra are included with the experimental details.
We were delighted to find the product obtained by treatment of 211 with DBU, as 
shown in Scheme 93, to be the tetracyclic dioxazolidinone 213. Since the conformation 
of the cyclohexane ring is locked in this compound, we were also now able to confirm 
the methyl group stereochemistry by observation of a large trons-diaxial coupling 
between the methine proton indicated and an adjcaent methylene proton.
R-i = Fmoc:
210, R2 = Me, 27 %
211, R2 = Ph, 34 %Me
(a) O\
Me Ri = Boc:
212, R2 = Me, 78 %OTBDMS197 OTBDMS
\ ;—^ 
FmocN.^ H
OPh
O r------
Me
(a)
Me
35% 'O
OTBDMSOTBDMS 12.4 Hz
211 213
Scheme 93. Reagents and Conditions: (a) DBU (2.8 equiv.), THF, room temp., 
lh .
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The spectral data obtained from compound 213 were in close agreement with those 
obtained from the natural product, and are summarised in Table 6.
NMe
■ • i s .
132
Cym'O 
11 OTBDMS
213
Lycoposerramine A 132 Compound 213
Position 6 h 6C 6h 6C
4 1.61 (br. s) 52.1 1.64 (d, 11.8) 37.8 or 37.1
2.04-1.96 (m)
5 3.66 (d, 4.3) 69.4 3.73-3.70 (m) 65.4
6 1.84 (m) 30.4 1.94 (ddd, 13.6,11.8, 4.1) 30.8
1.28 (dd, 13.1, 4.6) 1.40 (dt, 13.6, 3.8)
7 2.06 (m) 35.1 2.37 (dq, 11.5, 3.8) 34.3
8 1.02 (ddd, 13.1, 3.4) 31.8 1.24 (ddd, 14.1,12.4, 3.8) 32.3
1.42 (m) 1.48 (br. d, 14.1)
12 53.1 54.1
13 88.6 106.6
14 1.20 (dd, 12.7,12.7) 40.5 1.54 (t, 13.5) 37.8 or 37.1
1.84 (m) 2.04-1.96 (m)
15 1.93 (m) 22.6 2.04-1.96 (m) 23.6
16 0.91 (d, 6.4) 21.4 0.98 (d, 6.4) 21.3
18 157.0 154.1
Table 6. 1H and 13C NMR data of lycoposerramine A 132 and compound 213 in
CDCI3.
Given this result, we were optimistic that the target oxadiazolidinone ring system 
would be accessible by imine formation from the ketone of 211. Unfortunately, 
however, we were unable to achieve this, despite many attempts under various 
conditions. The reason for this is not clear, as the formation of imine 215 from the 
simplified model compound 214, shown in Scheme 94, appeared to be successful, as 
was the formation of oxime 215 under the conditions reported by Takayama.63
73
70%
OTBDMS
196
OTBDMS
(c)
OH
OTBDMSHO
216
Scheme 94. Reagents and Conditions: (a) H2, Pd/C, EtOH /  EtOAc (1:2), 4 h; (b) 
allylamine (3 equiv.), Me3AI, CH2CI2, 16 h; (c) NH2OH.HCI (1.2 equiv.), NaOAc (2 
equiv.), EtOH, reflux, 16 h.
5.4 Conclusion
The desymmetrising free radical cyclisation of 190 enabled access to an analog of our 
initial target 172. Mitsunobu reactions of 197 with protected hydroxylamine derivates 
then allowed the formation of the dioxazolidinone analog 213 of the core of 
lycoposerramine A in a novel cascade cyclisation.
Although imine formation would potentially allow oxadiazolidinone derivatives 202 to 
be prepared by this method, we were unable to achieve this with hydroxylamines 210- 
212. It may be possible to introduce the protected hydroxylamine subsequent to imine 
formation, however this was not investigated.
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Chapter 6
Studies Towards the Synthesis of 
Lycoposerramine S
6.1 Introduction
We began to consider the possibility of accessing the tricyclic pyrrolidine core of 
lycoposerramine S 13364 by a similar strategy, shown in Scheme 95. Although amine 
217 should be easily prepared from alcohol 197, cyclisation by an intramolecular 
reductive amination was not expected to be successful due to the requirement for the 
formation of a bridgehead imine.
PH
RH
Me Me Me
OTBDMS OTBDMS
NMe133 217 197
Cl
> Me'
OR'
219
RHI
Me
OR1
218
Scheme 95. Retrosynthesis of lycoposerramine S.
Cyclisation onto an alkene such as 218 would more likely be effective, but provides no 
simple opportunity to introduce the methyl group. We chose, therefore, to begin with 
the Birch reduction of p-toluic acid and accept the poor selectivity expected to result 
from alkylation of ester 2 2 0 .38
6.2 Results and Discussion
Lactone 221 was, indeed, obtained as nearly a 1:1 mixture of diastereoisomers by 
alkylation of 220 with epichlorohydrin, as shown in Scheme 96. As these were 
inseparable by tic, the crude mixture was reduced with NaBH4, allowing diols 222  and 
223 to be separated by careful chromatography. As we were unable to determine 
which was which, the first, slightly larger, fraction was chosen and protected as the 
TBDPS ether 224. Radical cyclisation, as shown in Scheme 97, resulted in a mixture of 
diastereoisomers 225 and 226, readily separable by chromatography.
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OH
OH OHHO
Me
220
Me
221
Me
222, 37 %
(c)
81 %
Me 
223, 31 %
TBDPSO
Scheme 96. Reagents and Conditions: (a) i) LDA, THF, -78 °C; ii) epichlorohydrin,
-78 °C to room temp.; (b) i) NaBH4, EtOH, ii) chromatography; (c) TBDPSCI, 
imidazole, DCM.
The major isomer 225 showed an nOe between the protons indicated, confirming the 
methyl group stereochemistry to be as required. The stereochemistry of the secondary 
alcohol was assumed to be as indicated and was, again, not possible to determine by 
nOe experiments.
TBDPSO
*OH
(a)
'C l
PH PH
+ MeMe
OTBDPS OTBDPS
226, 23 %225, 52 %
- nOe
Scheme 97. Reagents and Conditions: (a) Bu3SnH, AIBN, PhH, reflux, 16 h.
Introduction of the secondary amine was achieved by a Mitsunobu reaction of alcohol 
225 with phthalimide, followed by deprotection with hydrazine giving the free amine 
228, as shown in Scheme 98.
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NPhth NH
Me' Me'
72% 94%
OTBDPS OTBDPS OTBDPS
Me'
225 227 228
Scheme 98. Reagents and Conditions: (a) Phthalimide, PPh3/ DIAD, DCM, (b) 
N2H2.H20 , EtOH, reflux.
Although direct cyclisation of 228 in a hydroamination reaction would complete the 
tricyclic core in a single step, the silyl protecting group would be incompatible with the 
strong acids generally required. The use of a strong base or a transition metal catalyst 
is a possibility, but this was not investigated. An attempt was made at cyclisation by an 
aminomercuration reaction, as shown in Scheme 99, without success.
NH
Me'
OTBDPS
228
Me
OTBDPS
229
Scheme 99. Reagents and Conditions: (a) i) Hg(OAc)2, NaHC03, THF/H20, 16 h; 
ii) NaBH4.
Amine 228 was, therefore, protected as the 4-nitrobenzenesulfonamide 230, shown in 
Scheme 100, which underwent successful iodocyclisation to afford compound 231 in 
excellent yield. We were unable to remove dehalogenate this compound, however, 
and attempted deprotection of the nosyl group also failed.
NHNs
NslMeMe Me
93% 91 %
OTBDPS OTBDPSOTBDPS
228 230 231
Scheme 100. Reagents and Conditions: (a) 4 -N 02C6H4S02CI, Et3N, CH2CI2; (b) l2, 
NaHC03, MeCN.
Protection of amine 228 as the tosylate, followed by iodocyclisation, as shown in 
Scheme 101, finally allowed both dehalogenation and deprotection of 233, furnishing 
the target compound 229.
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NH NHTs
Me Me Me
84% 69%
OTBDPS OTBDPS OTBDPS
228 232 233
Me Me
82%
OTBDPS OTBDPS
229 234
Scheme 101. Reagents and Conditions: (a) TsCI, Et3N, CH2CI2; (b) l2/ NaHC03/ 
MeCN; (c) Bu3SnH, AIBN, PhH, reflux; (d) Na, naphthalene, THF, -78 °C.
15 HN,
Me
NMe9
15 HN,
Me
14 13 121
11 OTBDPS
229
Lycoposerramine S 133 Compound 229
Position 6 h 6c 6 h 6c
4 1.57 (m) 50.5 1.55 (d, 9.3) 44.9
1.71 (dt, 9.3, 2.2)
5 3.00 (br. s) 60.2 3.29 (br. s) 56.0
6 1.34 (m) 35.6 1.35 (dt, 12.3, 3.4) 38.2
1.75 (m) 1.85 (td, 12.3, 2.8)
7 1.94 (m) 35.0 2.11-2.05 (m) 34.1
8 1.05 (td, 13.0, 3.2) 33.0 0.98-0.88 (m) 33.3
1.43 (m) 1.45 (br. d, 13.7)
12 49.5 49.8
13 2.97 (br. s) 59.0 3.22 (br. s) 55.2
14 1.69 (m) 33.7 1.62 (br. d, 14.3) 34.6
1.00 (td, 12.2, 2.7) 0.98-0.88 (m)
15 1.87 (m) 20.7 1.86-1.75 (m) 19.7
16 0.88 (d, 6.4) 22.1 0.85 (dd, 6.5) 21.9
Table 7. *H and 13C NMR data of lycoposerramine S (133) and compound 229 in
CDCI3.
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The NMR data obtained from compound 22 9  show  many similarities with those of the 
natural product, as shown in Table 7 and Figures 12 and 13 .65
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Fig. 12. *H NMR Spectrum of Compound 2 2 9  in CDCI3.
Fig. 1 3 .1H NMR Spectrum of lycoposerramine S (133) in CDCI3.
6.3 The Azonane Ring
Completing the synthesis of these alkaloids v ia  th is  strategy requires a means by which 
to form the remaining 9-m em bered ring. W e  decided  to investigate the possibility of 
achieving this by alkylation of ketone 235, o b ta in e d  by oxidation of alcohol 191, as 
shown in Scheme 102.
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pH PTBDMSO TBDMSO TBDMSO
/H81 % 76%
191 235 236
Scheme 102. Reagents and Conditions: (a) PDC, CH2CI2, 16 h; (b) i) LDA, THF,
-78 °C; ii) allyl iodide, -78 °C to room temp., 16 h.
We were not surprised to find that alkylation of this compound with allyl iodide gave 
the wrong regioisomer 236, and thought this problem may be overcome by a different 
choice of protecting group, hopefully allowing enolate formation to be controlled. 
Ketone 237 was prepared, as shown in Scheme 103, however this did not change the 
regioselectivity of alkylation, which gave compound 238.
.0 OTBDMSO MOMO MOMO
7 H
6 7 % 4 7 %
237 238191
Scheme 103. Reagents and Conditions: (a) i) TBAF, THF, 30 min; ii) MOM-CI,
DIPEA, CH2CI2, 16 h; (b) i) LDA, THF, -78 °C; ii) allyl bromide, -78 °C to room 
temp., 16 h.
It may be simpler to introduce this fragment at an earlier point in the synthesis, Arndt- 
Eistert homologation of acid 239, prepared by the procedure reported by El-Sayed,26 
gave ester 240. This could presumably be alkylated and transformed into chloride 243, 
where the additional 3-carbon chain would be expected to reinforce the directing 
effect of the alcohol, allowing radical cyclisation to proceed with higher selectivity. 
There was insufficient time for this to be investigated, however.
81
TBDMSO.
239 240 241
OTBDMS
OH TBDMSO TBDMSO.
CHO
244 243 242
Scheme 104. Reagents and Conditions: (a) i) Me02CCI, Et3N, THF, 30 min; ii)
CH2N2; iii) Ag02CC6H5, MeOH, reflux.
6.4 Conclusion
The tricyclic core of lycoposerramine S was synthesized via a route involving a 
desymmetrising free radical cyclisation. Completion of the synthesis requires a means 
for forming the 9-membered azonane ring. An enolate alkylation strategy was 
investigated briefly, without success, and an alternative strategy proposed which we 
were unable to investigate.
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Chapter 7
Experimental Details
7.1 General Experimental Points
Melting points were determined on a Gallenkamp melting point apparatus and are 
uncorrected. Infrared spectra were recorded on a Perkin Elmer 1600 FTIR 
spectrophotometer. Mass spectra were recorded on a Fisons VG Platform II 
spectrometer and on a Micromass Q-TOF Micro spectrometer. NMR spectra were 
recorded on a Bruker DPX 400 spectrometer operating at 400 MHz for *H and at 100 
MHz for 13C at 25 °C, or on a Bruker Avance 500 spectrometer operating at 500 MHz 
for *H and 125 MHz for 13C at 25 °C. All chemical shifts are reported in ppm downfield 
from TMS, or relative to residual CHCI3. Coupling constants (7) are reported in Hz. 
Multiplicity in *H-NMR is reported as singlet (s), doublet (d), double doublet (dd), 
double triplet (dt), double quartet (dq), triplet (t), and multiplet (m). Multiplicity in 
13C-NMR was obtained using the DEPT pulse sequence. All NMR spectra were obtained 
in CDCI3, unless otherwise noted. Flash chromatography was performed using Matrex 
silica 60 35-70 micron.
Solvents for moisture sensitive reactions were dried by distillation; THF, benzene and 
toluene from sodium benzophenone ketal and CH2CI2 from CaH2. Such reactions were 
conducted under an atmosphere of dry nitrogen.
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7.2 Experimental Data for Chapter 2
Methyl l-(2-Bromobenzoyl)cyclohexa-2,5-dienecarboxylate (73b)
. .  O BrC02Me
73b72
2.5 M n-BuLi (4.4 mL, 11 mmol, 1.1 equiv.) was added to DPA (1.5 mL, 10.7 mmol, 1.0 
equiv.) at 0 °C. After stirring for 30 min, the resulting gel was dissolved in THF (10 mL) 
and cooled to -78 °C. A solution of methyl cyclohexa-2,5-diene-l-carboxylate 72 (1.5 g, 
10.8 mmol) in THF (5 mL) was added and the stirring was continued for another 30 
min. 2-Bromobenzoyl chloride (2.38 g, 10.8 mmol, 1.0 equiv.) was then added as a 
solution in THF (5 mL) and the reaction mixture was stirred for 1 h at -78 °C, then at 
room temperature for 18 h. 2 M aqueous HCI (50 mL) was added, the organic layer 
separated and the aqueous phase extracted with Et20  (2 x 20 mL). The combined 
organic extracts were dried over Na2S04 and concentrated in vacuo. The residue was 
purified by chromatography on silica (14%  EtOAc in hexane) to afford the title 
compound (2.98 g, 86  %) as a yellow solid, m.p. 43 - 45 °C; vmax (neat) 3051, 2952, 
2882, 1741, 1705, 1433, 1286, 1231, 1052, 922, 737 cm'1; 6 H (400 MHz) 7.49 (1 H, d, J 
7.4, aromatic CH), 7 .24 -7 .14  (3 H, m, 3 x aromatic CH), 6.03 (2 H, br. d, J 10.2, 2 x 
alkene CH), 5.93 (2 H, br. d, J 10.2, 2 x alkene CH), 3.78 (3 H, s, CH30), 2.63 (1 H, br. d, J 
23.5, one of ring CH2) and 2.45 (1 H, br. d, J 23.5, one of ring CH2); 6 c (100 MHz) 200.4 
(C), 170.4 (C), 170.4 (C), 140.7 (C), 133.0 (CH), 130.7 (CH), 128.6 (2 x CH), 127.2 (CH),
126.5 (CH), 122.6 (2 x CH), 118.7 (C), 62.7 (C), 53.0 (CH3) and 26.1 (CH2).
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l-(2-Bromophenyl)-(l-(hydroxymethyl)cyclohexa-2,5-dienyl)methanol (74b)
OH Br
HO
73b
A solution of methyl l-(2-bromobenzoyl)cyclohexa-2/5-dienecarboxylate 73b (2.98 g,
9.8 mmol) in THF (10 mL) was added to a stirred suspension of LiAIH4 (1.1 g, 28.9 
mmol, 3.0 equiv.) in THF (20 mL). After stirring for 1 h the reaction was quenched with 
2 M aqueous NaOH, dried over Na2S04 and concentrated in vacuo. The residue was 
chromatographed on silica (33 % EtOAc in hexane) to give the title compound (1.90 g, 
66  %) as a colourless viscous oil; vmax (neat) 3374, 3025, 2878, 2814, 1469, 1435, 1020 
and 749 cm'1; 6 H (400 MHz) 7.44 (1 H, dd, J 1 3 ,  1.8, aromatic CH), 7.41 (1 H, dd, J 8.0,
1.1, aromatic CH), 7 .24-7 .18  (1 H, m, aromatic CH), 7.03 (1 H, app. td, J 7.6, 1.7, 
aromatic CH), 6.00 (1 H, app. dtd, J 10.3, 3.3, 1.6, one of alkene CH), 5.83 (1 H, app. dq, 
J 10.3, 2.0, one of alkene CH), 5.77 (1 H, app. dtd, J 10.3, 3.3, 1.5, one of alkene CH),
5.56 (1 H, app. dq, J 10.3, 2.0, one of alkene CH), 5.21 (1 H, s, CHOH), 3.79 (1 H, d, J 
10.5, one of Ctf2OH), 3.49 (1 H, d, J 10.5, one of CH2OH), 2.49 (1 H, app. dtt, J 23.1, 3.6,
1.8, one of CH2) and 2.25 (1 H, app. double quintet, J 23.1, 2.7, one of CH2). 6 C (100 
MHz) 139.9 (C), 132.3 (CH), 130.2 (CH), 129.6 (CH), 129.0 (CH), 128.5 (CH), 126.9 (CH),
125.8 (CH), 125.4 (CH), 123.9 (C), 76.3 (CH), 69.2 (CH2), 48.8 (C) and 26.7 (CH2).
(l-(Hydroxymethyl)cyclohexa-2,5-dienyl)phenylmethanol (74c)
O OH
72 73c 74c
2.5 M n-BuLi was added to a cooled (-78 °C) solution of DPA (6.1 mL, 43.5 mmol, 1.0 
equiv.) in THF (20 mL). This was allowed to warm to room temperature and recooled 
to -78 °C. A solution of ester 72 (6.0 g, 43.5 mmol) in THF (4 mL) was added slowly and 
stirring continued for 30 min. A solution of benzoyl chloride (5.1 mL, 43.5 mmol, 1.0
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equiv.) in THF (5 mL) was added slowly and the reaction allowed to warm to room 
temperature. Saturated aqueous NH4CI (30 mL) was added, the organic layer separated 
and the aqueous phase extracted with Et20  (2 x 15 mL). The combined organic extracts 
were dried over Na2S04  and concentrated in vacuo. The residue was purified by 
Kugelrohr distillation (oven temp. 200 °C at 0.5 mm Hg) to give the keto-ester 73c (7.9 
g, 75 %) as a pale yellow oil.
This was added as a solution in THF (20 mL) to a suspension of LiAIH4 (2.5 g, 65 mmol, 2 
equiv.) in THF (60 mL). After stirring for 30 min the reaction was quenched with 2 M 
aqueous NaOH, dried over Na2S04 and concentrated in vacuo. The residue was purified 
by chromatography on silica (30 - 50 % EtOAc in petroleum ether) giving the title 
compound (5.89 g, 84 %) as a viscous, pale yellow oil. vmax (CH2CI2) 3362, 3027, 2876, 
1453, 1022 and 700 cm'1; 6 H (500MHz) 7.30 - 7.15 (5 H ,m ,5 x  aromatic CH), 5.93 (1 H, 
dtd, J 10.2, 3.3, 1.6, one of alkene CH), 5.81 (1 H, dtd, J 10.2, 3.3, 1.6, one of alkene 
CH), 5.67 (1 H, dq, J 10.2, 2.0, one of alkene CH), 5.41 (1 H, dq, J 10.2, 2.0, one of 
alkene CH), 4.59 (1 H, s, PhCH), 3.51 (1 H, d, J 10.5, one of CH2OH), 3.41 (1 H, d, J 10.5, 
one of CH2OH), 2.80 - 2.60 (1 H, br. s, OH), 2.50 (1 H, dtt, J 23.0, 3.5, 1.8, one of CH2), 
2.34 (1 H, dtt, J 23.0, 3.0, 2.4, one of CH2) and 2.25 - 2.00 (1 H, br. s, OH); 6 C (125 MHz)
140.4 (C), 128.9 (CH), 128.3 (CH), 127.6 (2 x CH), 127.5 (2 x CH), 127.5 (CH), 126.5 (CH),
126.1 (CH), 78.9 (CH), 6 8 .6  (CH2), 47.5 (C) and 26.8 (CH2).
l-(l-(Hydroxymethyl)cyclohexa-2,5-dienyl)ethanol (74a)
Me
72
HO'
74a
To a solution of DPA (2.0 mL, 14.3 mmol, 1.0 equiv.) in THF (50 mL) at -78 °C was added
2.5 M n-BuLi (5.7 mL, 14.3 mmol, 1.0 equiv.). After stirring for 30 min a solution of 
methyl cyclohexa-2 ,5 -diene-l-carboxylate 72 (2.0 g, 14.5 mmol) in THF (10 mL) was 
added and stirring was continued for another 30 min. Acetyl chloride (1.1 mL, 15.5 
mmol, 1.1 equiv.) was added and the reaction mixture was stirred for 1 h at -78 °C,
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then at room temperature for 18 h. Saturated NH4CI solution (50 mL) was added, the 
organic layer separated and the aqueous phase extracted with Et20 (2 x 20 mL). The 
combined organic extracts were dried over Na2S04 and concentrated in vacuo to give 
the crude keto-ester 73a (3.3 g) as an orange oil.
This was dissolved in THF (10 mL) and added to a stirred suspension of LiAIH4 (1.5 g,
39.5 mmol, 2.7 equiv.) in THF (30 mL). After stirring for 1 h, the reaction was quenched 
with 2 M NaOH, dried over Na2S04 and filtered. The filtrate was concentrated in vacuo 
and the residue chromatographed on silica (33 % EtOAc in hexane) to give the title 
compound (1.50 g, 67 %) as a colourless solid, m.p. 50 - 52 °C; vmax (CH2CI2) 3394, 3022, 
2973, 2879,1635,1421, 1372, 1130, 1025, 904 cm '1; 5H (400 MHz) 5.99 (1 H, m, one of 
alkene CH), 5.88 (1 H, m, one of alkene CH), 5.68 (1 H, app. dd, J 10.3, 2.0, one of 
alkene CH), 5.36 (1 H, app. dd, J 10.3, 2.0, one of alkene CH), 3.75 (1 H, q, J 6.4, OVOH), 
3.58 (1 H, d, J 10.5, one of CH2OH), 3.50 (1 H, d, J 10.5, one of CH2OH), 2.70 - 2.56 (2 H, 
m, CH2), 2.52 (2 H, br. s, 2 x OH) and 1.04 (3 H, d, J 6.4 Hz, CH3); 6C (100 MHz) 128.4 
(CH), 127.9 (CH), 127.0 (CH), 125.5 (CH), 72.9 (CH), 69.6 (CH2), 46.7 (C), 27.2 (CH2) and
19.1 (CH3).
l,3-Dimethyl-2,4-dioxaspiro(5.5)undeca-7,10-diene (60a)
Me
To a solution of l-(l-(hydroxymethyl)cyclohexa-2,5-dienyl)ethanol 74a (440 mg, 2.9 
mmol) and acetaldehyde (3.2 mL , 57.1 mmol, 20 equiv.) in CH2CI2 (20 mL) was added 
PPTS (500 mg, 2.0 mmol, 0.43 equiv.). After stirring for 18 h the reaction was quenched 
with water (20 mL), the organic layer separated and the aqueous phase extracted with 
CH2CI2 (2 x 10 mL). The combined organic extracts were dried over Na2S04 and 
concentrated in vacuo. The residue was purified by chromatography on silica (5 % Et20  
in petroleum ether) to give the title compound (444 mg, 85 %) as a colourless oil; vmax
74a 60a
88
(neat) 2981, 2844, 1454,1410, 1378, 1320,1234,1147, 956, 868 and 703 cm'1; 6H (400 
MHz) 6.04 - 5.96 (1 H, m, one of alkene CH), 5.89 - 5.77 (2 H, m, 2 x alkene CH),
5.09 - 5.01 (1 H, m, one of alkene CH), 4.70 (1 H, q, J 5.0, CH02), 3.65 (1 H, d, J 11.0, 
one of CH20), 3.52 (1 H, q, J 6.3, CH3CHO), 3.45 (1 H, d, J 11.0, one of CH20), 2.64 - 2.57 
(2 H, m, ring CH2), 1.30 (3 H, d, J 5.0, CH3) and 1.00 (3 H, d, J 6.3, CH3); 6C (100 MHz)
128.7 (CH), 126.6 (CH), 126.2 (CH), 125.3 (CH), 99.3 (CH), 79.2 (CH), 76.1 (CH2), 39.7 (C),
27.4 (CH2), 21.1 (CH3) and 16.9 (CH3).
3-Butyl-l-methyl-2,4-dioxaspiro[5.5]undeca-7,10-diene (60b)
n-Bu
OH OH O ^ O
74a 60b
To a solution of l-(l-(hydroxymethyl)cyclohexa-2/5-dienyl)-ethanol 74a (385 mg, 2.5 
mmol) and valeraldehyde (1.3 ml_, 12.5 mmol, 5 equiv.) in CH2CI2 (20 mL) was added 
PPTS (126 mg, 0.5 mmol, 0.2 equiv.). After stirring for 18 h the reaction was quenched 
with water (20 mL) and the organic layer separated. The aqueous phase was extracted 
with CH2CI2 (2 x 10 mL) and the combined organic extracts dried over Na2S0 4 and 
concentrated in vacuo. The residue was purified by chromatography on silica (5 % Et20  
in petroleum ether) to give the title compound (488 mg, 88 %) as a colourless oil. vmax 
(neat) 2956, 2860, 1455, 1410, 1376, 1146, 1022, 748 and 704 cm 1; 6H (400 MHz) 6.06 
(1 H, app. dq, J 10.3, 1.9, one of alkene CH), 5.90 (2 H, m, 2 x alkene CH), 5.12 (1 H, 
app. dq, J 11.0, 2.0, one of alkene CH), 4.60 (1 H, t, J 5.1, CH02), 3.73 (1 H, d, J 11.0, one 
of CH20), 3.57 (1 H, q, J 6.4, CHO), 3 .51(1  H, d, J 11.0, one of CH20), 2.70-2.65 (2 H, m, 
ring CH2), 1.69 - 1.63 (2 H, m, CH2CH02), 1.45 -1 .30  (4 H, m, alkyl CH2), 1.06 (3 H, d, J
6.4, CHOCH3) and 0.90 (3 H, t, J 7.2, CH2CH3); 6C (125 MHz) 128.6 (CH), 126.7 (CH),
126.4 (CH), 125.1 (CH), 102.5 (CH), 79.2 (CH), 76.2 (CH2), 39.9 (C), 34.7 (CH2), 27.4 
(CH2), 26.1 (CH2), 22.6 (CH2), 16.9 (CH3) and 14.0 (CH3).
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3-lsobutyl-l-methyl-2,4-dioxaspiro(5.5)undeca-7,10-diene (60c)
/'- Bu
OH OH
Me
74a 60c
To a solution of l-(l-(hydroxymethyl)cyclohexa-2,5-dienyl)-ethanol 74a (413 mg, 2.7 
mmol) and isovaleraldehyde (1.4 mL, 13.4 mmol, 5 equiv.) in CH2CI2 (20 mL) was added 
PPTS (135 mg, 0.54 mmol, 0.2 equiv.). After stirring for 18 h the reaction was quenched 
with water (20 mL) and the organic layer separated. The aqueous phase was extracted 
with CH2CI2 (2 x 10 mL) and the combined organic extracts dried over Na2S04 and 
concentrated in vacuo. The residue was purified by chromatography on silica (5 % Et20  
in petroleum ether) to give the title compound (518 mg, 87 %) as a colourless oil; vmax 
(neat) 3017, 2954, 2869,1454, 1410, 1375, 1261, 1099, 800 cm"1; 6H (400 MHz) 5.99 (1 
H, app. dd, J 10.4, 1.7, one of alkene CH), 5.87 - 5.78 (2 H, m, 2 x alkene CH), 5.05 (1 H, 
app. dd, J 10.4, 1.8, one of alkene CH), 4.58 (1 H, t, J 5.4, CH02), 3.66 (1 H, d, J 11.0, one 
of CH20), 3.50 (1 H, q, J 6.4, CH3CHO), 3.45 (1 H, d, J 11.0, one of CH20), 2.70 - 2.53 (2 
H, m, ring CH2), 1.76 (1 H, app. nonet, J 6.8, CH(CH3)2), 1.55 - 1.39 (2 H, m, 
CH2CH(CH3)2), 0.99 (3 H, d, J 6.4, CH3) and 0.85 (6 H, app. d, J 6.6, 2 x CH3); 6C (100 
MHz) 128.6 (CH), 126.7 (CH), 126.3 (CH), 125.2 (CH), 101.5 (CH), 79.3 (CH), 76.2 (CH2),
43.7 (CH2), 39.9 (C), 27.4 (CH2), 23.9 (CH), 23.0 (CH3), 22.7 (CH3) and 16.9 (CH3).
3-tert-Butyl-l-methyl-2,4-dioxaspiro[5.5]undeca-7,10-diene (60d)
f-Bu
To a solution of l-(l-(hydroxymethyl)cyclohexa-2,5-dienyl)-ethanol 74a (268 mg, 1.7 
mmol) and pivalaldehyde (0.95 mL, 8.7 mmol, 5 equiv.) in CH2CI2 (20 mL) was added
74a 60d
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PPTS (87 mg, 0.35 mmol, 0.2 equiv.). After stirring for 18 h the reaction was quenched 
with water (20 mL) and the organic layer separated. The aqueous phase was extracted 
with CH2CI2 (2 x 10 mL) and the combined organic extracts dried over Na2S04 and 
concentrated in vocuo. The residue was purified by chromatography on silica (5 -1 0 0  % 
Et20  in petroleum ether) to give the title compound (269 mg, 71 %) as a colourless oil; 
Vmax (neat) 2958, 2839, 1484, 1454, 1404, 1382, 1361, 1214, 1163, 1135, 1098, 1045, 
1022, 990, 942, 746 and 704 cm'1; 6H (400 MHz) 6.01 (1 H, app. dq, J 10.3, 2.0, one of 
alkene CH), 5.87 (2 H, m, 2 x alkene CH), 5.11 (1 H, app. dq, J 10.3, 2.0, one of alkene 
CH), 4.18 (1 H, s, CH02), 3.73 (1 H, d, J 10.8, one of CHzO), 3.52 (1 H, q, J 6.5, CHO), 3.48 
(1 H, d, J 10.8, one of CH20), 2.70 - 2.64 (2 H, m, ring CH2), 1.02 (3 H, d, J 6.5, CH3) and 
0.93 (9 H, s, C(CH 3)b); 6 c (125 MHz) 128.3 (CH), 127.0 (CH), 126.6 (CH), 124.8 (CH),
107.6 (CH), 79.0 (CH), 76.2 (CH2), 40.0 (C), 34.9 (C), 27.4 (CH2), 24.7 (CH3) and 16.9 
(CH3).
(l/?S,3SK)-l-Methyl-3-phenyl-2,4-dioxaspiro(5.5)undeca-7,10-diene (60e)
To a solution of l-(l-(hydroxymethyl)cyclohexa-2,5-dienyl)ethanol 74a (408 mg, 2.6 
mmol) and benzaldehyde (1.35 mL, 13.2 mmol, 5 equiv.) in CH2CI2 (20 mL) was added 
PPTS (132 mg, 0.53 mmol, 0.2 equiv.). After stirring for 18 h the reaction mixture was 
quenched with water (20 mL) and the organic layer separated. The aqueous phase was 
extracted with CH2CI2 (2 x 10 mL) and the combined organic extracts dried over Na2S04 
and concentrated in vacuo. The residue was purified by chromatography on silica (5 % 
Et20  in petroleum ether) to give the title compound (575 mg, 90 %) as a colourless oil; 
Vmax (neat) 3033, 2978, 2840,1452, 1400, 1373, 1161, 1132, 1087,1021, 970, 746 cm"1; 
6h (400 MHz) 7.47 - 7.43 (2 H, m, 2 x aromatic CH), 7.33 - 7.23 (3 H, m, 3 x aromatic 
CH), 6.14 (1 H, app. dq, J 10.4, 2.0, one of alkene CH), 5.91 - 5.83 (2 H, m, 2 x alkene 
CH), 5.50 (1 H, s, ArCHO), 5.12 (1 H, app. dq, J 10.4, 2.0, one of alkene CH), 3.83 (1 H, d,
Ph
74a 60e
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J 11.0, one of CH20), 3.74 (1 H, q, J 6.4, CH3CHO), 3.66 (1 H, d, J 11.0, one of CH20), 
2.72 - 2.56 (2 H, m, ring CH2) and 1.07 (3 H, d, J 6.4, CH3); 6C (100 MHz) 138.6 (C), 129.0 
(CH), 128.9 (CH), 128.4 (2 x CH), 126.6 (CH), 126.3 (2 x CH), 126.2 (CH), 125.4 (CH), 
102.0 (CH), 80.0 (CH), 76.6 (CH2), 39.9 (C), 27.5 (CH2) and 17.0 (CH3).
(lS/?,3Sfi)-l-(2-Bromophenyl)-3-methyl-2,4-dioxaspiro(5.5)undeca-7,10-diene (60f)
Me
OH OH Br O ^ O  Br
74b 60f
To a solution of l-(2-bromophenyl)-(l-(hydroxymethyl)-cyclohexa-2/5-dienyl)methanol 
74b (808 mg, 2.73 mmol) and acetaldehyde (5.0 mL, 89.4 mmol, 33 equiv.) in CH2CI2 
(20 mL) was added PPTS (0.5 g, 2.0 mmol, 0.7 equiv.). After stirring for 48 h the 
reaction was quenched with water (20 mL) and the organic layer separated. The 
aqueous phase was extracted with CH2CI2 (2 x 10 mL), the combined organic extracts 
dried over Na2S04 and concentrated in vacuo. The residue was purified by 
chromatography on silica (5 % Et20  in petroleum ether) to afford the title compound 
(667 mg, 76%) as an off-white solid, m.p. 52 - 54 °C; vmax (CH2CI2) 3025, 2991, 2858, 
2360, 1698, 1474, 1410, 1162, 1117, 1032, 911 cm'1; 6H (400 MHz) 7.37 (2 H, m, 2 x 
aromatic CH), 7.20 - 7.14 (1 H, m, aromatic CH), 7.01 (1 H, app. td, J 7.6, 1.8, aromatic 
CH), 6.21 (1 H, app. dq, J 10.3, 2.0 Hz, one of alkene CH), 5 .74-5 .68  (1 H, m, one of 
alkene CH), 5.65 - 5.59 (1 H, m, one of alkene CH), 5.48 (1 H, app. dq, J 10.1, 2.0, one of 
alkene CH), 5.08 (1 H, s, CHAr), 4.94 (1 H, q, J 5.0, CH3CHO), 3.81 (1 H, d, J 11.0, one of 
CH20), 3.76 (1 H, d, J 11.0, one of CH20), 2.34 (1 H, app. dtt, J 22.8, 3.7, 1.8, one of ring 
CH2), 1.90 (1 H, app. double quintet, J 22.8, 2.6, one of ring CH2) and 1.38 (3 H, d, J 5.0, 
CH3CHO); 6c (100 MHz) 137.3 (C), 131.9 (CH), 130.9 (CH), 128.9 (CH), 128.5 (CH), 126.4 
(CH), 126.4 (CH), 126.3 (CH), 125.3 (CH), 123.6 (C), 100.2 (CH), 83.7 (CH), 76.5 (CH2),
42.1 (C), 26.8 (CH2) and 21.1 (CH3) ppm.
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(lS/?,3S/?)-l-(2-Bromophenyl)-3-isobutyl-2,4-dioxaspiro(5.5)undeca-7,10-diene (60g)
i-Bu
60g74b
A solution of l-(2-bromophenyl)-(l-(hydroxymethyl)cyclohexa-2,5-dienyl)methanol 
74b (758 mg, 2.6 mmol) isovaleraldehyde (2.7 mL, 25.7 mmol, 10 equiv.) and PPTS (0.5 
g, 2.0 mmol, 0.8 equiv.) in CH2CI2 (20 mL) was stirred for 48 h. The reaction was 
quenched with water (20 mL), the organic layer separated and the aqueous phase 
extracted with CH2CI2 (2 x 10 mL) The combined organic extracts were dried over 
Na2S04 and concentrated in vacuo. The residue was chromatographed on silica (5 % 
Et20  in petroleum ether) to give the title compound (644 mg, 69 %) as a colourless oil; 
vmax (neat) 3026, 2956, 2923, 2854, 1467, 1439, 1362, 1260, 1128, 1017 and 804 cm"1; 
6h (400 MHz) 7.38 (1 H, dd, J 8.0, 1.1 Hz, aromatic CH), 7.36 (1 H, dd, J 7.8, 1.8, 
aromatic CH), 7.19 - 7.14 (1 H, m, aromatic CH), 7.00 (1 H, app. td, J 7.6, 1.8 Hz, 
aromatic CH), 6.19 (1 H, app. dq, J 10.4, 1.9, one of alkene CH), 5.72 - 5.67 (1 H, m, one 
of alkene CH), 5.65 - 5.59 (1 H, m, one of alkene CH), 5.49 (1 H, app. dq, J 10.2,1.9, one 
of alkene CH), 5.05 (1 H, s, ArCH), 4.82 (1 H, t, J 5.4, CHO), 3.81 (1 H, d, J 11.0, one of 
CH20), 3.74 (1 H, d, J 11.0, one of CH20), 2.35 (1 H, app. dtt, J 22.9, 3.7, 1.9, one of ring 
CH2), 1.89 (1 H, app. doubled quintet, J 22.9, 2.7, one of ring CH2), 1.80 (1 H, app. 
nonet, J 6.7, CH(CH3)2), 1.64 -1 .48  (2 H, m, CW2CH(CH3)2), 0.88 (3 H, d, J 6.7, CH3) and 
0.86 (3 H, d, J 6.7, CH3); 6C (100 MHz) 137.5 (C), 131.9 (CH), 131.0 (CH), 128.9 (CH),
128.4 (CH), 126.4 (CH), 126.3 (CH), 126.3 (CH), 125.4 (CH), 123.5 (C), 102.2 (CH), 83.8 
(CH), 76.5 (CH2), 43.7 (CH2), 42.1 (C), 26.8 (CH2), 23.8 (CH), 23.2 (CH3) and 22.8 (CH3).
93
(15/?,3S/?)-l-(2-Bromophenyl)-3-phenyl-2,4-dioxaspiro(5.5)undeca-7,10-diene (60h)
Ph
OH OH Br OA O Br
74b 60h
To a solution of l-(2-bromophenyl)-(l-(hydroxymethyl)cyclohexa-2/5-dienyl)methanol 
74b (1.0 g, 3.4 mmol) and benzaldehyde (3.5 mL, 34 mmol, 10 equiv.) in CH2CI2 (20 mL) 
was added PPTS (0.5 g, 2.0 mmol, 0.6 equiv.). The resulting mixture was stirred at 
room temperature for 6 d. The reaction mixture was quenched with saturated NaHCOs 
and the organic layer separated. The aqueous phase was extracted with CH2CI2 (2 x 20 
mL) and the combined organic extracts dried over Na2S04 and concentrated in vacuo. 
The residue was purified by chromatography on silica (5 % Et20  in petroleum ether) to 
give the title compound (716 mg, 55 %) as a colourless solid, m.p. 104-105 °C; vmax 
(CH2CI2) 3022, 2886, 2852, 1449, 1401, 1322, 1223, 1112, 1023 and 753 cm"1; 6H (400 
MHz) 7.82 (2 H, d, J 7.8, 2 x aromatic CH), 7.75 (1 H, dd, J 7.8, 1.6 Hz, aromatic CH), 
7.70 (1 H, dd, J 8.0, 0.9 Hz, aromatic CH), 7.67 - 7.58 (3 H, m, 3 x aromatic CH), 7.48 (1 
H, app. t, J 7.9, aromatic CH), 7.32 (1 H, app. td, J 7.7, 1.7, aromatic CH), 6.65 (1 H, app. 
dq, J 10.3,1.6 Hz, one of alkene CH), 6.11 - 6.02 (2 H, m, one of alkene CH and PhCHO), 
5.98 (1 H, br. d, J 10.1, one of alkene CH), 5.88 (1 H, app. dq, J 10.2, 1.7, one of alkene 
CH), 5.62 (1 H, s, ArCH), 4.30 (2 H, app. singlet, CH20), 2.75 - 2.63 (1 H, m, one of ring 
CH2) and 2.29 - 2.18 (1 H, m, one of ring CH2); 6C (100 MHz) 138.3 (C), 137.2 (C), 131.9 
(CH), 131.1 (CH), 129.1 (CH), 128.9 (CH), 128.7 (CH), 128.3 (2 x CH), 126.6 (CH), 126.4 
(CH), 126.3 (2 x CH), 126.1 (CH), 125.2 (CH), 123.6 (C), 102.5 (CH), 84.2 (CH), 76.9 (CH2),
42.3 (C) and 26.8 (CH2).
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3-Methyl-l-phenyl-2,4-dioxaspiro(5.5)undeca-7,10-diene (85a)
Me
74c 85a
To a solution of (l-(hydroxymethyl)cyclohexa-2/5-dienyl)phenylmethanol 74c (494 mg,
2.3 mmol) in CH2CI2 (20 mL) was added acetaldehyde (2.6 mL, 45.8 mmol, 20 equiv.), 
PTSA (approx. 20 mg) and DMF (1 mL). After stirring for 24 h the reaction was 
quenched with saturated aqueous NaHCC>3 (20 mL), the organic layer separated and 
the aqueous phase extracted with CH2CI2 (2 x 10 mL). The combined organic layers 
were dried over Na2S04 and concentrated in vacuo. The residue was purified by 
chromatography on silica (5 % Et20  in petroleum ether) to give the title compound 
(392 mg, 71 %) as a colourless oil. vmax (neat) 3031, 2961, 2845, 1496, 1454, 1410, 
1354, 1119, 1024 and 712 cm'1; 6H (500 MHz) 7 .20 -7 .11  (5 H, m, 5 x aromatic CH), 
6.11 (1 H, app. dq, J 10.2, 2.0, one of alkene CH), 5.69 (1 H, app. dtd, J 10.2, 3.4, 1.5, 
one of alkene CH), 5.58 (1 H, app. dtd, J 10.2, 3.4, 1.5, one of alkene CH), 5.26 (1 H, 
app. dq, J 10.2, 2.0, one of alkene CH), 4.89 (1 H, q, J 5.0, CH3CHO), 4.48 (1 H, s, ArCH), 
3.79 (1 H, d, J 11.0, one of CH20), 3.67 (1 H, d, J 11.0, one of CH20), 2.33 (1 H, app. dtt, 
J 22.8, 3.4, 2.0, one of ring CH2), 1.92 (1 H, app. dtt, J 22.8, one of ring CH2) and 1.41 (3
H, d, J 5.0, CH3); 6h (100 MHz) 138.2 (C), 129.2 (CH), 127.5 (CH), 127.2 (CH), 127.0 (CH),
126.4 (CH), 125.7 (CH), 125.4 (CH), 99.8 (CH), 85.6 (CH), 76.4 (CH2), 41.1 (C), 26.9 (CH2) 
and 21.1 (CH3).
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3-Butyl-l-phenyl-2,4-dioxaspiro[5.5]undeca-7,10-diene (85b)
n-Bu
85b74c
To a solution of (l-(hydroxymethyl)cyclohexa-2/5-dienyl)phenylmethanol 74c (452 mg,
2.1 mmol) in CH2CI2 (20 mL) was added valeraldehyde (1.1 mL, 10.5 mmol, 5 equiv.), 
PTSA (approx. 20 mg) and DMF (1 mL). After stirring for 24 h the reaction was 
quenched with saturated aqueous NaHCC>3 (20 mL), the organic layer separated and 
the aqueous phase extracted with CH2CI2 (2 x 10 mL). The combined organic layers 
were dried over Na2S04 and concentrated in vacuo. The residue was purified by 
chromatography on silica (5 % Et20  in petroleum ether) to give the title compound 
(394 mg, 66% ) as a colourless oil. vmax (neat) 3031, 2956, 2860, 1452, 1410, 1360, 
1142, 1025 and 713 cm'1; 6H (500 MHz) 7.19 - 7.11 (5 H ,m ,5 x  aromatic CH), 6.08 (1 H, 
app. dq, J 10.3, 2.0, one of alkene CH), 5.69 (1 H, app. dtd, J 10.3, 3.4, 1.5, one of 
alkene CH), 5.57 (1 H, app. dtd, J 10.3, 3.4, 1.5, one of alkene CH), 5.27 (1 H, app dq, J
10.3, 2.0, one of alkene CH), 4.73 (1 H, t, J 4.9, CHO), 4.47 (1 H, s, ArCH), 3.80 (1 H, d, J
11.0, one of CH20), 3.65 (1 H, d, J 11.0, one of CH20), 2.33 (1 H, app. dtt, J 22.8, 3.4,
2.0, one of ring CH2), 1.92 (1 H, app. dtt, J 22.8, 3.4, 2.0, one of ring CH2), 1.73 -1 .68 (2 
H, m), 1.45 -1 .37  (2 H, m), 1.29 (2 H, app. sextet, J 7.3, CH2CH3) and 0.85 (3 H, t, J 7.3, 
CH3); 6c (125 MHz) 138.5 (C), 129.1 (CH), 127.4 (CH), 127.1 (CH), 127.0 (CH), 126.5 
(CH), 125.8 (CH), 125.3 (CH), 102.7 (CH), 85.4 (CH), 76.4 (CH2), 41.3 (C), 34.7 (CH2), 26.9 
(CH2), 25.9 (CH2), 22.7 (CH2) and 14.0 (CH3).
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3-lsobutyl-l-phenyl-2,4-dioxaspiro[5.5]undeca-7,10-diene (85c)
OH OH
74c 85c
To a solution of (l-(hydroxymethyl)cyclohexa-2,5-dienyl)phenylmethanol 74c (474 mg,
2.2 mmol) in CH2CI2 (20 mL) was added isovaleraldehyde (1.2 mL, 11.0 mmol, 5 equiv.), 
PTSA (approx. 20 mg) and DMF (1 mL). After stirring for 24 h the reaction was 
quenched with saturated aqueous NaHC03 (20 mL), the organic layer separated and 
the aqueous phase extracted with CH2CI2 (2 x 10 mL). The combined organic layers 
were dried over Na2S04 and concentrated in vacuo. The residue was purified by 
chromatography on silica (5 % Et20  in petroleum ether) to give the title compound 
(410 mg, 66%) as a colourless oil. vmax (neat) 3033, 2957, 2867, 1450, 1411, 1361, 
1122, 1022 and 706 cm'1; 6H (400 MHz) 7.25 - 7.19 (5 H, m, 5 x aromatic CH), 6.15 (1 H, 
app. dq, J 10.1, 2.0, one of alkene CH), 5.77 (1 H, app. dtd, J 10.1, 3.3, 1.5, one of 
alkene CH), 5.63 (1 H, app. dtd, J 10.1, 3.3, 1.5, one of alkene CH), 5.34 (1 H, app. dq, J 
10.1, 2.0, one of alkene CH), 4.84 (1 H, t, J 5.3, CHO), 4.55 (1 H, s, ArCHO), 3.86, (1 H, d, 
J 11.0, one of CH20), 3.73 (1 H, d, J 11.0, one of CH20), 2.40 (1 H, app. dtt, J 23.0, 3.3,
2.0, one of ring CH2), 1.99 (1 H, app. dtt, J 23.0, 3.3, 2.0, one of ring CH2), 1.95 -1 .84 (1 
H, m, CH(CH3)2), 1.70 -1.65 (2 H, m, CH2CHO) and 0.95 (6 H, d, J 6.7, CH3); 6C (125 MHz)
138.5 (C), 129.1 (CH), 127.4 (CH), 127.0 (CH), 127.0 (CH), 126.6 (CH), 125.9 (CH), 125.2 
(CH), 101.9 (CH), 85.5 (CH), 76.5 (CH2), 43.1 (CH2), 41.4 (C), 26.9 (CH2), 23.8 (CH), 23.1 
(CH3) and 22.9 (CH3).
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l,3-Diphenyl-2,4-dioxaspiro[5.5]undeca-7,10-diene (g5e)
Ph
OH OH OA.O
74c 85e
To a solution of (l-(hydroxymethyl)cyclohexa-2,5-dienyl)phenylmethanol 74c (474 mg,
2.2 mmol) in CH2CI2 (20 mL) was added benzaldehyde dimethyl acetal (1.7 mL, 11.0 
mmol, 5 equiv.), PTSA (approx. 20 mg) and DMF (1 mL). After stirring for 24 h the 
reaction was quenched with saturated aqueous NaHC03 (20 mL), the organic layer 
separated and the aqueous phase extracted with CH2CI2 (2 x 10 mL). The combined 
organic layers were dried over Na2S04 and concentrated in vacuo. The residue was 
purified by chromatography on silica (5 % Et20  in petroleum ether) to give the title 
compound (280 mg, 42 %) as a colourless solid. vmax (CH2CI2) 3032, 2956, 2842, 1497, 
1452, 1399, 1360, 1123, 1027 and 698 cm'1; 6H (500 MHz) 7.56 - 7.52 (2 H, m, 2 x 
aromatic CH), 7.36 - 7.27 (3 H, m, 3 x aromatic CH), 7.25 - 7.21 (2 H, m, 2 x aromatic 
CH), 7.19 - 7.12 (3 H, m, 2 x aromatic CH), 6.23 (1 H, app. dq, J 10.2, 2.0, one of alkene 
CH), 5.75 (1 H, app. dtd, J 10.2, 3.4, 1.5, one of alkene CH), 5.70 (1 H, s, ArCH02), 5.61 
(1 H, app. dtd, J 10.2, 3.4, 1.5, one of alkene CH), 5.35 (1 H, app. dq, J 10.2, 2.0, one of 
alkene CH), 4.72 (1 H, s, ArCHO), 3.97 (1 H, d, J 11.0, one of CH20), 3.90 (1 H, d, J 11.0, 
one of CH20), 2.36 (1 H, app. dtt, J 22.8, 3.6, 1.8, one of ring CH2) and 1.94 (1 H, app. 
dtt, J 22.8, 3.0, 2.4, one of ring CH2); 6C (125 MHz) 138.5 (C), 138.2 (C), 129.5 (CH),
128.9 (CH), 128.3 (CH), 127.5 (CH), 127.2 (CH), 127.0 (CH), 126.3 (CH), 126.3 (CH),
125.6 (CH), 125.6 (CH), 102.1 (CH), 86.0 (CH), 76.8 (CH2), 41.4 (C) and 26.9 (CH2).
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7.2.1 Prins Reactions with TiCI4
Prins Cyclisation of Acetaldehyde Acetal 60a
60a
Cl
HO. Me
Me Me
HO
Me
Me Me
63a 61a 62a
Titanium tetrachloride (0.32 mL, 2.9 mmol, 2 equiv.) was added to a cooled (-78 °C) 
solution of acetaldehyde acetal 60a (260 mg, 1.44 mmol) in CH2CI2 (10 mL). After 
stirring for 1 h the reaction was quenched with saturated aqueous NaHC03 solution 
(10 mL). The organic layer was separated and the aqueous phase extracted with CH2CI2 
(2 x 20 mL). The combined organic extracts were dried over Na2S04 and concentrated 
in vacuo. The residue was purified by chromatography on silica (14 % EtOAc in 
petroleum ether) to give compound 61a as a yellow oil (73 mg, 28%) and compound 
62a as a pale yellow oil (61 mg, 20 %), respectively. While compound 63a was not 
isolated its existence was evident from the data obtained from the crude reaction 
mixture.
((l/?S,2/?S,4Sff,5/?S,9/?S)-9-Chloro-2,4-dimethyl-3-oxabicyclo-(3.3.1)non-7-en-l- 
yl)methanol (62a)
62a (61 mg, 20 %): (Found: MNH„+ 234.1256. ChH2135CIN02 requires M, 234.1255); vmax 
(CH2CI2) 3418, 2978, 1684, 1376, 1075, 722 cm'1; 6H (400 MHz) 5.92 (1 H, app. dt, J
10.0, 3.4, CCH=CH), 5.02 (1 H, app. dq, J 10.0, 1.8, CCH=CH), 4.45 (1 H, app. dd, J 3.3,
1.2, CHCI), 3.91 (1 H, d, J 11.2, one of CH2OH), 3.72 (1 H, q, J 6.3, CCHCH3), 3.70 (1 H, 
app. dq, J 1.7, 6.4, CHCHCH3 ), 3.57 (1 H, d, J 11.2, one of CH2OH), 2.33 (1 H, app. ddt, J
19.3, 5.9, 2.9, one of CH2CH=CH), 2.28 - 2.20 (1 H, m, one of CH2CH=CH), 2.00 -1.95 (1 
H, m, CHCHCH3), 1.17 (3 H, d, J 6.4, CHCHCH3 ) and 1.09 (3 H, d, J 6.3, CCHCH3); 6C (100 
MHz) 130.8 (CH), 121.8 (CH), 76.5 (CH), 76.3 (CH), 63.5 (CH2), 63.3 (CH), 45.6 (C), 41.2
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(CH), 22.7 (CH2), 19.0 (CH3) and 16.3 (CH3). m /z (Cl) 234 (M+NH4\  100 %), 198 (79), 181 
(48), 137 (27), 121 (27).
(15ff,3RS,3aS/?,7a5fi)-l,3,3a,6,7,7a-Hexahydro-l,3-dimethylisobenzofuran-4- 
carbaldehyde (61a)
61a (73 mg, 28%): (Found: M* 180.1161. CuHi60 2 requires M, 180.1150); vmax (CH2CI2) 
2924, 1686, 1458, 1375, 1259, 1165 cm '1; 6H (400 MHz) 9.40 (1 H, s, CHO), 6.95 (1 H, 
br. singlet, C=CH), 4.39 - 4.30 (1 H, m, CCHCHO), 4.02 - 3.94 (1 H, m, CH2CHCHO), 3.18 
(1 H, app. t, J 8.0, CCHCHO), 2.54 - 2.42 (1 H, m, one of CH2CH=C), 2.28 - 2.15 (1 H, m, 
one of CH2CH=C), 2.00 -1 .86  (1 H, m, CH2CHCHO), 1.76 -1.67 (1 H, m, one of 
CH2CHCHO), 1.41 -1 .27 (1 H, m, one of CH2CHCHO), 1.18 (3 H, d, J 6.4, CH2CHCHCH3) 
and 0.87 (3 H, d, J 6.4, CCHCHCH3); 6C (100 MHz) 194.5 (CH), 152.8 (CH), 140.9 (C), 76.2
(CH), 74.8 (CH), 40.2 (CH), 39.4 (CH), 25.7 (CH2), 19.8 (CH3), 19.2 (CH2) and 15.1 (CH3). 
m /z  (El) 180 (M*, 12 %), 178 (37), 136 (100), 107 (98), 79 (98).
Prins Cyclisation of Isobutyi Acetal 60c
Titanium tetrachloride (0.18 mL, 1.6 mmol) was added to a cooled (-78 °C) solution of 
isobutyl acetal 60c (188 mg, 0.85 mmol) in CH2CI2 (10 mL). After stirring for 2 h the 
reaction was quenched with saturated aqueous NaHCOs solution (10 mL). The organic 
layer was separated and the aqueous phase extracted with CH2CI2 (2 x 20 mL). The 
combined organic extracts were dried over Na2S04 and concentrated in vacuo. The 
residue was purified by chromatography on silica (14% EtOAc in petroleum ether) to 
give compound 61c as a yellow oil (70 mg, 37%), and compound 62c as a pale yellow 
solid (31 mg, 14%), respectively. While compound 63c was not isolated its existence 
was evident from the data obtained from the crude reaction mixture.
60c 63c 61c 62c
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((lRS,2/?5,4S/?,5/?S,9/?S)-9-Chloro-4-isobutyl-2-methyl-3-oxabicyclo(3.3.1)non-7-en-l- 
yl)methanol (62c)
62c (31 mg, 14 %): m.p. 70 - 72 °C; (Found: MNH4* 276.1723. C14H2735CIN02 requires M, 
276.1725); v™  (neat) 3442, 3024, 2955, 1467, 1369, 1107 and 1042 cm"1; 6H (400 
MHz) 5.92 (1 H, app. dt, J 10.0, 3.5, CCH=CH), 5.02 (1 H, app. dq, J 10.0, 1.9, CCH=CH), 
4.48 (1 H, app. dd, J 3.2, 1.3, CHCI), 3.91 (1 H, d, J 11.4, one of CH2OH), 3.69 (1 H, q, J
6.4, CCHO), 3.57 (1 H, d, J 11.4, one of CH2OH), 3.56 - 3.51 (1 H, m, CHCHO), 2.32 (1 H, 
app. ddt, J 19.3, 6.0, 2.7, one of CH2CH=CH), 2.24 - 2.16 (1 H, m, one of CH2CH=CH),
2.01 -1 .96  (1 H, m, CHCHO), 1.67 (1 H, app. nonet, J 6.6, isobutyl CH), 1.53 (1 H, app. 
ddd, J 13.9, 8.4, 6.4, one of isobutyl CH2), 1.16 -1 .10  (1 H, m, 1 H, one of isobutyl CH2),
1.08 (3 H, d, J 6.4, CCHCH3), 0.84 (3 H, d, J 6.4, CH3) and 0.83 (3 H, d, J 6.4, CH3); 6C (100 
MHz) 130.9 (CH), 121.9 (CH), 79.1 (CH), 76.4 (CH), 63.5 (CH and CH2), 45.9 (C), 42.0 
(CH2), 40.2 (CH), 24.6 (CH), 23.2 (CH2), 23.0 (CH3), 22.5 (CH3) and 16.2 (CH3) ppm. m /z
(Cl) 276 (M + NH„\ 100 %), 240 (50), 223 (22), 179 (23).
(15R,3S/?,3a5R,7aSR)-l-lsobutyl-l,3,3a,6,7,7a-hexahydro-3-methylisobenzofuran-4- 
carbaldehyde (61c)
61c (70 mg, 37%): (Found: M* 222.1623. Ci4H220 2 requires M, 222.1611); vmax (neat) 
2954, 1684, 1642, 1466, 1371, 1093 cm"1; 6H (400 MHz) 9.39 (1 H, s, CH=0), 6.94 (1 H, 
app. d, J 5.1, HC=C), 4.31 (1 H, app. dq, J 9.9, 6.4, CCHCHO), 3.86 (1 H, ddd, J 7.3, 6.1,
4.0, CH2CHCHO), 3.16 (1 H, app. t, J 8.1, CCHCHO), 2.45 (1 H, app. dtd, J 20.0, 4.2, 1.1, 
one of CH2CH=C), 2.26 - 2.12 (1 H, m, one of CH2CH=C), 1.90 (1 H, app. ddt, J 13.1, 6.9,
4.0, CH2CHCHO), 1.72 -1 .59  (2 H, m, one of CH2CHCHO and isobutyl CH), 1.47 (1 H, 
app. dt, J 13.6, 7.2, one of isobutyl CH2), 1.41 -1 .27  (2 H, m, one of isobutyl CH2 and 
one of CH2CHCHO) and 0.91 - 0.84 (9 H, m, 3 x CH3); 6C (100 MHz) 194.5 (CH), 152.7 
(CH), 141.0 (C), 78.7 (CH), 74.5 (CH), 39.4 (CH), 39.2 (CH), 38.8 (CH2), 25.7 (CH2), 25.5 
(CH), 23.3 (CH3), 22.8 (CH3), 19.8 (CH3) and 19.3 (CH2). m /z  (Cl) 222 (M +, 1 %), 178 (26), 
136 (59), 107 (81), 91 (100).
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Prins Cyclisation of Benzaldehyde Acetal 60e
60e
Me
Me
HO
|CP"' Ph
62e 61 e
Titanium tetrachloride (0.17 mL, 1.5 mmol, 2 equiv.) was added to a cooled (-78 °C) 
solution of benzaldehyde acetal 60e (183 mg, 0.76 mmol) in CH2CI2 (10 mL). After 
stirring for 15 min the reaction was quenched with saturated aqueous NaHC03 
solution (10 mL). The organic layer was separated and the aqueous phase extracted 
with CH2CI2 (2 x 20 mL). The combined organic extracts were dried over Na2S04 and 
concentrated in vacuo. The residue was purified by chromatography on silica (10 % 
EtOAc in petroleum ether) to give the aldehyde 61e as a colourless solid (36 mg, 20 %) 
and alcohol 62e as a colourless solid (80 mg, 38 %), respectively.
((l/?5,2f?5,4S/?,5f?S,9/?S)-9-Chloro-2-methyl-4-phenyl-3-oxabicyclo(3.3.1)non-7-en-l- 
yi)methanol (62e)
62e (80 mg, 38%): m.p. 144 -145  °C; (Found: [M - OC2H4]* 234.0829. Ci4HiS35CIO 
requires M, 234.0811); vmax (CH2CI2) 3429, 3030, 2924, 1653, 1451, 1387, 1368, 1310, 
1250, 1119, 1058, 1031, 724 cm'1; 6H (400 MHz) 7.31 - 7.16 (5 H, m, 5 x aromatic CH), 
5.87 (1 H, app. dt, J 10.0, 3.4, CCH=CH), 5.06 (1 H, app. dq, J 10.0,1.9, CCH=CH), 4.70 (2 
H, m, CHCHO and CHCI), 3.96 (1 H, d, J 11.2, one of CH2OH), 3.90 (1 H, q, J 6.2, CCHO), 
3.64 (1 H, d, J 11.2, one of CH2OH), 2.42 - 2.36 (1 H, m, CHCHO), 2.09 (1 H, app. ddt, J
19.3, 6.7, 2.7, one of CH2CH=CH), 1.87 -1 .7 8  (1 H, m, one of CH2CH=CH) and 1.20 (3 H, 
d, J 6.2, CH3); 6c (100 MHz) 140.2 (C), 130.9 (CH), 128.2 (2 x CH), 127.2 (CH), 125.6 (2 x 
CH), 121.5 (CH), 81.7 (C), 77.1 (CH), 63.6 (CH2), 63.1 (CH), 46.6 (C), 41.9 (CH), 23.2 (CH2) 
and 16.3 (CH3). m /z  (El) 234 ([M - OC2H4]*, 8 %), 198 (12), 181 (15), 107 (25), 91 (100).
102
(l/?5,3/?5,3a5/?,7a5/?)-l,3,3a,6,7,7a-Hexahydro-3-methyl-l-phenylisobenzofuran-4- 
carbaldehyde (61e)
61e (36 mg, 20%): m.p. 9 4 -9 6  °C; (Found: MNa+ 265.1200. Ci6Hi8Na02 requires M, 
265.1199); vmax (CH2CI2) 2966, 2925, 2885, 2805, 1671, 1637, 1449, 1172, 1092 and 
1027 cm'1; 6H (400 MHz) 9.40 (1 H, s, HC=0), 7.27 (3 H, m, 3 x aromatic CH), 7.22 - 7.15 
(2 H, m, 2 x aromatic CH), 6.94 (1 H, app. d, J 4.8, HC=C), 5.04 (1 H, d, J 4.4, CH2CHCHO),
4.57 (1 H, dq, J 10.0, 6.4, CCHCHO), 3.39 (1 H, app. t, J 8.2, CCHCHO), 2.35 (1 H, app. 
dtd, J 20.0, 5.3, 1.3, one of CH2CH=C), 2.21 (1 H, app. ddt, J 13.1, 6.8, 4.6, CH2CHCHO), 
2.14 - 2.02 (1 H, m, one of CH2CH=C), 1.18 (1 H, app. dq, J 13.3, 5.3, one of CH2CHCHO),
1.09 -1 .01 (1 H, m, one of CH2CHCHO) and 0.99 (3 H, d, J 6.4, CH3); 6C (100 MHz) 194.3 
(CH), 152.9 (CH), 140.8 (C), 138.9 (C), 128.1 (2 x CH), 127.0 (CH), 125.9 (2 x CH), 82.1 
(CH), 75.1 (CH), 41.6 (CH), 39.6 (CH), 25.7 (CH2), 20.2 (CH2) and 20.0 (CH3). m /z  (APCI) 
260 (M + NH„*, 100), 257 (54), 198 (13).
Prins Cyclisation of Acetaldehyde Acetal 60f
60f
HO
Me
H
62f
HO
Me
63f
HO.
Me
75f
Me
61f
Titanium tetrachloride (0.18 mL, 1.64 mmol, 2.2 equiv.) was added to a cooled (-78 °C) 
solution of acetaldehyde acetal 60f (235 mg, 0.73 mmol) in CH2CI2 (10 mL). After 
stirring for 30 min the reaction was quenched with saturated NaHC03 (10 mL). The 
organic layer was separated and the aqueous phase extracted with CH2CI2 (2 x 10 mL).
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The combined organic extracts were dried over Na2S04 and concentrated in vacuo. The 
residue was purified by chromatography on silica (17% EtOAc in hexane) to give 
compound 75f as a colourless oil (40 mg, 17 %), compound 62f as a pale yellow oil (26 
mg, 10 %) and compound 61f as a colourless oil (104 mg, 44 %), respectively. While 
compound 63f was not isolated, its existence was evident from the data obtained from 
the crude reaction mixture.
((lS/?,3S/?,3aS/?,7aS/?)-3-(2-Bromophenyl)-6-chloro-l,3,3a,6,7,7a-hexahydro-l- 
methylisobenzofuran-4-yl)methanol (63f)
This compound was not isolated pure. These data are obtained from the crude 
reaction mixture under the above conditions. 6H (400 MHz) 7.44 (1 H, d, J 8.2, aromatic 
CH), 7.22 - 7.17 (1 H, m, aromatic CH), 7.10 - 7.02 (2 H, m, 2 x aromatic CH), 5.84 (1 H, 
d, J 5.0, HC=C), 5.41 (1 H, d, J 9.9, ArCHO), 4.72 - 4.64 (1 H, m, CICHCH=C), 4.10 (1 H, dq 
J 6.3, 4.8, MeCHO), 3.48 (1 H, d, J 14.4, one of Ctf2OH), 3.35 - 3.28 (2 H, m, CtfCHAr and 
one of CH2OH), 2.70 - 2.61 (1 H, m, CtfCHMe), 2.15 - 2.20 (2 H, m, CH2CHCI) and 1.30 (3 
H, d, J 6.3, CH3); 6C (100 MHz) 140.9 (C), 138.0 (C), 132.5 (CH), 129.8 (CH), 129.4 (CH),
127.6 (CH), 125.0 (CH), 124.0 (C), 81.1 (CH), 76.9 (CH), 64.6 (CH2), 53.9 (CH), 43.3 (CH),
36.9 (CH), 29.9 (CH2) and 14.8 (CH3).
((lf?S,25/?,45/?,5/?S,9flS)-2-(2-Bromophenyl)-9-chloro-4-methyl-3- 
oxabicyclo(3.3.1)non-7-en-l-yl)methanol (62f)
62f (26 mg, 10%): (Found: MH* 356.0167. C16H180279Br35CI requires M 356.0173); vmax 
(CH2CI2) 3578, 3024, 2925, 1725, 1694, 1470, 1440, 1386, 1204, 1084 cm’ 1; 6H (400 
MHz) 7.46 (1 H, dd, J 8.0, 1.2, aromatic CH), 7.40 (1 H, dd, J 7.8, 1.7, aromatic CH), 
7.23 - 7.17 (1 H, m, aromatic CH), 7.08 (1 H, app. dt, J 7.6, 1.7, aromatic CH), 6.01 (1 H, 
app. dt, J 9.9, 3.4, one of alkene CH), 4.97 (1 H, s, ArCHO), 4.81 (1 H, app. dq, J 9.9,1.9, 
one of alkene CH), 4.68 (1 H, dd, J 3.3, 1.5 Hz, CHCI), 3.89 (1 H, dq, J 1.7, 6.3, MeCHO), 
3.60 (1 H, d, J 12.3, one of CH2OH), 3.22 (1 H, d, J 12.3, one of CH2OH), 2.47 - 2.30 (2 H, 
m, OV2CH=CH), 2.12 - 2.06 (1 H, m, CHCHO) and 1.22 (3 H, d, J 6.3, CH3); 6C (100 MHz)
137.5 (C), 132.3 (CH), 131.5 (CH), 130.3 (CH), 129.7 (CH), 127.3 (CH), 123.5 (C), 121.8
104
(CH), 80,7 (CH), 77.3 (CH), 63.2 (CH2), 63.1 (CH), 46.5 (C), 41.1 (CH), 22.8 (CH2) and 18.9 
(CH3)- m /z  (APCI) 361 (MH* (81Br37CI), 13 %), 359 (MH* (79Br37CI), 48), 257 (44), 187 (65), 
185 (75), 157 (25), 155 (65), 149 (29), 137 (100).
(lS^BS/^BaS^yaSR^B-^-BromophenylJ-ljS/Sa^y^a-hexahydro-l-
methylisobenzofuran-4-carbaldehyde (61f)
61f (104 mg, 44%): (Found: MH+ 321.0480. Ci6Hi879Br02 requires M, 321.0490); vmax 
(CH2CI2) 2935, 1685, 1641, 1472, 1441, 1392, 1 2 1 2 , 1162, 1089 and 1018 cm'1; 6 H (400 
MHz) 8.79 (s, 1 H, CHO), 7.38 (1 H, app. dd, J 8.7, 1.1, aromatic CH), 7.11 - 7.04 (2 H, m, 
2 x aromatic CH), 6.97 - 6.91 (1 H, app. ddd, J 8.1, 6.5, 2.5, aromatic CH), 6.75 (1 H, app. 
ddd, J 5.0, 3.3, 1.0, one of alkene CH), 5.54 (1 H, d, J 9.4, ArCH), 4.07 (1 H, dq, J 6.5, 5.1, 
MeCH), 3.56 (1 H, m, CHCHAr), 2.45 (1 H, app. dq, J 19.1, 4.8, one of CH2CH=C), 
2.32-2 .24  (1 H, m, CHCHMe), 2 .2 4 -2 .1 3  (1 H, m), 1.80- 1.63 (2 H, m, C=CHCH2CH2) 
and 1.31 (3 H, d, J 6.5, CH3); 6 H (100 MHz) 192.2 (CH), 151.0 (CH), 141.0 (C), 137.6 (C),
132.6 (CH), 130.3 (CH), 128.8 (CH), 126.5 (CH), 125.1 (C), 81.4 (CH), 77.1 (CH), 39.9 
(CH), 39.5 (CH), 24.7 (CH2), 20.2 (CH2) and 14.8 (CH3). m /z  (APCI) 323 (MH+ (81Br), 89 
%), 321 (MH+ (79Br), 100), 305 (24), 303 (27), 279 (40), 277 (27), 243 (16), 229 (11), 185 
(18).
((lSff,3S/?,3aSK,7aSff)-3-(2-bromophenyl)-l-methyl-l,3,3a,7a- 
tetrahydroisobenzofuran-4-yl)methanol (75f)
75f (40 mg, 17%): 6 H (400 MHz) 7.40 - 7.30 (2 H, m, 2 x aromatic CH), 7.12 (1 H, app. td, 
J 7.8, 1.0, aromatic CH), 7.00 (1 H, app. td, J 7.6, 1.7, aromatic CH), 5.85 (1 H, ddd, J 9.9,
5.5, 2.6, C=CHCH=CH), 5.74 (1 H, dd, J 9.9, 2.6, C=CHCH=Ctf), 5.69 (1 H, d, J 5.5, 
C=CHCH=CH), 5.49 (1 H, d, J 9.8, ArCH), 4.24 (1 H, app. quintet, J 6.1, CH3CH), 3.69 (1 H, 
d, J 11.5, one of CH2OH), 3.59 (1 H, dd, J 11.4, 9.8 Hz, CCHCHAr) 3.51 (1 H, d, J 11.5, one 
of CH2OH), 3.17 (1 H, app. ddt, J 11.4, 5.0, 2.6, CHCHCH3), 1.51 (1 H, br. s, OH), 1.43 (3 
H, d, J 6.3, CH3); Hydrogen connectivity fully supported by 1H-1H COSY NMR 
spectroscopy.
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Prins Cyclisation of 3-Methylbutyraldehyde Acetal 60g
60g
Cl
HO. HO
/-Bu i- Bu/-Bu
63g 61 g 75g
Titanium tetrachloride (0.18 mL, 1.64 mmol, 2.7 equiv.) was added to a cooled (-78 °C) 
solution of 3-methylbutyraldehyde acetal 60g (217 mg, 0 .6  mmol) in CH2CI2 (10  mL). 
After stirring for 2 h the reaction was quenched with saturated NaHC03 solution (10 
mL). The organic layer was separated and the aqueous phase extracted with CH2CI2 (2 x 
20 mL). The combined organic extracts were dried over Na2S04 and concentrated in 
vacuo. The residue was purified by chromatography on silica (14 % EtOAc in petroleum 
ether) to give compound 75g as a colourless oil (12 mg, 6  %) and compound 61g as a 
colourless oil (46 mg, 21 %). While compound 63g was not isolated, its existence was 
evident from the data obtained from the crude reaction mixture.
((lS^SS^SaSfJ^aS^-S-tZ-BromophenylJ-e-chloro-l^^a^^^a-hexahydro-l- 
isobutylisobenzofuran-4-yl)methanol (63g)
This compound was not isolated pure. These data are obtained from the crude 
reaction mixture under the above conditions. 6 H (400 MHz) 7.44 (1 H, d, J 7.9, aromatic 
CH), 7.21 - 7.16 (1 H, m, aromatic CH), 7.10 - 7.01 (2 H, m, aromatic CH), 5.86 (1 H, dd, J
5.0, 1.0, C=CH), 5.40 (1 H, d, J 9.9, ArCHO), 4.71 - 4.62 (1 H, m, CHCI), 4.00 (1 H, app. dt, 
J 7.8, 4.9, /-BuCHO), 3.51 (1 H, d, J 14.3, one of CH2OH), 3.32 (1 H, d, J 14.3, one of 
CH2OH), 3.30 (1 H, app. t, J 8.7, HC=CCHO), 2.72 - 2.62 (1 H, m, /-BuCHC/-/), 2.14 - 2.03 
(2 H, m, CH2CHCI), 1.78 -1 .40  (4 H, m, isobutyl CH2, isobutyl CH and OH) and 0.91 (6 H, 
app. d, J 5.0, 2 x CH3); 6 c (100 MHz) 141.0 (C), 138.2 (C), 132.5 (CH), 129.9 (CH), 129.4 
(CH), 127.6 (CH), 124.8 (CH), 124.1 (C), 81.0 (CH), 76.4 (CH), 64.7 (CH2), 54.1 (CH), 43.3 
(CH), 38.3 (CH), 36.2 (CH), 29.9 (CH2), 25.6 (CH), 23.3 (CH3) and 22.8 (CH3).
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(lSR,3SR,3aSR,7aSR)-3-(2-Bromophenyl)-l,3,3a,6,7,7a-hexahydro-l- 
isobutylisobenzofuran-4-carbaldehyde (61g)
61g (46 mg, 21%): (Found: MH* 363.0946. Ci9H2479Br02 requires M, 363.0960); vmax 
(CH2CI2) 2952, 1687, 1641, 1469, 1367, 1208, 1160, 1026, 751 cm"1; 6 H (400 MHz) 8.79 
(s, 1 H, CHO), 7.37 (1 H, d, J 7.6, aromatic CH), 7.11 - 7.05 (2 H, m, aromatic CH), 6.94 (1 
H, app. ddd, 8.1, 6.0, 2.9, aromatic CH), 6.72 (1 H, br. app. t, J 3.6, one of alkene CH), 
5.51 (1 H, d, J 9.5, ArCHO), 3.95 (1 H, app. dt, J 7.9, 5.1, /BuCHO), 3.54 (1 H, app. t, J 8 .6 , 
CHCHAr), 2.45 (1 H, app. dq, J 19.4, 4.7, one of CH2CH=C), 2 .30-2 .22  (1 H, m, 
/BuCHCH), 2.22 - 2.11 (1 H, m, one of CH2CH=C), 1.80 -1 .40  (5 H, m, ring CH2, /Bu CH2 
and isobutyl CH) and 0.91 (6  H, app. d, J 6 .6 , 2 x CH3); 6 „ (100 MHz) 192.2 (CH), 150.8 
(CH), 141.1 (C), 137.8 (C), 132.6 (CH), 130.5 (CH), 128.7 (CH), 126.4 (CH), 125.1 (C), 81.2 
(CH), 79.7 (CH), 39.8 (CH), 38.9 (CH), 38.4 (CH2), 25.7 (CH), 24.7 (CH2), 23.4 (CH3), 22.8 
(CH3) and 20.2 (CH2). m/z (ES+) 365 (M H+ (slBr), 100 %), 363 (MH* (79Br), 95), 347 (18), 
345 (17), 279 (25), 277 (23), 207 (54), 179 (19).
((15R,35R,3aSR,7a5R)-3-(2-Bromophenyl)-6-chloro-l,3,3a,7a-tetrahydro-l- 
isobutylisobenzofuran-4-yl)methanol (75g)
75g (12 mg, 6  %): 6H (400 MHz) 7.42 - 7.33 (2 H, m, aromatic CH), 7.12 (1 H, app. dt, J
7.6, 1.0, aromatic CH), 7.04 - 6.95 (1 H, m, aromatic CH), 5.83 (1 H, ddd, J 9.9, 5.5, 2.6, 
C=CHCH=CH), 5.72 (1 H, dd, J 9.9, 2.6, C=CHCH=CH), 5.67 (1 H, d, J 5.5, C=CHCH=CH),
5.46 (1 H, d, J 9.8, ArCH), 5.14 (1 H, app. dt, J 7.9, 5.0, /BuCH), 3.74 (1 H, d, J 11.4, one 
of CH2OH), 3.56 (1 H, dd, J 11.1, 9.8, CCHCHAr), 3.52 (1 H, d, J 11.4, one of CH2OH),
3.19 (1 H, app. ddt, J 11.1, 4.7, 2.3, CHCH/Bu), 1.80 (1 H, br. s, OH), 1.76 -1 .54  (3 H, m, 
isobutyl CH2 and CH), 0.94 (3 H, d, J 6.4, CH3) and 0.93 (3 H, d, J 6.5, CH3).
107
Prins Cydisation of Benzaldehyde Acetal 60h
HO.
Ph
PhCl HPh
63h 62h 7860h
Titanium tetrachloride (0.16 mL, 1.5 mmol, 2 equiv.) was added to a cooled (-78 °C) 
solution of benzaldehyde acetal 60h (280 mg, 0.73 mmol) in CH2CI2 (10  mL). After 
stirring for 15 min the reaction was quenched with saturated aqueous NaHC03 
solution (10 mL). The organic layer was separated and the aqueous phase extracted 
with CH2CI2 (2 x 20 mL). The combined organic extracts were dried over Na2S04 and 
concentrated in vacuo. The residue was purified by chromatography on silica (10%  
EtOAc in petroleum ether) to give compound 62h as a colourless solid (85 mg, 28 %), 
compound 78 as a pale yellow oil (30 mg, 9 %) and compound 63h as a pale yellow 
solid (74 mg, 24 %), respectively.
((lf?S,3Sfi,3aS/?,7aS/?)-3-(2-Bromophenyl)-6-chloro-l,3,3a,6,7,7a-hexahydro-l- 
phenylisobenzofuran-4-yl)methanol (63h)
63h (74 mg, 24 %): m.p. 50 - 52 °C; (Found: MNH4+ 400.0909. C2iH23 79BrN02 requires 
M, 400.0912); vmax (CH2CI2) 3426, 3061, 3021, 2929, 1732, 1567, 1470, 1367, 1267, 
1206, 1121, 916 cm"1; 6 H (400 MHz) 7.82 (2 H, d, J 7.8, 2 x aromatic CH), 7.14 (3 H, m, 3 
x aromatic CH), 7.10 - 7.05 (2 H, m, 2 x aromatic CH), 7.05 - 6.99 (2 H, m, 2 x aromatic 
CH), 6.14 (1 H, d, J 7.4, C=CH), 5.36 (1 H, d, J 5.0, CCHCHO), 5.25 (1 H, d, J 9.2, 
CH2CHCHO), 3.53 (1 H, app. t, J 5.7, CCHCHO), 3 .40-3 .32  (1 H, m, CH2CHCHO),
3.32 - 3.26 (1 H, m, CHCI), 2.93 (1 H, d, J 13.5, one of CH2OH), 2.84 (1 H, d, J 13.5, one 
of CH2OH) and 2.01 -1 .89  (2 H, m, CH2CHCHO); 6 C (100 MHz) 139.0 (C), 136.4 (C), 135.9 
(C), 132.6 (CH), 132.2 (CH), 130.9 (CH), 130.8 (CH), 129.1 (CH), 128.6 (CH), 127.6 (CH),
127.6 (CH), 127.0 (CH), 126.7 (CH), 121.3 (C), 83.6 (CH), 77.6 (CH), 64.7 (CH2), 44.1 
(CH), 37.7 (CH), 35.1 (CH) and 29.6 (CH2). m /z  (ES+) 402 (MNH4+ - HCI, (slBr), 86  %), 400 
(89), 367 (84), 365 (100).
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((lR5,25/?,4Sff,5R5,9fiS)-2-(2-Bromophenyl)-9-chloro-4-phenyl-3- 
oxabicyclo(3.3.1)non-7-en-l-yl)methanol (62h)
62h (85 mg, 28 %): m.p. 70 - 72 °C. vmax (CH2CI2) 3466, 3061, 3027, 2924, 1472, 1266, 
1122, 1071, 1030, 751 cm"1; 6 H (400 MHz) 7.59 (1 H, dd, J 7.9, 1.6, aromatic CH), 7.49 
(1 H, dd, J 8.0, 0.9, aromatic CH), 7.32 - 7.24 (5 H, m, 5 x aromatic CH), 7.23 - 7.17 (1 H, 
m, aromatic CH), 7.12 (1 H, app. td, J 7.7, 1.7, aromatic CH), 5.99 (1 H, app. dt, J 9.9,
3.4, CCH=CH), 5.16 (1 H, s, CCHO), 4.92 (2 H, m, CHCI and CHCHO), 4.87 (1 H, app. dd, J
9.9,1.6, CCH=CH), 3.66 (1 H, dd, J 12.3, 7.6 Hz, one of CH2OH), 3.31 (1 H, dd, J 12.3, 4.8, 
one of CH2OH), 2.52 - 2.47 (1 H, m, CHCHO), 2.19 (1 H, app. ddt, J 19.4, 6.7, 2.6, one of 
CH2CH=CH), 2.14 - 2.09 (1 H, m, OH) and 2.01 -1 .91  (1 H, m, one of CH2CH=CH); 6 C (100 
MHz) 139.6 (C), 137.5 (C), 132.3 (CH), 131.6 (CH), 130.6 (CH), 129.8 (CH), 128.3 (2 x 
CH), 127.4 (CH), 127.3 (CH), 125.6 (2 x CH), 123.5 (C), 121.7 (CH), 82.4 (CH), 80.9 (CH),
63.2 (CH2), 62.7 (CH), 46.6 (C), 41.1 (CH) and 23.2 (CH2) ppm.
((IRS,35R,3aRS,7f?5,7a5R)-3-(2-Bromophenyl)-7-ch loro-1,6,7,7a-tetra hydro-1- 
phenylisobenzofuran-3a-yl)methanol (78)
78 (30 mg, 9 %): vmax (neat) 3450, 3065, 3032, 2931, 1470, 1439, 1374, 1269, 1206, 
1067, 1020, 909, 733 cm"1; 6 H (400 MHz) 7.54 (1 H, dd,7 7.9, 1.6, aromatic CH), 7.49 (1 
H, dd, J 8.0, 0.9, aromatic CH), 7.42 (2 H, d, J 7.4, 2 x aromatic CH), 7.35 - 7.22 (4 H, m, 
4 x aromatic CH), 7.12 (1 H, app. td, J 7.6, 1.6, aromatic CH), 5.66 (1 H, app. dt, J 10.2,
4.1, CCH=CH), 5.25 (1 H, d, J 7.5, CHCHCHO), 5.23 (1 H, s, CCHO), 4.81 (1 H, app. dt, J
10.2, 1.7, CCH=CH), 4.04 - 4.01 (1 H, m, CHCI), 3.89 (1 H, d, J 11.3, one of CH2OH), 3.83 
(1 H, J 11.3, one of CH2OH), 3.23 (1 H, app. t, J 7.0, CHCHCHO) and 2.20 - 2.06 (2 H, m, 
CH2CH=CH); 6 c (100 MHz) 137.6 (C), 137.2 (C), 132.6 (CH), 130.9 (CH), 129.4 (CH), 128.3 
(2 X CH), 127.7 (CH), 127.7 (CH), 127.2 (CH), 127.0 (CH), 126.5 (2 x CH), 122.6 (C), 82.4 
(CH), 81.3 (CH), 66.3 (CH2), 55.4 (CH), 55.0 (C), 51.3 (CH) and 32.5 (CH2).
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7.2.2 Prins Reactions with Triflic Acid
Prins Cyclisation of Acetaldehyde Acetal 60a
60a
Me
Me
Me Me
61a 84a
Reaction of acetal 60a (183 mg, 1.02 mmol) with TfOH (0.15 mL, 1.6 mmol, 1.6 equiv.) 
in CH2CI2 (10  mL) at 0  °C for 10  min gave 61a (1 2 0  mg, 66  %) as a yellow solid followed 
by 84a (10 mg, 6  %) as a yellow oil.
(lSf?,3flS/3aSfi,7aS/?)-l,3-dimethyl-l,3/3a,6,7,7a-hexahydroisobenzofuran-4- 
carbaldehyde (61a)
61a (120 mg, 66  %): See data in Section 7.2.1.
l-((15A?,3aS/?,7aS/?)-l-Methyl-l,3,3a,6,7,7a-hexahydroisobenzofuran-4-yl)ethanone
(84a)
84a (10 mg, 6 %): vmax (CH2CI2) 2966, 2925, 2885, 2805, 1671, 1637, 1449, 1172, 1092 
and 1027 cm'1; 6 H (400 MHz) 6.97 (1 H, br. d, J 5.7, CH2CH=C), 4.26 (1 H, dd, J 8.4, 9.6, 
one of CHCH20), 4.09 (1 H, dq, J 6.4, 4.4, MeCHO), 3.37 (1 H, app. t, J 8.4, one of 
CHCHzO), 3.18 (1 H, app. br. q, J 8.2, C=CCH), 2.42 (1 H, dtd, J 19.4, 5.7, 1.9, one of 
CH2CH=C), 2.28 (3 H, s, CH3), 2.27 - 2.15 (1 H, m, one of CH2CH=C), 1.96 (1 H, ddt, J
13.1, 6 .6 , 4.2, one of C=CHCH2CH2), 1.73 - 1.65 (1 H, m, CHCHMe), 1.34 -1 .19  (1 H, m, 
one of C=CHCH2CH2) and 1.22 (3 H, d, J 6.4, CH3); 6 C (100 MHz) 199.1 (C), 141.4 (CH),
140.8 (C), 77.4 (CH), 72.2 (CH2), 40.2 (CH), 38.1 (CH), 25.5 (CH2), 25.2 (CH3), 18.0 (CH2) 
and 15.1 (CH3).
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Prins Cyclisation of Valeraldehyde Acetal 60b
60b
Me
Me
n-Bun-Bu
61b 84b
Reaction of acetal 60b (200 mg, 0.90 mmol) with TfOH solution (1.51 mL, 1.1 mmol, 1.2 
equiv.) in CH2CI2 (10  mL) at 0  °C to r.t. for 1 h 30 min gave 61b (120 mg, 60 %) as a 
yellow oil followed by 84b (15 mg, 8  %) as a yellow oil.
(lS/?,3flS/3aS/?,7aS/?)-l-Butyl-3-methyl-l,3,3a,6,7,7a-hexahydroisobenzofuran-4- 
carbaldehyde (61b)
61b (120 mg, 60%): vmax (CH2CI2) 2934, 2870, 1683, 1458, 1376, 1458, 1375, 1223, 
1163, 1093, 960, 735 and 684 cm '1; 6 H (400 MHz) 9.43 (1 H, s, CHO), 7.00 (1 H, br. d, J
4.5, CH=CC=O), 4.39 (1 H, app. dq, J 9.8, 6.4, MeCHO), 3.82 (1 H, td, J 6 .8 , 4.0, BuCHO), 
3.21 (1 H, app. br. t, J 8.2, CHCHMe), 2.52 (1 H, dtd, J 20.2, 5.4, 1.5, one of CH2CH=C),
2.32 - 2.20 (1 H, m, one of CH2CH=C), 1.97 (1 H, ddt, J 13.1, 6 .8 , 4.1, CHCHBu), 1.74 (1 
H, br. dt, J 13.4, 4.4), 1.64 -1 .59  (1 H, m, one of CHOCH2CH2), 1.59 -1.49 (1 H, m, one 
of CHOCH2CH2), 1.59 - 1.27 (5 H, m) and 0.95 - 0.89 (6  H, m, 2 x CH3); 6C (100 MHz)
194.4 (C), 152.7 (CH), 140.9 (C), 80.8 (CH), 74.5 (CH), 39.1 (CH), 39.0 (CH), 29.5 (CH2),
28.7 (CH2), 25.7 (CH2), 22.9 (CH2), 19.8 (CH3), 19.1 (CH2) and 14.0 (CH2).
l-((15R,3aSR,7aSR)-l-Butyl-l,3,3a,6,7,7a-hexahydroisobenzofuran-4-yl)ethanone
(84b)
84b (15 mg, 8  %): vma, (CH2CI2) 2933, 2870, 1667, 1467, 1383, 1356, 1250, 1061 and 
783cm"1; 6 H (400 MHz) 6.97 (1 H, br. d, J 5.1, CH=CC=0), 4.25 (1 H, dd, J 9.6, 8.3, one of 
CH20), 3.88 (1 H, td, J 6.7, 4.3, BuCHO), 3.36 (1 H, app. t, J 8.5, one of CH20), 3.16 (1 H, 
app. br. q, J 8 .6 , CHCH20), 2.40 (1 H, dtd, J 19.4, 5.6, 1.7, one of CH2CH=C), 2.28 (3 H, s, 
CH3), 2.27 - 2.15 (1 H, m, one of CH2CH=C), 1.99 (1 H, ddt, J 13.1, 6.3, 4.2, CHCHO),
1.70 -1 .63 (1 H, m, one of CHCH2CH2), 1.63 -1 .46 (2 H, m, CHOCH2CH2), 1.46 -1.22 (5
111
H, m) and 0.90 (3 H, t, J 7.0, CH3); 6 C (100 MHz) 199.1 (C), 141.4 (CH), 140.8 (C), 82.1 
(CH), 72.0 (CH2), 39.2 (CH), 37.9 (CH), 29.8 (CH2), 28.9 (CH2), 25.5 (CH2), 25.2 (CH3), 22.9 
(CH2), 18.0 (CH2) and 14.0 (CH3).
Prins Cyclisation of Isovaleraldehyde Acetal 60c
60c
/-Bu
61c
/-Bu
84c
Reaction of acetal 60c (218 mg, 0.98 mmol) with TfOH solution (1.54 mL, 1.1 mmol, 1.1 
equiv.) in CH2CI2 (10 mL) at 0 °C for 1 h 30 min gave 61c (116 mg, 53 %) as a yellow oil 
followed by 84c (15 mg, 7 %) as an orange oil.
(15/?,3/?5,3a5/?,7a5f?)-l-lsobutyl-3-methyl-l,3,3a,6,7,7a-hexahydroisobenzofuran-4- 
carbaldehyde (61c)
61c (116 mg, 53 %): See data in Section 7.2.1.
l-((15/?,3a5/?,7aSf?)-l-lsobutyl-l,3,3a,6,7,7a-hexahydroisobenzofuran-4-yl)ethanone
(84c)
84c: (15 mg, 7 %): vmax (CH2CI2) 2952, 2869, 1667, 1467, 1426, 1384, 1248 and 1063 
cm 1; 6 h (400 MHz) 6.97 (1 H, br. d, J 5.0, CHC=CC=0), 4.25 (1 H, dd, J 9.7, 8.3, one of 
Ctf20), 4.01 - 3.95 (1 H, m, CHO), 3.36 (1 H, app. t, J 8.3, one of CH2O), 3.17 (1 H, app. 
br. q, J 8.3, CHCH20), 2.40 (1 H, dtd, J 19.4, 5.8, 2.1, one of CH2CH=C), 2.27 (3 H, s, CH3), 
2.26-2.15 (1 H, m, one of CH2CH=C), 1.98 (1 H, ddt, J 13.1, 6.4, 4.1, CHCHO),
1.77 - 1.60 (2 H, m, CH(CH3)2 and one of CH2CH2CH=C), 1.51 (1 H, ddd, J 14.2, 8.1, 6.5, 
one of CH2CHO), 1.40 -1 .18  (2 H, m, one of CH20  and one of CH2CHO), 0.94 (3 H, d, J
6 .6 , CH3) and 0.93 (3 H, d, J 6 .6 , CH3); 6 C (100 MHz) 199.1 (C), 141.3 (CH), 140.9 (C),
80.0 (CH), 72.0 (CH2), 39.6 (CH), 39.0 (CH2), 37.9 (CH), 25.6 (CH), 25.6 (CH2), 25.2 (CH3),
23.3 (CH3), 22.7 (CH3) and 18.2 (CH2).
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Prins Cydisation of Pivalaldehyde Acetal 60d
60d
Me
Me
f-Bu f-Bu
61 d 84d
Reaction of acetal 60d (219 mg, 0.99 mmol) with TfOH solution (1.55 mL, 1.1 mmol, 1.1 
equiv.) in CH2CI2 (10 mL) at 0  °C to r.t. for 4 h gave unreacted acetal 60d (55  mg, 25 %), 
followed by 61d (24 mg, 11 %) as a yellow oil, and finally 84d (11 mg, 5 %) as a yellow 
oil.
(IRS, 3flS,3aS/?,7aS/?)-l-tert-Butyl-3-methyl-l, 3,3a, 6,7,7a-hexahydroisobenzofuran-4- 
carbaldehyde (61d)
61d (24 mg, 11 %): vmax (CH2CI2) 2958, 1683, 1461, 1367, 1161, 1094, 1033, 939, 800 
and 678 cm'1; 6 H (400 MHz) 9.45 (1 H, s, CHO), 6.97 (1 H, br. d, J 5.4, CH=CC=0), 4.41 (1 
H, dq, J 9.9, 6.4, CH3CHO), 3.48 (1 H, d, J 3.7, C(CH3)3CHO), 3.15 (1 H, br. t, J 8.0, 
CHCHCH3), 2.50 (1 H, dtd, J 20.1, 5.5, 1.1, one of CH2CH=C), 2.28 - 2.16 (1 H, m, one of 
CH2CH=C), 2.02 (1 H, ddt, J 13.3, 6 .6 , 4.0, CHCHC(CH3)3), 1.90 (1 H, br. dt, J 13.1, 4.8, 
one of CH2CH2CH=C), 1.51 (1 H, qd, J 13.1, 5.2, one of CH2CH2CH=C), 1.01 (9 H, s, 
C(CH3)3) and 0.91 (3 H, d, J 6.4, CH3); 6 C (100 MHz) 194.4 (CH), 152.2 (CH), 141.0 (C),
88.2 (CH), 73.9 (CH), 39.3 (CH), 39.3 (CH), 33.1 (C), 27.5 (CH3), 26.1 (CH2), 21.0 (CH2) 
and 20.0 (CH3).
l-((lR5,3aSW,7aSR)-l-tert-Butyl-l,3,3a,6,7,7a-hexahydroisobenzofuran-4-yl)ethanone
(84d)
84d (11 mg, 5 %): vmax (CH2CI2) 2961, 1671, 1365, 1259, 1056, 800, 733 and 700 cm'1; 
6h (400 MHz) 6.96 (1 H, br. d, J 5.9, CH=CC=0), 4.29 (1 H, dd, J 8.1, 9.6, one of CH20), 
3.55 (1 H, d, J 3.8, CHO), 3.38 (1 H, dd, J 8.1, 9.2, one of CH20), 3.13 (1 H, br. q, J 8 .6 , 
CHCH20), 2.39 (1 H, dtd, J 19.3, 5.9, 1.5, one of CH2CH=C), 2.27 (3 H, s, CH3) and 
2.24-2.15 (1 H, m, one of CH2CH=C), 6 C (100 MHz) 199.1 (C), 141.1 (CH), 140.7 (C),
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89.7 (CH), 71.6 (CH2), 39.6 (CH), 38.0 (CH), 33.5 (C), 27.5 (CH3), 26.1 (CH2), 25.2 (CH3) 
and 19.9 (CH2).
Prins Cyclisation of Benzaldehyde Acetal 60e
Ph
( X ,
H Ph
60e 61e
Reaction of acetal 60e (237 mg, 0.98 mmol) with TfOH solution (2.10 mL, 1.5 mmol, 1.5 
equiv.) in CH2CI2 (10 mL) at 0 °C for 5 min and chromatography on silica (6  % to 10 % 
EtOAc in petroleum ether) gave 61e (100 mg, 42 %) as a yellow oil.
(lfl5,3/?5,3aSfl,7aS/?)-3-Methyl-l-phenyl-l,3,3a,6,7,7a-hexahydroisobenzofuran-4- 
carbaldehyde (61e)
61e (100 mg, 42 %): See data in Section 7.2.1.
Prins Cyclisation of Acetaidehyde Acetal 85a
Reaction of acetal 85a (0.6 mmol) with TfOH at 0 °C, as specified in Table 3, followed 
by chromatography on silica (10 % to 15 % EtOAc in petroleum ether) gave 86a (see 
Table 3) as a yellow solid, followed by 87a (see Table 3) as a yellow solid.
85a 86a 87a
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(l/?5,3/?S,3aS/?,7aS/?)-3-Methyl-l-phenyl-l,3,3a,6,7,7a-hexahydroisobenzofuran-4- 
carbaldehyde (86a)
86a: vmax (CH2CI2) 3033, 2977, 2933, 2867, 1683, 1450, 1273, 1175, 1092, 1 02 0 , 734 
and 701 cm '1; 6 H (400 MHz) 9.04 (1 H, s, CHO), 7.20 - 7.16 (4 H, m, 4 x aromatic CH), 
7.16 - 7.19 (1 H, m, ArCH), 6 .6 8  (1 H, br. d, J 3.9, HC=C), 5.33 (1 H, d, J 10.2, ArCHO), 
4.25 (1 H, qd, J 6.3, 4.4, CH3CHO), 3.60 (1 H, br. t, J 8.4, CCHCHO), 2.43 (1 H, dtd, J 20.0,
5.3, 1.7, one of CH2CH=C), 2.25 - 2.13 (1 H, m, one of CH2CH=C), 2.09 (1 H, ddt, J 13.0,
6.9, 4.5, one of CH2CHCHO), 1.86 -1 .7 8  (1 H, m, CH2CHCHO), 1.68 (1 H, qd, J 13.0, 5.5, 
one of CH2CHCHO) and 1.40 (3 H, d, J 6.4, CH3); 6 C (100 MHz) 193.7 (C), 151.6 (CH), 
141.0 (C), 140.0 (C), 127.9 (2 x CH), 127.4 (2 x CH), 127.0 (CH), 82.1 (CH), 77.0 (CH),
41.1 (CH), 39.9 (CH), 25.2 (CH2), 19.0 (CH2) and 14.9 (CH3).
(15/?,3f?S,3aS/?,7aSf?)-3-Methyl-l-phenyl-l,3,3a,6,7,7a-hexahydroisobenzofuran-4- 
carbaldehyde (87a)
87a: vmax (CH2CI2) 3033, 2978, 2933, 2867, 1689, 1450, 1383, 1217, 1167, 1083, 1 0 1 1 , 
756 and 700 cm-1; 6 H (400 MHz) 9.23 (1 H, s, CHO), 7 .30-7.21 (5 H, m, 5 x aromatic 
CH), 6 .8 6  (1 H, dd, J 5.1, 2.5, CH=C), 4.56 (1 H, qd, J 6.4, 4.9, CCHCHO), 4.53 (1 H, d, J
8.9, PhCHO), 3.29 (1 H, br. t, J 7.4, CCHCHO), 2.57 (1 H, dtd, J 20.2, 5.4, 1.7, one of 
CH2CH=C), 2 .3 6 -2 .2 4  (1 H, m, one of CH2CH=C), 2.16 (1 H, br. dq, J 12.8, 4.9, 
CH2CHCHMe), 1.80 (1 H, br. dt, J 13.3, 4.5, one of CH2CHCHMe), 1.63 (1 H, qd, J 13.3,
5.6, one of CH2CHCHMe) and 1.25 (3 H, d, J 6.4, CH3); 6C (100 MHz) 192.5 (C), 151.2 
(CH), 142.8 (C), 140.7 (C), 128.1 (2 x CH), 127.6 (CH), 126.7 (2 x CH), 85.7 (CH), 78.0 
(CH), 45.2 (CH), 41.2 (CH), 25.9 (CH2), 18.8 (CH2) and 15.8 (CH3).
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Prins Cyclisation of Valeraldehyde Acetal 85b
n-Bu
85b 86b
Reaction of acetal 85b (0.6 mmol) with TfOH at 0 °C, as specified in Table 3, followed 
by chromatography on silica (10 % to 15 % EtOAc in petroleum ether) gave 86b (see 
Table 3) as a yellow oil.
(lrtS,3rt<S/3a5fl,7a5/?)-3-Butyl-l-phenyl-l,3,3a,6,7,7a-hexahydroisobenzofuran-4- 
carbaldehyde (86b)
86b: vmax (CH2CI2) 3056, 2956, 2870, 1689, 1451, 1273, 1 11 0 , 736 and 713 cm'1; 6 H 
(400 MHz) 9.04 (1 H, s, CHO), 7.19 - 7.09 (5 H, m, ArH), 6.67 (1 H, br. d, J 3.3, CH=C), 
5.31 (1 H, d, J 10.2, PhCHO), 4.03 (1 H, td, J 6 .8 , 4.2, BuCHO), 3.57 (1 H, br. t, J 8.3, 
CCHCHO), 2.41 (1 H, dtd, J 20.2, 5.3, 1.4, one of CH2CH=C), 2.24 - 2.06 (2 H, m, one of 
CH2CH=C), 1.87 -1 .75 (2 H, m), 1.75 -1 .63  (2 H, m), 1.57 -1.47 (1 H, m), 1.45 -1.30 (3 
H, m), 0.94 (2 H, t, J 7.1, CH3); 6 C (100 MHz) 192.4 (C), 151.2 (CH), 143.1 (C), 140.9 (C),
128.1 (2 x CH), 127.5 (CH), 126.6 (2 x CH), 85.4 (CH), 82.7 (CH), 45.1 (CH), 40.2 (CH),
30.2 (CH2), 28.7 (CH2), 25.9 (CH2), 22.9 (CH2), 18.7 (CH2) and 14.0 (CH3).
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Prins Cyclisation of Isobutyraidehyde Acetal 85c
i- Bu
86c85c
Reaction of acetal 85c (0.6 mmol) with TfOH at 0 °C, as specified in Table 3, followed by 
chromatography on silica (10 % to 15 % EtOAc in petroleum ether) gave 86c (see Table 
3) as a yellow oil.
(lS/?,3Srt/3a5fl,7aS/?)-l-lsobutyl-3-phenyl-l,3/3a,6,7,7a-hexahydroisobenzofuran-4- 
carbaldehyde (86c)
86c: Vmax (CH2CI2) 2955, 2869, 1685, 1451, 1271,1174,1109, 735 and 701 cm"1; 6 H (400 
MHz) 9.04 (1 H, s, CHO), 7.19 - 7.08 (5 H, m, 5 x aromatic CH), 6 .66  (1 H, br. d, J 4.0, 
CH=C), 5.30 (1 H, d, J 10.2, ArCH), 4.13 (1 H, ddd, J 7.7, 5.5, 4.5, /BuCHO), 3.61 - 3.53 (1 
H, m, CCHCHAr), 2.40 (1 H, dtd, J 20.1, 5.3, 1.5, one of C=CHCH2), 2.24 - 2.04 (2 H, m, 
two of butyl CH2), 1.87 -1 .62  (4 H, m, four of butyl CH2), 1.53 (1 H, ddd, J 13.0, 7.0, 5.7, 
one of CCH2CH2), 1.00 (3 H, app. d, J 6.5, CH3) and 0.99 (3 H, app. d, J 6.5, CH3); 6 C (100 
MHz) 193.7 (CH), 151.5 (CH), 141.0 (C), 140.2 (C), 127.8 (2 x CH), 127.3 (2 x CH), 126.8 
(CH), 81.7 (CH), 79.5 (CH), 40.9 (CH), 39.1 (CH), 38.5 (CH2), 25.6 (CH), 25.2 (CH2), 23.3 
(CH), 22.8 (CH) and 19.0 (CH2).
I
117
Prins Cyclisation of Benzaldehyde Acetal 85e
(
H Ph
85e 86e
Reaction of acetal 85e (0.6 mmol) with TfOH at 0 °C, as specified in Table 3, followed 
by chromatography on silica (10 % to 15 % EtOAc in petroleum ether), gave 86e (see 
Table 3) as a yellow oil.
(lf?S,35/?,3a5fl,7a5fl)-l,3-Diphenyl-l,3,3a,6,7,7a-hexahydroisobenzofuran-4- 
carbaldehyde (86e)
86e: vmax (CH2CI2) 3030, 2926, 2856, 1702, 1599, 1495, 1451, 1268, 1025, 734 and 700 
cm-1; 6 h (400 MHz) 8.98 (1 H, s, CHO), 7.40 (2 H, app. d, J 8.3, ArH), 7.32 (2 H, app. t, J
7.5, ArH), 7.25 - 7.19 (2 H, m, ArH), 7.19 - 7.13 (2 H, m, ArH), 7.13 - 7.09 (2 H, m, ArH), 
6.59 (1 H, br. d, J 3.4, HC=C), 5.45 (1 H, d, J 10.3, CCHCHOCH), 5.20 (1 H, d, J 4.4, 
CHjCHCHO), 3.72 (1 H, br. t, J 8.4, C=CCHCHO), 2.35 (1 H, ddt, J 13.2, 6.8, 4.6, one of 
CH2CHCHO), 2.21 (1 H, dtd, J 20.2, 5.4, 1.4, one of CH2CH=C), 1.99 (1 H, dddt, J 20.2,
11.7, 6.0, 2.5, one of CH2CH=C), 1.43 (1 H, br. qd, J 13.2, 5.6, one of CH2CHCHO) and
1.19 -1 .10  (1 H, m, CH2CHCHO); 6 c (100 MHz) 193.6 (C), 151.8 (CH), 140.7 (C), 139.9 
(C), 138.5 (C), 128.1 (2 x CH), 128.0 (2 x CH), 127.5 (2 x CH), 127.1 (CH), 127.0 (CH),
125.5 (2 x CH), 82.3 (CH), 82.1 (CH), 41.0 (CH), 41.0 (CH), 25.1 (CH2) and 19.8 (CH2).
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7.3 Experimental Data for Chapter 3
G eneral Procedure 1 - Formation of Lactones (121 and 127) and Ketoesters (122)
Methyl cyclohexa-2/5-diene-l-carboxylate 72 (1.38 g, 10 mmol) in THF (3 ml) was 
added dropwise to a cooled (-78 °C) solution of LDA (11 mmol, 1.1 equiv.) in THF (30 
ml). The resulting suspension was stirred for 30 min before addition of the epoxide or 
cx-bromoketone (11 mmol, 1.1 equiv.). The reaction was allowed to warm slowly to 
room temperature and monitored by TLC. On completion (typically 4 h) the reaction 
was quenched with saturated aqueous NH4CI (30 ml). The phases were separated and 
the aqueous phase extracted with ether (2 x 25 ml). The combined organic phases 
were dried (Na2S04), filtered and concentrated in vacuo. The residue was purified by 
chromatography on silica gel.
G eneral Procedure 2  - Reduction of Lactones (121 and 127) and Ketoesters (122)
The lactone 121 or 127, or ketoester 122 (5 mmol) in THF (5 ml) was added to a 
suspension of LiAIH4 (380 mg, 10 mmol, 2 equiv.) in THF (20 ml). After stirring for 15 
min, the reaction was quenched with 2M aqueous NaOH (2 ml), dried over Na2S04 and 
filtered. Concentration of the filtrate followed by chromatography on silica gave the 
diol.
G eneral Procedure 3  - lodocyclisation Reactions
Iodine (762 mg, 3 mmol) and NaHC03 (252 mg, 3 mmol) were added to a solution of 
diol (1 mmol) in acetonitrile (10 ml). Stirring was continued for the time shown in Table 
5, Scheme 58, or Scheme 61, before addition of saturated aqueous sodium thiosulfate 
(15 ml). The organic phase was separated and the aqueous phase extracted with ether 
(2 x 10 ml). The combined organic phases were dried (Na2S04), filtered and 
concentrated in vacuo and the residue purified by chromatography on silica gel.
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l-(l-(Hydroxymethyl)cyclohexa-2,5-dienyl)propan-2-ol (113a)
121d72
xMeHO'
OH
113a
Lactone 121d was prepared from epichlorohydrin according to general procedure 1. 
Reduction according to general procedure 2 followed by Kugelrohr distillation (200 °C, 
0.5 mmHg) gave the title compound (741 mg, 87 %, 2 steps) as a colourless solid, m.p. 
70 - 72 °C (Found: M +-H20, 150.1040. Ci0Hi4O requires M, 150.1045); vmax (Nujol) 3244, 
1060,1021, 739 and 713 cm 1; 6 H (400 MHz) 6.07 - 5.97 (2 H, m, 2 x alkene CH), 5.68 (1 
H, app. dq, J 10.1, 2.0, one of alkene CH), 5.43 (1 H, app. dq, J 10.1, 2.0, one of alkene 
CH), 4 .04 -3 .95  (1 H, m, CHOH), 3.35 (2 H, app. s, CH2OH), 2.79-2.63 (2 H, m, 
CH2CH=CH), 2.24 (1 H, br. s, OH), 1.79 (1 H, br. s, OH), 1.53 (1 H, dd, J 14.2, 9.2, one of 
CH2), 1.41 (1 H, dd, J 14.2, 2.2, one of CH2) and 1.14 (3 H, d, J 6.3, CH3); 6 C (100 MHz)
130.5 (CH), 129.5 (CH), 128.1 (CH), 127.4 (CH), 70.4 (CH2), 65.5 (CH), 46.4 (CH2), 42.3 
(C), 26.5 (CH2) and 24.0 (CH3); m /z  (TOF ES+) 150 (M-H20 , 1%), 119 (14), 92 (18) and 91 
(100).
l-(l-(Hydroxymethyl)cydohexa-2,5-dienyl)-hexan-2-ol (113b)
CO2M6
72 121b 113b
Lactone 121b was prepared according to general procedure 1. Reduction according to 
general procedure 2  followed by Kugelrohr distillation (220 °C, 0.5 mmHg) gave the 
title compound (1.97 g, 8 6 %, 2 steps) as a colourless oil (Found: MH+, 211.1696. 
C13H23O2 requires M, 211.1698); vmax (neat) 3417, 2950, 1652, 1463, 1204, 1141, 1048, 
887, 776, 730 and 667 cm’1; 6 H (400 MHz) 6.05 - 5.97 (2 H, m, 2 x alkene CH), 5.69 (1 H, 
app. dq, J 10.3, 2.1, one of alkene CH), 5.43 (1 H, app. dq, J 10.3, 2.1, one of alkene CH),
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3.82 - 3.76 (1 H, m, CHOH), 3.35 (2 H, app. s, Ctf2OH), 2.79 - 2.64 (2 H, m, Ctf2CH=CH), 
2.10 (2 H, br. s, 2 x OH), 1.49 (1 H, dd, J 14.2, 9.0, one of CH2), 1.43 (1 H, dd, J 14.2, 2.4, 
one of CH2), 1.40 - 1.24 (6 H, m, 3 x CH2) and 0.88 (3 H, t, J 7.0, CH3); 6C (100 MHz)
130.6 (CH), 129.6 (CH), 127.9 (CH), 127.3 (CH), 70.4 (CH2), 69.2 (CH), 44.8 (CH2), 42.2 
(C), 37.6 (CH2), 27.7 (CH2), 26.5 (CH2), 22.7 (CH2) and 14.1 (CH3); m /z  (TOF ES+) 252 
(MH+.CH3CN, 100%), 211 (MH+, 12), 193 (14) and 175 (3).
l-(l-(Hydroxymethyl)cyclohexa-2,5-dienyl)-3,3-dimethylbutan-2-ol (113c)
72 122c
HO'
OH
113c
Ketoester 122c (2.37 g, 90 %) was prepared according to General Procedure 1. 
Reduction according to General Procedure 2  followed by crystallisation from 
Et20/petroleum ether gave the title compound (1.2 g, 57 %) as a colourless solid, m.p. 
8 1 -8 4  °C (Found: M +-H 20, 193.1585. Ci3H20O requires M, 193.1592); vmax (Nujol) 
3280, 1063, 1010 and 714 cm'1; 6H (400 MHz) 6.05 - 5.97 (2 H, m, 2 x alkene CH), 5.67 
(1 H, app. dq, J 10.0, 2.0, one of alkene CH), 5.42 (1 H, app. dq, J 10.3, 2.2, one of 
alkene CH), 3 .45-3 .36  (3 H, m, CH2OH and CHOH), 2 .81-2.65 (2 H, m, CH2CH=CH),
2.05 (1 H, br. s, OH), 1.77 (1 H, br. s, OH), 1.53 (1 H, dd, J 14.3, 0.8, one of CH2CHO),
1.38 (1 H, dd, J 14.3, 9.5, one of CH2CHO) and 0.87 (9 H, s, C(CH3)3); 6C (100 MHz) 130.5 
(CH), 129.8 (CH), 127.9 (CH), 127.4 (CH), 76.5 (CH), 70.4 (CH2), 42.2 (C), 39.5 (CH2), 34.8 
(C), 26.5 (CH2) and 25.7 (CH3); m /z  (TOF AP+) 193 (M - H20, 48%) and 175 (100).
l-Chloro-3-(l-(hydroxymethyl)cyclohexa-2,5-dienyl)propan-2-ol (113d)
CH2CI
121d72
HO'
OH
113d
121
Lactone 121d (5.47 g, 97 %) was prepared according to General Procedure 1. Sodium 
borohydride (1.9 g, 50.4 mmol, 2 equiv.) was added in one portion to a solution of the 
crude lactone (5.0 g, 25.2 mmol) in ethanol (200 ml). The reaction was stirred for 2 h 
until complete consumption of starting material was evident (TLC). Glacial acetic acid 
was carefully added until hydrogen evolution ceased and the ethanol removed under 
reduced pressure. Water (200 ml) and diethyl ether (100 ml) were added to dissolve 
the residue and the organic layer separated. The aqueous phase was further extracted 
with diethyl ether (2 x 50 ml) and the combined organic extracts washed with water (2 
x 100 ml). The organic layer was dried over sodium sulfate and concentrated in vacuo. 
Chromatography of the residue on silica (33 % EtOAc in petroleum ether) gave the title 
compound (3.5 g, 70%) as a colourless oil (Found: M +-H , 201.0683. C10Hi4CIO2 
requires M, 201.0682); vmax (neat) 3372, 2920, 1422, 1328, 1047, 947, 877 and 720 cm' 
lm, 6h (400 MHz) 6.09 - 6.01 (2 H, m, 2 x alkene CH), 5.67 (1 H, app. dq, J 10.2, 2.1, one 
of alkene CH), 5.48 (1 H, app. dq, J 10.6, 2.1, one of alkene CH), 4 .04-3 .97  (1 H, m, 
CHOH), 3.58 (1 H, dd, J 11.1, 4.0, one of CH2CI), 3.49 (1 H, dd, J 11.1, 6.6, one of CH2CI), 
3.41 (2 H, app. s, Ctf2OH), 2.76 - 2.71 (2 H, m, CH2CH=CH), 2.56 (1 H, br. s, OH), 1.77 (1 
H, br. s, OH), 1.67 (1 H, dd, J 14.3, 8.1, one of CCH2CHOH) and 1.58 (1 H, dd, J 14.3, 3.4, 
one of CCH2CHOH); 6c (100 MHz) 129.5 (CH), 129.4 (CH), 128.0 (CH), 127.7 (CH), 70.3 
(CH2), 69.0 (CH), 50.3 (CH2), 41.9 (C), 41.8 (CH2) and 26.5 (CH2); m /z  (TOF ES+) 203 
(M+ - H (37CI), 12%), 201 (37), 95 (46) and 91 (100).
3-(l-(Hydroxymethyl)cyclohexa-2,5-dienyl)propane-l,2-diol (113e)
CHoOH
Lactone 121e (330 mg, 23 %) was prepared according to General Procedure 1. 
Reduction according to General Procedure 2 followed by chromatography on silica 
(EtOAc) gave the title compound (179 mg, 56 %) as a colourless solid, m.p. 78 - 80  °C; 
Vmax (Nujol) 3272, 1234, 1036 and 715 cm'1; 6 H (400 MHz) 6 .0 0 -5 .9 3  (2 H, m, 2 x
CO2M6
72 121e 113e
122
alkene CH), 5.62 (1 H, app. dq, J 10.2, 2.1, one of alkene CH), 5.37 (1 H, app. dq, J 10.1,
2.1, one of alkene CH), 3.85 (1 H, dddd, J 8.9, 7.5, 3.2, 2.5, CHOH), 3.50 (1 H, dd, J 11.0,
3.2, one of CH2OH), 3.36 (1 H, dd, J 11.0, 7.5, one of CH2OH), 3.32 (2 H, app. s, CH2OH), 
2.68 - 2.64 (2 H, m, CH2CH=CH), 2.46 (1 H, br. s, OH), 1.94 (1 H, br. s, OH), 1.70 (1 H, br. 
s, OH), 1.50 (1 H, dd, J 14.3, 8.9, one of CCH2CHOH) and 1.33 (1 H, dd, J 14.3, 2.5, one 
of CCH2CHOH); 6 C (100 MHz) 130.0 (CH), 129.5 (CH), 127.9 (CH), 127.4 (CH), 70.4 (CH2),
69.6 (CH), 67.1 (CH2), 41.9 (C), 40.9 (CH2) and 26.5 (CH2).
l-Cyclohexyl-2-(l-(hydroxymethyl)cyclohexa-2,5-dienyl)ethanol (113f)
121f72
HO
OH
113f
Lactone 121f (1.39 g, 55 %) was prepared according to General Procedure 1. Reduction 
according to General Procedure 2 gave the title compound (0.65 g, 91 %) as a 
colourless oil (Found: M+-OH, 219.1760. C15H23O requires M, 219.1749); vmax (neat) 
3364, 2910, 2855, 1451, 1422, 1035 and 711 cm'1; 6 H (400 MHz) 6.05 - 5.96 (2 H, m, 2 x 
alkene CH), 5.68 (1 H, app. dq, J 10.4, 2.1, one of alkene CH), 5.41 (1 H, app. dq, J 10.4,
2.1, one of alkene CH), 3.59 (1 H, app. dt, J 8.5, 4.4, CHOH), 3.37 (2 H, app. s, CH2OH), 
2.79 - 2.64 (2 H, m, CH2CH=CH), 2.01 (1 H, br. s, OH), 1.78 - 1.59 (7 H, m), 1.49 -1.42 (2 
H, m, CH2) and 1.32-0.93 (5 H, m); 6 C (100 MHz) 130.6 (CH), 129.7 (CH), 127.9 (CH),
127.4 (CH), 73.0 (CH), 70.4 (CH2), 44.2 (CH), 42.3 (C), 41.9 (CH2), 29.0 (CH2), 27.7 (CH2),
26.5 (CH2), 26.5 (CH2), 26.3 (CH2) and 26.2 (CH2); m /z  (TOF ES+) 219 (M - OH, 89%), 201 
(100) and 155 (62).
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2-(l-(Hydroxymethyl)cyclohexa-2,5-dienyl)-l-phenylethanol (113g)
Ph
72 122g
Ph
HO
OH
113g
Ketoester 122g (3.2 g, 87 %) was prepared according to General Procedure 1. 
Reduction according to General Procedure 2, followed by crystallisation 
(CH2CI2/hexane) gave the title compound (1.0 g, 35 %) as a colourless solid, m.p. 
7 7 -8 0  °C (Found: MH+, 231.1378. C15Hi90 2 requires M, 231.1385); vmax (Nujol) 3281, 
1048, 1021, 712 and 699 cm'1; 6H (400 MHz) 7 .36-7.33 (3 H, m, aromatic CH), 
7 .31 -7 .24  (2 H, m, aromatic CH), 6.13 (1 H, app. dtd, J 10.2, 3.2, 1.6, one of alkene 
CH), 6.05 (1 H, app. dtd, J 10.2, 3.2, 1.6, one of alkene CH), 5.82 (1 H, app. dq, J 10.2,
2.0, one of alkene CH), 5.50 (1 H, app. dq, J 10.2, 2.0, one of alkene CH), 4.92 (1 H, app. 
br. d, J 9.7, CHOH), 3.44 (1 H, d, J 11.1, one of CH2OH), 3.40 (1 H, d, J 11.1, one of 
CH2OH), 2.86 - 2.71 (2 H, m, CH2CH=CH), 2.54 (1 H, br. s, OH), 1.89 (1 H, dd, J 14.4, 9.7, 
one of CH2), 1.79 (1 H, br. s, OH) and 1.67 (1 H, dd, J 14.4, 2.3, one of CH2); 6C (100 
MHz) 144.8 (C), 130.3 (CH), 129.4 (CH), 128.4 (CH), 128.3 (CH), 127.6 (CH), 127.4 (CH),
125.7 (CH), 71.9 (CH), 70.4 (CH2), 47.5 (CH2), 42.6 (C) and 26.6 (CH2); m /z (TOF ES+) 
231 (MH+, 41%), 230 (M +, 63), 213 (16), 195 (19), 132 (25) and 105 (100).
2-(l-(Hydroxymethyl)cyclohexa-2,5-dienyl)-2-phenylethanol (113h)
"Ph
121h72
HO
OH
113h
Lactone 121h (1.29 g, 40 %) was prepared from styrene oxide according to General 
Procedure 1. Reduction according to General Procedure 2 followed by chromatography 
on silica (33 % EtOAc in petroleum ether) gave the title compound (1.1 g, 84%) as a 
colourless solid, m.p. 8 3 -8 6  °C (Found: MH+, 231.1397. Ci5Hig02 requires M, 
231.1385); vmax (Nujol) 3265, 1377, 1032, 1000, 724 and 698 cm 1; 6H (400 MHz)
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7.28 - 7.13 (5 H, m, aromatic CH), 5.99 (1 H, app. dtd, J 10.2, 3.3, 1.7, one of alkene 
CH), 5.89 (1 H, app. dtd, J 10.3, 3.3, 1.7, one of alkene CH), 5.60 (1 H, app. dq, J 10.2,
2.1, one of alkene CH), 5.43 (1 H, app. dq, J 10.3, 2.1, one of alkene CH), 3-92 (1 H, dd, J
11.3, 5.4, one of Ctf2OH), 3.82 (1 H, dd, J 11.3, 9.1, one of CH2OH), 3.27 (1 H, d, J 10.6, 
one of CH2OH), 3.07 (1 H, d, J 10.6, one of CH2OH), 2.86 (1 H, dd, J 9.1, 5.4, CHAr), 2.60 
(1 H, app. dtt, J 23.2, 3.5,1.9, one of CH2CH=CH) and 2.53 (1 H, app. dtt, J 23.2, 3.1, 2.2, 
one of CH2CH=CH); 6c (100 MHz) 138.2 (C), 129.6 (CH), 129.6 (CH), 128.4 (CH), 128.3 
(CH), 128.1 (CH), 127.1 (CH), 126.6 (CH), 69.0 (CH2), 63.7 (CH2), 54.2 (CH), 44.5 (C) and
26.6 (CH2); m /z  (TOF ES+) 272 (M H+.CH3CN, 43 %), 231 (MH+, 12), 213 (100) and 195 
(58).
(15R,2ft5)-2-(l-(Hydroxymethyl)cyclohexa-2,5-dienyl)cyclohexanol (ll3i)
121 i
HO'
113172
Lactone 121i (1.19 g, 34 %) was prepared according to General Procedure 1. Reduction 
according to General Procedure 2  followed by chromatography on silica (33 % EtOAc in 
petroleum ether) gave the title com pound  (1.1 g, 92 %) as a colourless solid, m.p. 
67 - 70 °C (Found: MH+, 209.1540. Ci3H2i0 2 requires M, 209.1542); vmax (CH2CI2) 3296, 
2926, 2855, 1450, 1422, 1352, 1058, 980 and 713 cm'1; 6H (400 MHz) 5.95 (1 H, app. 
dtd, J 10.2, 3.3, 1.7, one of alkene CH), 5.87 (1 H, app. dtd, J 10.2, 3.3, 1.6, one of 
alkene CH), 5.72 (1 H, app. dq, J 10.3, 2.0, one of alkene CH), 5.53 (1 H, app. dq, J 10.3,
2.0, one of alkene CH), 3.61 (1 H, app. dt, J 10.1, 4.3, CHOH), 3.58 (1 H, d, J 10.8, one of 
CH2OH), 3.49 (1 H, d, J 10.8, one of CH2OH), 2.99 (2 H, br. s, OH), 2.71 - 2.58 (2 H, m, 
CH2CH=CH), 1.99 -1 .92 (1 H, m), 1.76 - 1.59 (3 H, m), 1.43 (1 H, ddd, J 12.5, 10.1, 3.7, 
CHCHOH), 1.33 - 1.04 (3 H, m) and 0.96 (1 H, app. dq, J 12.8, 3.3, one of CH2); 6c (100 
MHz) 130.0 (CH), 129.4 (CH), 127.0 (CH), 125.4 (CH), 71.3 (CH), 69.8 (CH2), 50.0 (CH),
44.8 (C), 36.4 (CH2), 26.8 (CH2), 26.7 (CH2), 25.7 (CH2) and 24.7 (CH2); m /z  (TOF ES+) 
250 (M H +.CH3CN, 100 %), 209 (MH+, 38), 191 (12) and 173 (11).
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((2S/?,3a/?5,7/?S,7a/?S)-7-lodo-2-methyl-2,3,3a,6,7,7a-hexahydrobenzofuran-3a- 
yl)methanol (114a) and ((l/?5,3ft5/5S/?,9f?5)-9-lodo-3-methyl-2-oxabicyclo(3.3.1)non- 
6-en-5-yl)methanol (115a)
Me
HO'
114a 115a
HO
OH
113a
lodocyclisation of diol 113a (178 mg, 1.06 mmol) according to General Procedure 3 
followed by chromatography on silica (10%  EtOAc in petroleum ether) gave the title 
compounds as colourless oils (115a: 17 mg, 5.5 %; 114a: 204 mg, 65.5 %).
Data for compound 114a: Found: MH+, 295.0202. C10H16IO2 requires M, 295.0195; vmax 
(neat) 3444, 2966, 1456, 1384, 1205, 1060, 834, 724 and 668 cm 1; 6H (400 MHz) 5.74 
(1 H, app. dt, J 10.0, 3.9, CH2CH=CH), 5.68 (1 H, app. dt, J 10.0, 1.5, CH2CH=CH), 
4.38 -4 .36  (2 H, m, CHICHO and CHICHO), 4.11 (1 H, app. doubled quintet, J 8.7, 6.1, 
CH3CHO), 3.69 (1 H, d, J 10.7, one of CH2OH), 3.60 (1 H, d, J 10.7, one of CH2OH), 
2.81-2 .74  (1 H, m, one of CH2CH=CH), 2.62 (1 H, dddd, J 17.8, 7.7, 3.6, 1.9, one of 
CH2CH=CH), 1.95 (1 H, dd, J 12.5, 6.4, one of CH2CHO), 1.73 (1 H, br. s, OH), 1.59 (1 H, 
dd, J 12.5, 8.7, one of CH2CHO) and 1.26 (3 H, d, J 6.0, CH3); 6C (100 MHz) 130.4 (CH),
127.3 (CH), 83.3 (CH), 73.3 (CH), 68.6 (CH2), 50.8 (C), 43.5 (CH2), 33.8 (CH2), 27.0 (CH) 
and 21.0 (CH3). m /z  (TOF ES+) 295 (MH*, 56%), 277 (100), 132 (37) and 119 (40).
Data for compound 115a: Found: MH+, 295.0179. CioHi6l02 requires M, 295.0195; vmax 
(CH2CI2) 3396, 2933, 1457, 1417, 1380, 1344, 1209, 1153, 1046, 789, 720 and 688 cm 1; 
6h (400 MHz) 6.01 (1 H, app. dt, J 10.0, 3.4, CH2CH=CH), 5.29 (1 H, app. dq, J 10.0, 2.0, 
CH2CH=CH), 4.50 - 4.48 (1 H, m, CHICHO), 4.29 (1 H, app. br. t, J 4.5, CHICHO), 3.97 (1 
H, app. dqd, J 12.2, 6.1, 2.8, CH3CHO), 3.63 (1 H, dd, J 10.9, 4.8, one of CH2OH), 3.50 (1 
H, dd, J 10.9, 5.4, one of CH2OH), 2.83 (1 H, app. ddt, J 19.9, 5.4, 2.5, one of 
CH2CH=CH), 2.34 (1 H, app. br. d, J 19.9, one of CH2CH=CH), 1.80 (1 H, dd, J 13.0, 11.3, 
one of CH2CHO), 1.67 (1 H, br. t, J 5.6, OH), 1.57 (1 H, dd, J 13.0, 2.8, one of CH2CHO) 
and 1.14 (3 H, d, J 6.1, CH3); 6C (100 MHz) 128.4 (CH), 127.2 (CH), 72.7 (CH), 71.4 (CH2),
126
65.0 (CH), 41.2 (CH2), 40.2 (C), 36.2 (CH), 30.1 (CH2) and 21.2 (CH3); m /z  (TOF ES+) 295
(10 %), 277 (18), 208 (100) and 146 (14).
((25/?,3a/?5/7/?5/7a/?5)-2-Butyl-7-iodo-2,3/3a/6/7/7a-hexahydrobenzofuran-3a- 
yl)methanol (114b)
n-Bu
HO'
114b
HO
OH
113b
lodocyclisation of diol 113b (480 mg, 2.29 mmol) according to General Procedure 3 
followed by chromatography on silica (14%  EtOAc in petroleum ether) gave the title 
compound (153 mg, 65 %) as a pale yellow oil (Found: MH+, 337.0667. Ci3H22l0 2 
requires M, 337.0665); vma* (neat) 3419, 2928, 2863, 1456, 1046 and 728 cm'1; 6 H (400 
MHz) 5.75 (1 H, app. dt, J 9.9, 3.8, CH2CH=CH), 5.68 (1 H, app. br. d, J 9.9, CH2CH=CH), 
4.37 (1 H, app. dt, J 4.5, 7.2, CHICHO), 4.34 (1 H, d, J 7.3, CHICHO), 3.92 (1 H, app. dq, J
9.0, 6.3, BuCHO), 3.69 (1 H, d, J 10.7, one of CH2OH), 3.60 (1 H, d, J 10.7, one of 
CH2OH), 2.77 (1 H, app. dtd, J 17.9, 4.5, 1.3, one of CH2CH=CH), 2.62 (1 H, dddd, J 17.9,
7.2, 3.5, 1.8, one of CH2CH=CH), 1.91 (1 H, dd, J 12.5, 6.3, one of CH2CHO), 1.71 (1 H, 
br. s, OH), 1.70 -1.62 (1 H, m, one of CH2), 1.61 (1 H, dd, J 12.5, 9.0, one of CH2CHO),
1.50 -1 .39 (1 H, m, one of CH2), 1.35 -1 .2 4  (4 H, m, 2 x CH2) and 0.89 (3 H, t, J 7.0, 
CH3); 6 c (100 MHz) 130.4 (CH), 127.3 (CH), 82.8 (CH), 77.4 (CH), 68 .6  (CH2), 50.3 (C),
41.7 (CH2), 35.3 (CH2), 33.7 (CH2), 28.2 (CH2), 26.7 (CH), 22.7 (CH2) and 14.0 (CH3); m /z  
(TOF ES+) 337 (MH+, 81 %), 319 (71), 268 (100), 250 (87), 209 (48), 191 (46), 173 (34), 
161 (49) and 132 (38).
r
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((2RS,3aRS,7RS,7aRS)-2-tert-Buty\-7-\o6o-2f3,33,6,7,7a-hexahy6robenzofuran-3a-
yl)methanol (114c)
J-Bu
HO
114c
HO
OH
113c
lodocyclisation of diol 113c (186 mg, 0.89 mmol) according to General Procedure 3 
followed by chromatography on silica (14 % EtOAc in petroleum ether) gave the title 
compound (265 mg, 89 %) as a colourless solid, m.p. 84 - 86  °C (Found: MH+, 337.0675. 
C13H22IO2 requires M, 337.0665); vmax (CH2CI2) 3389, 2954, 2858, 1464, 1396, 1362, 
1205, 1044, 973, 780 and 727 cm'1; 6 H (400 MHz) 5.71 (1 H, app. dt, J 10.0, 3.9, 
CH2CH=CH), 5.62 (1 H, app. dt, J 10.0, 1.5, CH2CH=CH), 4.36 (1 H, app. td, J 7.0, 4.8, 
CHICHO), 4.23 (1 H, d, J 7.0, CHICHO), 3.65 (1 H, dd, J 10.4, 4.5, one of CH2OH),
3.58 - 3.52 (2 H, m, one of CH2OH and tBuCHO), 2.73 (1 H, app. dtd, J 17.9, 4.6,1.6, one 
of CH2CH=CH), 2.52 (1 H, dddd, J 17.9, 6.9, 3.8, 1.7, one of CH2CH=CH), 1.67 (1 H, dd, J
12.5, 9.9, one of CH2CHO), 1.61 (1 H, dd, J 12.5, 6.5, one of CH2CHO), 1.56 (1 H, br. s, 
OH) and 0.82 (9 H, s, C(CH3)3); 6 C (100 MHz) 130.4 (CH), 127.2 (CH), 85.0 (CH), 82.3 
(CH), 68.3 (CH2), 49.9 (C), 36.8 (CH2), 33.2 (CH2), 33.1 (C), 26.6 (CH) and 25.7 (3 x CH3); 
m /z  (TOF ES+) 337 (MH+, 28 %) and 319 (100).
Single crystal X-ray diffraction data for this compound has been deposited with the 
CCDC, number 646880, and can be obtained free of charge via 
http://www.ccdc.cam.ac.uk/data request/cif. The Ortep plot (50% probability thermal 
ellipsoids) is shown below:
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((2/?S,3aR5,7/?S,7a/?S)-2-(Chloromethyl)-7-iodo-2,3,3a,6,7,7a-hexahydrobenzofuran- 
3a-yl)methanol (114d)
f H 2C\
HO
114d
HO'
OH
113d
lodocyclisation of diol 113 (81 mg, 0.40 mmol) according to General Procedure 3 
followed by chromatography on silica (14 % EtOAc in petroleum ether) gave the title 
compound (115 mg, 87%) as a colourless oil; (Found: M +-l, 201.0681. Ci0Hi435CIO2 
requires M, 201.0682); vmax (neat) 3418, 2936, 2874, 1424, 1371, 1315, 1204, 1140, 
1047, 971 and 729 cm4; 6 H (400 MHz) 5.77 (1 H, app. dt, J 10.0, 3.9, CH2CH=CH), 5.68 
(1 H, app. dt, J 10.0, 1.7, CH2CH=CH), 4.43 (1 H, d, J 7.0, CHICHO), 4.37 (1 H, app. td, J
6 .8 , 4.8, CHICHO), 4 .24 -4 .17  (1 H, m, CH2CHO), 3.77 (1 H, d, J 10.8, one of CH2OH),
3.70 (1 H, d, J 10.8, one of CH2OH), 3.62 (1 H, dd, J 11.2, 4.9, one of CH2CI), 3.57 (1 H, 
dd, J 11.2, 5.6, one of CH2CI), 2.82 (1 H, app. dtd, J 18.1, 4.3, 1.7, one of CH2CH=CH), 
2.61 (1 H, dddd, J 18.1, 6.4, 3.9, 1.7, one of CH2CH=CH) and 1.98 (2 H, app. d, J 7.7, 
CH2CHO); 6 c (100 MHz) 130.3 (CH), 127.4 (CH), 83.3 (CH), 78.7 (CH), 68.5 (CH2), 50.2
129
(C), 43.4 (CH2), 33.9 (CH2), 27.1 (CH) and 21.1 (CH3); m /z (TOF ES+) 203 ((M -lf  (37CI),
11 %), 201 ((M-l)* (35CI), 32), 105 (28) and 91 (100).
((ZflS^aflS^flS^aflSJ-Z-Hydroxymethyl-y-iodo-ZjB/Sa^^ya-hexahydrobenzofuran-
3a-yl)methanol (114e)
pH2OH
HO‘
114e
HO
OH
113e
lodocyclisation of triol 113e (45 mg, 0.25 mmol) according to General Procedure 3 
followed by chromatography on silica (67 % EtOAc in petroleum ether) gave the title 
compound (69 mg, 91 %) as a colourless solid, m.p. 87 - 88  °C (Found: MH+.CH3CN, 
352.0407. C12H19INO3 requires M, 352.0410); vmax (Nujol) 3215, 1144, 1042, 1029 and 
726 cm4 ; 6 H (400 MHz) 5.69 - 5.60 (2 H, m, 2 x alkene CH), 4.34 (1 H, d, J 8.2, CHICHO),
4.28 (1 H, app. td, J 8.1, 4.8, CHICHO), 4 .11 -4 .02  (1 H, m, CH2CHO), 3.76 (1 H, dd, J
12.0, 2.4, one of CH2OH), 3.64 (1 H, d, J 10.8, one of CH2OH), 3.54 (1 H, d, J 10.8, one of 
CH2OH), 3.48 (1 H, dd, J 12.0, 4.1, one of CH2OH), 2.74 (1 H, app. dtd, J 17.9, 4.6, 1.1, 
one of CH2CH=CH), 2.62 - 2.54 (1 H, dddd, J 17.9, 7.8, 2.9, 1.9, one of CH2CH=CH), 2.38 
(1 H, br. s, OH), 2.23 (1 H, br. s, OH), 1.88 (1 H, dd, J 12.7, 8.4, one of CH2CHO) and 1.79 
(1 H, dd, J 12.7, 7.4, one of CH2CHO); 6 C (100 MHz) 130.3 (CH), 127.3 (CH), 83.7 (CH),
77.4 (CH), 68.2 (CH2), 63.9 (CH2), 50.5 (C), 36.5 (CH2), 34.3 (CH2) and 26.6 (CH2); m /z  
(TOF ES+) 352 (MH+.CH3CN, 32 %), 328 (25), 293 (100) and 165 (42).
130
((2/?S,3a/?S,7K5,7aRS)-2-Cyclohexyl-7-iodo-2,3,3a,6,7,7a-hexahydrobenzofuran-3a-
yl)methanoi (114f)
xc-C6Hi i
HO
114f
HO'
OH
113f
lodocyclisation of diol 113 (277 mg, 1.17 mmol) according to General Procedure 3 
followed by chromatography on silica (14 % EtOAc in petroleum ether) gave the title 
compound (188 mg, 44 %) as a pale yellow oil (Found: MH+, 363.0828. C15H24IO2 
requires M, 363.0821); vmax (neat) 3403, 2914, 1446, 1385, 1356, 1266, 1204, 1048, 
975, 777 and 668  cm'1; 6 H (400 MHz) 5.75 (1 H, app. dt, J 9.9, 3.9, CH2CH=CH), 5.68 (1 
H, app. br. d, J 9.9, CH2CH=CH), 4.38 (1 H, app. td, J 7.2, 4.7, CHICHO), 4.31 (1 H, d, J 
7.4, CHICHO), 3.71 - 3.61 (2 H, m, one of CH2OH and CH2CHO), 3.59 (1 H, d, J 10.4, one 
of CH2OH), 2.77 (1 H, app. dtd, J 17.8, 4.5, 1.3, one of CH2CH=CH), 2.60 (1 H, dddd, J
17.8, 7.2, 3.6, 1.8, one of CH2CH=CH), 1.95 -1 .87  (1 H, br. resonance, OH), 1.81 (1 H, 
dd, J 12.5, 6.3, one of CH2CHO), 1.76 -1 .5 4  (5 H, m), 1.44 -1.35 (1 H, m), 1.30 -1.10 (3 
H, m) and 0.99-0 .83  (3 H, m); 6 C (100 MHz) 130.4 (CH), 127.3 (CH), 82.5 (CH), 81.6 
(CH), 68 .5  (CH2), 50.0 (C), 42.7 (CH), 39.3 (CH2), 33.5 (CH2), 30.0 (CH2), 28.6 (CH2), 26.9 
(CH), 26.5 (CH2), 25.9 (CH2) and 25.8 (CH2); m /z  (TOF ES+) 363 (MH+, 100 %), 294 (61), 
276 (73) and 199 (58).
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([2RS,3aRS,7RS,7aRS)-7-\odo-2-pheny\-2,3,3a,6,7t7a-hexahy/6robenzoiuran-3a- 
yl)methanol (114g) and ((lRS,3S/?,55/?,9/?S)-9-lodo-3-phenyl-2-oxabicyclo(3.3.1)non- 
6-en-5-yl)methanol (115g)
Ph
HO'
114g
HO
115g
HO'
OH
113g
lodocyclisation of diol 113g (198 mg, 0.86 mmol) according to General Procedure 3 
followed by chromatography on silica (14 % EtOAc in petroleum ether) gave compound 
114g (181 mg, 59 %) as a colourless solid and compound 115g (12 mg, 4 %) as a pale 
yellow waxy solid.
Data for compound 114g: Found: M H+, 357.0363. C15H18IO2 requires M, 357.0352; vmax 
(Nujol) 3442, 1199, 1014, 721 and 700 cm 1; 6 H (400 MHz) 7.29 - 7.18 (5 H, m, 5 x 
aromatic CH), 5.80 (1 H, app. dt, J 10.2, 4.0, CH2CH=CH), 5.68 (1 H, app. br. d, J 10.2, 
CH2CH=CH), 4.89 (1 H, dd, J 9.6, 6.2, CHAr), 4.56 (1 H, d, J 6.2, CHICHO), 4.46 (1 H, app. 
q, J 5.6, CHICHO), 3.76 (1 H, dd, J 10.7, 6.9, one of CH2OH), 3.67 (1 H, dd, J 10.7, 50.0, 
one of CH2OH), 2.83 (1 H, app. br. d, J 18.3, one of CH2CH=CH), 2.57 (1 H, app. br. dt, J
18.3, 4.9, one of CH2CH=CH), 2.15 (1 H, dd, J 12.6, 6.2, one of CH2CHAr), 1.99 (1 H, dd, J
12.6, 9.6, one of CH2CHAr) and 1.62 (1 H, dd, J 6.9, 5.0, OH); 6 C (100 MHz) 141.7 (C),
129.7 (CH), 128.5 (CH), 127.7 (CH), 127.3 (CH), 125.8 (CH), 82.6 (CH), 79.3 (CH), 68.2 
(CH2), 50.3 (C), 45.1 (CH2), 32.8 (CH2) and 25.9 (CH); m/z (TOF ES+) 374 (MH+.NH4, 
43 %), 357 (MH*, 52), 339 (43), 311 (30), 270 (25), 194 (38) and 183 (100).
Single crystal X-ray diffraction data for this compound has been deposited with the 
CCDC, number 646881, and can be obtained free of charge via 
http://www.ccdc.cam.ac.uk/data reauest/cif. The Ortep plot (50% probability thermal 
ellipsoids) is shown below:
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Data for compound 115g: Found: M H+, 357.0314. Ci5Hi8I0 2 requires M, 357.0352; vmax 
(CH2CI2) 3427, 2920, 2852, 1494, 1453, 1415, 1344, 1264, 1151, 1026, 979, 937, 745 
and 689 cm'1; 6H (400 MHz) 7.28 - 7.18 (5 H, m, 5 x aromatic CH), 6.07 (1 H, app. dt, J
10.1, 3.3, CH2CH=CH), 5.33 (1 H, app. dq, J 10.1, 1.7, CH2CH=CH), 4.83 (1 H, dd, J 11.5,
2.8, CHAr), 4.60 - 4.58 (1 H, br. s, CHICHO), 4.42 (1 H, app. t, J 4.4, CHICHO), 3.61 (1 H, 
br. d, J 10.8, one of CH2OH), 3.47 (1 H, dd, J 10.8, 3.0, one of CH2OH), 2.86 (1 H, app. 
ddt, J 20.0, 5.2, 2.6, one of CH2CH=CH), 2.40 (1 H, br. app. d, J 20.0, one of CH2CH=CH),
2.06 (1 H, dd, J 13.4, 11.5, one of CH2CHAr), 1.73 (1 H, dd, J 13.4, 2.8, one of CH2CHAr) 
and 1.51 (1 H, br. s, OH); 6C (100 MHz) 141.7 (C), 128.9 (CH), 128.4 (CH), 127.6 (CH),
127.1 (CH), 126.0 (CH), 73.0 (CH), 71.5 (CH), 71.3 (CH2), 41.7 (CH2), 40.5 (C), 35.6 (CH) 
and 30.1 (CH2); m /z  (TOF ES+) 357 (M H+, 12 %), 270 (100), 211 (49), 193 (41) and 183 
(35).
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((3/?S,3aS/?,7/?S,7a/?S)-7-lodo-3-phenyi-2,3,3a,6,7,7a-hexahydrobenzofuran-3a- 
yl)methanol (114h) and ((l#5,45/?,5ft5,9/?5)-9-lodo~4-phenyl-2-oxabicyclo(3.3.1)non-
6-en-5-yl)methanol (115h)
lodocyclisation of diol 113h (200 mg, 0.87 mmol) according to General Procedure 3 
followed by chromatography on silica (14 % EtOAc in petroleum ether) gave compound 
114h (243 mg, 79 %) as a colourless solid, m.p. 89 - 91 °C and compound 115h (10 mg, 
3 %) as a pale yellow waxy solid.
Data for compound 114h: Found: M +.NH3, 374.0599. C15H21NO2I requires M, 374.0617; 
Vmax (Nujol) 3313, 1044, 1011, 726 and 704 cm 1; 6 H (400 MHz) 7.28 - 7.18 (3 m, m, 3 x 
aromatic CH), 7.12 - 7.09 (2 H, m, 2 x aromatic CH), 5.75 (1 H, app. dt, J 10.2, 4.1, 
CH2CH=CH), 4.94 (1 H, app. br. d, J 10.2, CH2CH=CH), 4.54 (1 H, d, J 6.0, CHICHO), 4.39 
(1 H, app. q, J 5.8, CHICHO), 4.09 (1 H, dd, J 8 .6 , 7.2, one of CH20), 3.93 (1 H, dd, J 9.6,
8 .6 , one of CH20), 3.78 (1 H, d, J 11.0, one of CH2OH), 3.54 (1 H, dd, J 9.6, 7.2, CHAr),
3.50 (1 H, d, J 11.0, one of CH2OH), 2.76 (1 H, app. dtd, J 18.0, 4.5, 2.1, one of 
CH2CH=CH), 2 .56-2 .48  (1 H, m, one of CH2CH=CH) and 1.52 (1 H, br. s, OH); 6 C (100 
MHz) 136.6 (C), 129.3 (2 x CH), 128.2 (2 x CH), 128.1 (CH), 127.3 (CH), 127.1 (CH), 82.4 
(CH), 71.6 (CH2), 66.2 (CH2), 52.2 (C), 50.8 (CH), 32.4 (CH2) and 26.1 (CH); m /z  (TOF ES+) 
398 (MH+.CH3CN, 100 %), 374 (59), 357 (59) and 270 (30).
Data for compound 115h: Found: MH+, 357.0364. Ci5Hi8l02 requires M, 357.0352; vmax 
(CH2CI2) 3436, 2924, 1494, 1462, 1416, 1352, 1266, 1151, 1062, 970, 910, 8 6 8 , 796, 
721, 734 and 702 cm'1; 6 H (400 MHz) 7.24 - 7.16 (3 H, m, aromatic CH), 7.12 (2 H, app. 
br. d, J 6.5, aromatic CH), 6.13 (1 H, app. dt, J 10.0, 3.2, CH2CH=CH), 4.99 (1 H, app. dq, 
J 10.0, 1.6, CH2CH=CH), 4 .76 -4 .73  (1 H, m, CHICHO), 4.33 (1 H, app. br. t, J 4.3, 
CHICHO), 3.98 (1 H, app. t, J 11.7, one of CH20), 3.75 (1 H, dd, J 11.7, 4.6, one of CH20),
3.47 (1 H, dd, J 11.9, 4.6, CHAr), 3.41 (1 H, d, J 11.1, one of CH2OH), 3.20 (1 H, d, J 11.1, 
one of CH2OH), 2.89 (1 H, app. dtt, J 20.1, 5.3, 2.6, one of CH2CH=CH), 2.42 (1 H, app.
113h 114h 115h
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br. d, J 20.1, one of CH2CH=CH) and 1.45 (1 H, br. s, OH); 6C (100 MHz) 137.8 (C), 129.2 
(CH), 128.3 (4 x CH), 127.5 (CH), 125.1 (CH), 72.6 (CH), 67.7 (CH2), 64.0 (CH2), 47.6 (CH),
43.8 (C), 37.0 (CH) and 30.3 (CH2); m /z  (TOF ES+) 374 (MH+.NH4, 63 %), 357 (MH+,29), 
310 (50), 280 (30) and 229 (100).
((4aSfl,5aKS,6KS,9a5K,9b/?5)-6-lodo-l,2,3,4,4a,5a,6,7,9a,9b- 
decahydrodibenzo(b,d)furan-9a-yl)methanol (114i)
HO'
114i
HO
OH
113i
lodocyclisation of diol 113i (223 mg, 1.07 mmol) according to General Procedure 3 
followed by chromatography on silica (14%  EtOAc in petroleum ether) gave the title 
compound (222 mg, 62 %) as a colourless oil (Found: MH+.CHsCN, 376.0770. Ci5H23IN02 
requires M, 376.0774); vmax (neat) 3418, 2929, 2858, 1454, 1427, 1336, 1197, 1125, 
1088, 1052, 959, 878, 836 and 726 cm'1; 6H (400 MHz) 5.95 - 5.90 (1 H, m, CH2CH=CH),
5.59 (1 H, app. br. dd, J 10.4, 2.6, CH2CH=CH), 4.52 (1 H, app. q, J 3.5, CHICHO), 4.48 (1 
H, d, J 3.5, CHICHO), 3.90 (1 H, d, J 11.0, one of CH2OH), 3.80 (1 H, d, J 11.0, one of 
CH2OH), 3.12 (1 H, app. dt, J 10.7, 4.0, CHCHO), 2.75 (1 H, app. ddt, J 18.5, 4.7, 2.5, one 
of CH2CH=CH), 2.56 - 2.49 (1 H, m, one of CH2CH=CH), 2.09 - 2.04 (1 H, m), 1.90 -1.65  
(5 H, m) and 1.31 -1 .00 (4 H, m); 6C (100 MHz) 127.3 (CH), 126.9 (CH), 81.5 (CH), 81.1 
(CH), 66.8 (CH2), 51.8 (CH), 49.0 (C), 31.6 (CH2), 30.9 (CH2), 26.6 (CH), 25.4 (CH2), 25.1 
(CH2) and 24.0 (CH2); m /z  (TOF AP+) 376 (MH+.CH3CN, 100 %) and 173 (10).
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{(lSR,2RS,6RS,8RS,13RS)-13-\o6o-7-oxotr\cyc\o[6A.l2'6.0)\ri6ec-3-en-2-y\)methano\
(115i)
HO'
115i
HO'
OH
113i
lodocyclisation of compound 113i (113 mg, 0.54 mmol) according to General Procedure 
3, with the omission of NaHC03, followed by chromatography on silica (14 % EtOAc in 
petroleum ether) gave the title compound (103 mg, 57 %) as a colourless oil (Found: 
MH+.CH3CN, 376.0770. C15H23INO2 requires M, 376.0774); vmax (CH2CI2) 3425, 2927, 
2857, 1448, 1416, 1365, 1264, 1150, 1067, 962, 923, 904, 8 6 8 , 805, 737 and 700 cm 1; 
6 h (400 MHz) 5.98 (1 H, app. dt, J 10.1, 3.1, CH2CH=CH), 5.03 (1 H, app. dq, J 10.1, 2.0, 
CH2CH=CH), 4.67 - 4.65 (1 H, m, CHICHO), 4.29 - 4.25 (1 H, m, CHICHO), 3.75 (1 H, d, J
11.5, one of CH2OH), 3.53 (1 H, d, J 11.5, one of CH2OH), 3.33 (1 H, app. td, J 10.5, 3.9, 
CHCHO), 2.81 (1 H, app. ddt, J 20.0, 5.6, 2.8, one of CH2CH=CH), 2.31 (1 H, app. br. dt, J
20.0, 2.5, one of CH2CH=CH), 1.87 -1 .5 0  (6  H, m, cyclohexane CH and OH), 1.31 -1.09  
(3 H, m, cyclohexane CH) and 0.77 (1 H, app. qd, J 12.4, 3.6, cyclohexane CH); 6 C (100 
MHz) 129.5 (CH), 125.6 (CH), 72.5 (CH), 72.2 (CH), 66.7 (CH2), 46.6 (CH), 42.7 (C), 38.9 
(CH), 32.3 (CH2), 30.5 (CH2), 26.3 (CH2), 25.7 (CH2) and 24.5 (CH2); m /z (TOF AP+) 376 
(MH+.CH3CN, 100 %) and 173 (9).
3-{l-(Hydroxymethyl)cyclohexa-2,5-dienyl)-2-methylpropan-l-ol (118)
CH3
C02Me
72
OH
127
OHHO'
118
H,C
126
A solution of methyl cyclohexa-2 ,5 -diene-l-carboxylate 72 (1.50 g, 10.9 mmol) in THF 
(3 ml) was added dropwise to a cooled (-78 °C) solution of LDA (12 mmol, 1.1 equiv.) in
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THF (30 ml). The resulting suspension was stirred for 30 min before addition of 5- 
methyl-2,2-dioxo-l,3,2-dioxathiane 12666 (1.82 g, 12 mmol) as a solution in THF (5 mL). 
After stirring at -78 °C for 1 h the reaction was allowed to warm to room temperature 
and stirred overnight. 2M aqueous HCI (50 ml) was added, the organic layer separated 
and the aqueous phase extracted with diethyl ether (2 x 25 ml). The combined organic 
extracts were dried over sodium sulfate and concentrated in vacuo. Chromatography 
of the residue on silica (14 % EtOAc in petroleum ether) gave the lactone, 127 (1.29 g, 
67 %), as a pale yellow oil. A solution of lactone 127 (1.20 g, 6.7 mmol) in THF (4 ml) 
was added to a suspension of LiAIH4 (0.46 g, 13.5 mmol, 2 equiv.) in THF (20 ml). After 
stirring for 15 min the reaction was quenched with sufficient 2M aqueous NaOH to 
turn the aluminium salts into a granular consistency. The mixture was dried over 
sodium sulfate, filtered and concentrated to give a residue that was purified by 
chromatography on silica (33 % EtOAc in petroleum ether) to give the title compound 
(0.59 g, 48 %) as a colourless oil (Found: MH+, 183.1370. C11H19O2 requires M, 
183.1385); vmax (CDCI3) 3358, 2922, 1456, 1423, 1378, 1034, 947 and 711 cm'1; 5H (400 
MHz) 5.96 - 5.87 (2 H, m, 2 x alkene CH), 5.40 (1 H, app. dq, J 10.1, 2.1, one of alkene 
CH), 5.35 (1 H, app. dq, J 10.1, 2.1, one of alkene CH), 3.37 (1 H, dd, J 10.4, 6.0, one of 
CH2OH), 3.33 (1 H, dd, J 10.4, 6.3, one of CH20 H), 3.25 (1 H, d, J 10.5, one of CH2OH), 
3.23 (1 H, d, J 10.5, one of CH20 H), 2.68 - 2.56 (2 H, m, CH2CH=CH), 1.69 -1.61 (1 H, m, 
CHCH3), 1 54, (2 H, br. s, OH), 1.38 (1 H, dd, J 13.9, 4.7, one of CH2CHCH3), 1.03 (1 H, 
dd, J 13.9, 6 .6 , one of CW2CHCH3) and 0.86 (3 H, d, J 6 .8 , CH3); 6C (100 MHz) 130.4 (CH),
130.0 (CH), 127.7 (CH), 127.1 (CH), 70.7 (CH2), 68.7 (CH2), 43.3 (C), 40.2 (CH2), 32.4 
(CH), 26.6 (CH2) and 18.9 (CH3); m /z  (TOF ES+) 224 (MH+.CH3CN, 100 %), 183 (MH+, 11) 
and 165 (53).
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((3SA?,4a/?5,8/?S,8a/?5)-8-lodo-3-methyl-3,4,4a,7,8,8a-hexahydro-2H-chromen-4a- 
yl)methanol (119) and ((ISA?,4SA?,6/?5,105/?)-10-iodo-4-methyl-2-oxabicyclo(4.3.1)dec-
7-en-6-yl)methanol (120)
Me Me
HO OH
118
HO
119 120
lodocyclisation of diol 118 (60 mg, 0.33 mmol) according to General Procedure 3 
followed by chromatography on silica (14 % EtOAc in petroleum ether) gave compound 
119 (42 mg, 41 %) as a colourless oil and compound 120 (10 mg, 10 %) as a colourless 
oil.
119 (42 mg, 41%): Found: MH+, 309.0372. Ci0Hi4O requires M, 309.0352; vmax (neat) 
3406, 2923, 2874, 1456, 1383, 1213, 1090, 1053, 923 and 717 cm'1; 6H (400 MHz) 5.66 
(1 H, app. dt, J 10.1, 3.8, CH2CH=CH), 5.37 (1 H, app. br. d, J 10.1, CH2CH=CH), 4.49 (1 H, 
app. q, J 6.0, CHICHO), 3.99 (1 H, d, J 6.2, CHICHO), 3.96 (1 H, dd, J 11.3, 4.9, one of 
CH2OH), 3.78 (1 H, ddd, J 11.2, 4.6, 0.9, one of CH20), 3.54 (1 H, dd, J 11.3, 8.3, one of 
CH2OH), 3.11 (1 H, dd, J 11.2, 8.5, one of CH20), 3.04 (1 H, dddd, J 18.9, 6.2, 4.2, 1.8, 
one of CH2CH=CH), 2.72 (1 H, dddd, J 18.9, 5.5, 3.5, 2.4, one of CH2CH=CH), 1.80 -1.72  
(1 H, m, CHCH3), 1.64 (1 H, dd, J 8.3, 4.9, OH), 1.56 - 1.53 (2 H, m, CH2CHCH3) and 0.89 
(3 H, d, J 6.8, CH3); 6c (100 MHz) 131.2 (CH), 126.4 (CH), 76.4 (CH), 70.2 (CH2), 69.4 
(CH2), 41.7 (C), 39.0 (CH2), 34.9 (CH2), 27.1 (CH), 22.2 (CH) and 18.1 (CH3); m /z  (TOF 
ES+) 350 (MH+.CH3CN, 11 %), 309 (MH+, 12), 291 (100), 181 (20), 164 (47) and 145 (27).
120 (10 mg, 10%): Found: MH+, 309.0367. Ci0Hi4O requires M, 309.0352; vmax (CDCI3) 
3432, 2922, 1460, 1421, 1273, 1106, 1055, 872, 806 and 690 cm'1; 6H (400 MHz) 
5.79 - 5.73 (1 H, m, one of alkene CH), 5.22 (1 H, app. ddt, J 10.4, 2.9,1.6, one of alkene 
CH), 4.76 (1 H, app. dt, J 3.5, 1.6, CHICHO), 4.53 - 4.50 (1 H, m, CHICHO), 3.64 - 3.56 (2 
H, m, CH2OH), 3.49 (1 H, app. dt, J 12.9, 2.2, one of CH20), 3.35 (1 H, dd, J 12.9, 9.8, 
one of CH20), 2.90 (1 H, app. dq, J 18.5, 2.9, one of CH2CH=CH), 2.31 (1 H, app. ddq, J
18.5, 5.2, 1.7, one of CH2CH=CH), 1.88 (1 H, app. br. t, J 7.0, OH), 1 .86-1.79 (1 H, m, 
CHCH3), 1.70 (1 H, ddd, J 14.0, 4.6, 1.7, one of CH2CHCH3), 1.54 (1 H, dd, J 14.0, 12.4,
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one of CH2CHCH3) and 0.83 (3 H, d, J 6.9, CH3); 6 C (100 MHz) 126.0 (CH), 125.4 (CH),
77.3 (CH2), 74.7 (CH), 69.5 (CH2), 42.6 (C), 42.2 (CH2), 37.1 (CH), 33.1 (CH), 32.0 (CH2) 
and 17.9 (CH3); m /z  (TOF AP+) 309 (MH+, 100 %) and 291 (23).
((lR5,55/?,7/?S,85R)-8-lodo-7-methyl-6-oxabicyclo(3.2.1)oct-2-en-l-yl)methanol (116a) 
and l-((lS/?,55/?,85ft)-8-iodo-6-oxabicyclo(3.2.1)oct-2-en-l-yl)ethanol (117a)
lodocyclisation of diol 74a (90 mg, 0.58 mmol) according to General Procedure 3 
followed by chromatography on silica (14 % EtOAc in petroleum ether) gave a mixture 
of the title compounds (118 mg, 72 %) as a colourless oil. Further chromatography on 
silica gel (10% EtOAc in petroleum ether) provided analytical samples of the individual 
compounds.
Data for compound 116a: Found: M +.CH3CN, 322.0327. CnHi7IN02 requires M, 
322.0304; vmax (CH2CI2) 3419, 2927, 1417, 1379, 1318, 1235, 1202, 1172, 1124, 1056, 
1004, 918, 876, 848, 815, 737 and 638 cm'1; 6H (400 MHz) 5.74 (1 H, app. dtd, J 9.8, 3.1,
1.5, CH2CH=CH), 5.14 (1 H, app. dq, J 9.8, 1.7, CH2CH=CH), 4.47 (1 H, dd, J 5.4, 1.2, 
CHICHO), 4.27 (1 H, app. br. dd, J 5.0, 1.9, CHICHO), 4.21 (1 H, q, J 6.2, CHCH3), 3.63 (1 
H, dd, J 11.4, 5.4, one of CH2OH), 3.59 (1 H, dd, J 11.4, 5.1, one of CH2OH), 2.59 (1 H, br. 
app. dq, J 18.7, 1.7, one of CH2CH=CH), 2.26 (1 H, app. dq, J 18.7, 2.6, one of 
CH2CH=CH), 1.61 (1 H, app. t, J 5.3, OH) and 1.18 (3 H, d, J 6.2, CH3); 6C (100 MHz)
127.0 (CH), 126.9 (CH), 80.2 (CH), 75.5 (CH), 62.1 (CH2), 49.7 (C), 35.4 (CH2), 27.5 (CH) 
and 16.8 (CH3); m /z  (TOF ES+) 322 (MH+.CH3CN, 6 %), 280 (9), 262 (49), 218 (100) and 
132 (60).
Data for compound 117a: Found: MH+.CH3CN, 322.0300. CnHi7lN02 requires M, 
322.0304; vmax (CH2CI2) 3435, 2930, 1458, 1418, 1376, 1250, 1169, 1073, 1013, 919, 
872, 824 and 725 cm'1; 6H (400 MHz) 5.66 (1 H, app. dtd, J 9.8, 3.2, 1.5, CH2CH=CH),
5.51 (1 H, app. dq, J 9.8, 1.8, CH2CH=CH), 4.46 (1 H, dd, J 5.5, 1.5, CHICHO), 4.36 - 4.33
H H
74a 116a 117a
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(1 H, m, CHICHO), 3.93 (1 H, d, J 6.8, one of CH20), 3.86 (1 H, q,J  6.5, CHCH3), 3.80 (1 H, 
d, J 6.8, one of CH20), 2.61 (1 H, app. doubled quintet, J 18.8, 2.2, one of CH2CH=CH),
2.34 - 2.28 (1 H, m, one of CH2CH=CH), 1.60 (1 H, br. s, OH) and 1.20 (3 H, d, J 6.5, CH3); 
6c (100 MHz) 130.3 (CH), 126.2 (CH), 77.2 (CH), 73.7 (CH2), 66.5 (CH), 50.4 (C), 34.8 
(CH2), 26.9 (CH) and 18.6 (CH3); m /z  (TOF ES+) 322 (MH+.CH3CN, 28%) and 263 (100).
((IRS, SSR,7RS, 85fi)-7-(2-Bromophenyl)-8-iodo-6-oxabicyclo(3.2.1)oct-2-en-l- 
yl)methanol (116b) and (2-bromophenyl)-((15R,55R,8SR)-8-iodo-6- 
oxabicyclo(3.2.1)oct-2-en-l-yl)methanol (117b)
HO' OH
74b
H
HO
116b
lodocyclisation of diol 74b (191 mg, 0.65 mmol) according to General Procedure 3 
followed by chromatography on silica (14 % EtOAc in petroleum ether) gave compound 
116b (109 mg, 40 %) as a colourless solid and compound 117b (88 mg, 32 %) as a 
colourless oil.
116b (109 mg, 40 %): m.p. 130 - 132 °C; vmax (CH2CI2) 3454, 2906, 1470, 1418, 1267, 
1203, 1171, 1105, 1036, 1011, 916, 750, 732 and 637 cm'1; 6H (400 MHz) 7.43 (1 H, dd, 
J 8.0, 1.2, aromatic CH), 7.35 (1 H, dd, J 7.9, 1.7, aromatic CH), 7.22 (1 H, app. td, J 7.9, 
0.8, aromatic CH), 7.09 (1 H, app. td, J 7.6, 1.8, aromatic CH), 5.79 (1 H, app. dtd, J 9.8,
3.1, 1.6, CH2CH=CH), 5.48 (1 H, s, CHAr), 4.83 (1 H, dd, J 5.5, 1.3, CHICHO), 4.63 (1 H, 
app. dq, J 9.8, 1.9, CH2CH=CH), 4.50 (1 H, br. app. dd, J 5.1, 2.0, CHICHO), 3.70 (1 H, dd, 
J 12.5, 5.9, one of CH2OH), 3.58 (1 H, dd, J 12.5, 7.9, one of CH2OH), 2.78 (1 H, br. app. 
d, J 19.0, one of CH2CH=CH), 2.55 (1 H, app. dq, J 19.0, 2.5, one of CH2CH=CH) and 2.02 
(1 H, dd, J 7.9, 5.9, OH); 6C (100 MHz) 136.4 (C), 132.3 (CH), 130.9 (CH), 129.5 (CH),
127.2 (CH), 126.9 (CH), 126.4 (CH), 122.6 (C), 82.6 (CH), 76.1 (CH), 60.6 (CH2), 52.5 (C),
35.3 (CH2) and 27.5 (CH).
140
117b (88 mg, 32 %): vmax (CH2C12) 3396, 2892, 1469, 1436, 1418, 1262, 1194, 1167, 
1029, 972, 918, 877, 825, 736 and 623 cm'1; 6H (400 MHz) 7.50 (1 H, dd, J 8.1, 1.2, 
aromatic CH), 7.36 (1 H, dd, J 7.9, 1.8, aromatic CH), 7.28 (1 H, app. td, J 7.9, 1.2, 
aromatic CH), 7.12 (1 H, ddd, J 8.0, 7.3, 1.8, aromatic CH), 5.61 - 5.55 (1 H, m, one of 
alkene CH), 5.44 (1 H, app. dq, J 9.9, 1.9, one of alkene CH), 5.40 (1 H, d, J 3.9, CHAr),
4.65 (1 H, dd, J 5.6, 1.6, CHICHO), 4.37 - 4.34 (1 H, m, CHICHO), 4.29 (1 H, d, J 6.5, one 
of CH20), 3.70 (1 H, d, J 6.5, one of CH2O), 2.66 (1 H, app. doubled quintet, J 18.8, 2.2, 
one of CH2CH=CH), 2.26 (1 H, app. dq, J 18.8, 2.3, one of CH2CH=CH) and 2.22 (1 H, br. 
s, OH); 6C (100 MHz) 139.8 (C), 132.9 (CH), 129.7 (CH), 129.7 (CH), 128.8 (CH), 128.0 
(CH), 125.7 (CH), 124.2 (C), 76.6 (CH), 73.8 (CH2), 71.2 (CH), 51.3 (C), 34.5 (CH2) and 
27.7 (CH).
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7.4 Experimental Data for Chapter 4
tert-Butyl(((2/?S,3aS/?,7aS/?)-2-(tert-butyldimethylsilyloxy)-2,3,3a,7a-tetrahydro-lH- 
inden-3a-yl)methoxy)dimethylsilane (175)
PTBDMS
TBDMSO TBDMSO'
173 175
1.6 M BuLi (12.1 mL, 19.4 mmol, 1.1 equiv.) was slowly added to a solution of chloride 
173 (7.6 g, 17.7 mmol) in THF (50 mL) at -78 °C. The cooling bath was removed and the 
reaction allowed to warm to room temperature. After stirring for 1 h at this 
temperature, 2 M HCI (50 mL) was added, the organic layer was separated and the 
aqueous phase extracted with Et20  (2 x 20 mL). The combined organic extracts were 
dried over Na2S04 and concentrated in vacuo to give the title compound as a pale 
yellow oil (6.75 g, 97 %); (Found: M 0 2H+, 427.2729. C22H43 0 4Si2 requires M, 427.2700); 
Vmax (CH2CI2) 2942, 2855, 1472, 1255, 1098, 836 and 774 cm'1; 6 H (500 MHz) 5.78 - 5.74 
(1 H, m, one of alkene CH), 5.74 - 5.71 (2 H, m, 2 x alkene CH), 5.43 (1 H, d, J 9.5, one of 
alkene CH), 4.12 (1 H, app. tt, J 5.5, 3.8, CHOTBDMS), 3.46 (1 H, d, J 9.2, one of CH20),
3.34 (1 H, d, J 9.2, one of CH20), 2.66 - 2.60 (1 H, m, ring junction CH), 1.97 -1.90 (2 H, 
m, one of CCH2CHO and one of CHCH2CHO), 1.67 (1 H, dd, J 13.6, 5.6, one of 
CCH2CHO), 1.59 (1 H, ddd, J 12.4, 10.2, 5.5, one of CHCH2CHO), 0.87 (18 H, s, 2 x 
SiC(CH3)3), 0.04 (6 H, s, 2 x SiCH3), 0.01 (3 H, s, SiCH3) and 0.01 (3 H, s, SiCH3); 6C (125 
MHz) 132.4 (CH), 129.9 (CH), 120.8 (CH), 120.3 (CH), 70.4 (CH), 69.6 (CH2), 46.3 (CH2),
46.0 (C), 44.3 (CH2), 37.8 (CH), 25.9 (CH3), 25.9 (CH3), 18.3 (C), 18.1 (C), -4.7 (CH3), -4.8 
(CH3) and -5.4 (CH3); m/z (TOF ES+) 428 (10) and 427 (MH+, 100 %).
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Endoperoxides 180 and 181
PTBDMS (DTBDMS (DTBDMS
T B D M S O ^ '>  /  T B D M S O ^'> TB D M S O ^'>
181175 180
A solution of diene 175 (2.67 g, 6.7 mmol) and Rose bengal (cat., approx 100 mg) in IPA 
(50 mL) was cooled to approximately 15 °C by an external flow of tap-water. While 
passing a steady stream of dry 0 2, the solution was irradiated by a 500 W halogen 
lamp from a distance of approximately 10 cm for 18 h. The solvent was removed in 
vacuo, with the minimum heat possible, and the residue purified by chromatography 
on silica [ 1 - 2 %  Et20  in petroleum ether) giving the major isomer 180 (1.53 g, 53 %) 
and minor isomer 181 (0.81 g, 28 %), both pale yellow oils.
180 (1.53 g, 53 %): Found: MH+ 427.2719, C22H43 0 4Si2 requires 427.2700; vmax (CH2CI2) 
2955, 2856, 1636, 1472, 1361, 1254, 1071, 836 and 774 cm'1; 6H (400 MHz) 6.65 (1 H, 
ddd, J 7.9, 6.1, 1.5, one of alkene CH), 6.52 (1 H, ddd, J 7.9, 6.1,1.5, one of alkene CH), 
4.73 (1 H, app. dt, J 6.1, 1.5, CCHO), 4.61 (1 H, app. ddt, J 6.1, 4.4, 1.5, CHCHO), 4.20 (1 
H, app. tt, J 4.4, 1.8, CHOTBDMS), 3.88 (1 H, dd, J 8.9, 1.3, one of CH2OTBDMS), 3.81 (1 
H, d, J 8.9, one of CH2OTBDMS), 2.18 (1 H, app. td, J 8.4, 4.4, ring junction CH), 2.03 (1 
H, app. dt, J 13.8, 1.8, one of CCH2CHO), 1.82 (1 H, ddt, J 13.3, 8.4, 1.8, one of 
CHCH2CHO), 1.19 (1 H, ddd, J 13.3, 8.4, 4.4, one of CHCtf2CHO), 1.14 (1 H, dd, J 13.8, 
4.4, one of CCH2CHO), 0.89 (9 H, s, SiC(CH3)3), 0.87 (9 H, s, SiC(CH3)3), 0.05 (6 H, s, 2 x 
SiCH3), 0.02 (3 H, s, SiCH3) and 0.02 (3 H, s, SiCH3); 6C (125 MHz) 133.1 (CH), 131.3 (CH), 
74.3 (CH), 74.0 (CH), 73.6 (CH), 66.7 (CH2), 49.1 (C), 41.9 (CH), 41.1 (CH2), 39.9 (CH2), 
25.9 (CH3), 25.9 (CH3), 18.3 (C), 18.0 (C), -4.8 (CH3), -4.9 (CH3), -5.3 (CH3) and -5.4 (CH3); 
m /z  (TOF ES+) 427 (MH+, 100 %) and 295 (10).
181 (0.81 g, 28 %): Found: MH+ 427.2730, C22H430 4Si2 requires 427.2700; vmax (CH2CI2) 
2942, 2856, 1466, 1361, 1255, 1094, 836 and 775 cm'1; 6H (400 MHz) 6.63 - 6.60 (2 H, 
m, 2 x alkene CH), 4 .64 -4 .58  (1 H, m, CHOTBDMS), 4 .54-4.49 (1 H, m, one of 
HC=CHCHO), 4 .35 -4 .31  (1 H, m, one of HC=CHCHO), 3.64 (1 H, d, J 9.3, one of 
CH2OTBDMS), 3.23 (1 H, d, J 9.3, one of CH2OTBDMS), 2.19 (1 H, dd, J 13.3, 4.8, one of
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CCH2CHO), 2.12 (1 H, ddd, J 13.1, 7.1, 4.8, one of CHCH2CHO), 1.86 (1 H, ddd, J 13.3,
3.0, 2.0, one of CCH2CHO), 1.77 (1 H, dddd, J 13.1, 8.6, 3.0, 2.0, one of CHCtf2CHO), 
1.61 (1 H, ddd, J 8.6, 7.1, 2.0, ring junction CH), 0.88 (9 H, s, SiC(CH3)3), 0.87 (9 H, s, 
SiC(CH3)3), 0.06 (6 H, s, 2 x SiCH3), 0.01 (3 H, s, SiCH3) and 0.00 (3 H, s, SiCH3); 6C (125 
MHz) 132.1 (CH), 131.3 (CH), 76.4 (CH), 76.2 (CH), 74.6 (CH), 70.2 (CH2), 48.1 (C), 39.2 
(CH), 38.9 (CH2), 37.0 (CH2), 25.9 (CH3), 25.8 (CH3), 18.1 (C), 18.1 (C), -4.7 (CH3), -4.8 
(CH3), -5.4 (CH3) and -5.6 (CH3); m /z  (TOF ES+) 427 (MH+, 100 %) and 295 (10).
(2/?S,3a/?S,7S/?,7aSf?)-2-(terf-Butyldimethylsilyloxy)-7a-((te/t-
butyldimethylsilyloxy)methyl)-7-hydroxy-3,3a,7,7a-tetrahydro-lH-inden-4(2H)-one
(182) and (2/?S,3affS,7flS,7a5/?)-2-(fe/t-butyldimethy!silyloxy)-7a-((ferf- 
butyldimethylsilyloxy)methyl)-7-hydroxy-3,3a,7,7a-tetrahydro-lH-inden-4(2H)-one
(183)
P TBDMS TBDMSO P TBDMS TBDMSO /> TBDMS
TBDMSO
175
HO,, ^
Oxidation of diene 175 (3.80 g, 9.6 mmol) was conducted as described above, after 18 
h irradiation the lamp and oxygen supply were removed and Et3N (10 mL) added. After 
stirring for a further 48 h the solvent was removed in vacuo and the residue 
chromatographed on silica (5 - 10 % EtOAc in petroleum ether) to give the title 
compounds 182 (1.51 g, 37 %) as a light yellow oil, followed by 183 (1.03 g, 25 %) as a 
yellow oil.
182 (1.51 g, 37 %): Found: MH+ 427.2701, C22H430 4Si2 requires M, 427.2700; vmax 
(CH2CI2) 3448, 2943, 2857, 1666, 1472, 1256, 1083, 837 and 776 cm 1; 6H (400 MHz) 
6.95 (1 H, dd, J 10.2, 2.2, HC=CHC=0), 5.95 (1 H, dd, J 10.2, 1.9, CH=CHC=0), 4.67 (1 H, 
d, J 7.4, OH), 4.33 - 4.38 (1 H, app. tt, J 5.7, 2.3, CHOTBDMS), 4.37 - 4.33 (1 H, app. tt, J
7.4, 2.2, CHOH), 4.09 (1 H, d, J 10.0, one of CH2OTBDMS), 3.61 (1 H, d, J 10.0, one of 
CH2OTBDMS), 2.66 (1 H, dd, J 11.3, 8.1, ring junction CH), 2.38 (1 H, dd, J 14.4, 6.2, one 
of CCH2CHO), 2.08 -1 .94  (2 H, m, CHCW2CHO), 1.72 (1 H, br. d, J 14.4, one of CCH2CHO),
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0.89 (9 H, s, SiC(CH3)3), 0.87 (9 H, s, SiC(CH3)3), 0.09 (3 H, s, SiCH3); 0.07 (3 H, s, SiCH3) 
and 0.04 (6 H, s, 2 x SiCH3); 6C (125 MHz) 153.0 (CH), 127.2 (CH), 72.7 (CH), 71,8 (CH),
69.6 (CH2), 51.8 (C), 51.0 (CH), 45.0 (CH2), 38.7 (CH2), 25.8 (CH3), 25.7 (CH3), 18.0 (C), -
4.8 (CH3), -4.8 (CH3) and -5.7 (CH3); m/z (TOF ES+) 427 (MH+, 10 %), 336 (77), 295 (62), 
277 (100) and 163 (11).
183 (1.03 g, 25 %): Found: MH+ 427.2729, C22H430 4Si2 requires M, 427.2700; vmax 
(CH2CI2) 3449, 2943, 2857, 1675, 1471, 1362, 1256 and 1085 cm'1; 6H (400 MHz) 6.74 (1 
H, dd, J 10.3, 1.9, CH=CHC=0), 5.95 (1 H, dd, J 10.3, 2.4, CH=CHC=0), 4.81 (1 H, app. q, J
2.2, CHOH), 4.28 - 4.22 (1 H, m, CHOTBDMS), 3.93 (1 H, d, J 9.4, one of CH2OTBDMS),
3.74 (1 H, d, J 9.4, one of CH2OTBDMS), 3.43 (1 H, d, J 3.0, OH), 2.62 (1 H, ddd, J 13.8,
7.1, 2.3, one of CHCH2CHO), 2.45 (1 H, br. d, J 8.4, ring junction CH), 2.02 (1 H, dd, J
14.5, 8.1, one of CCH2CHO), 1.88 (1 H, ddd, J 13.8, 8.4, 5.7, one of CHCH2CHO), 1.75 (1 
H, br. d, J 14.5, one of CCH2CHO), 0.92 (9 H, s, SiC(CH3)3), 0.86 (9 H, s, SiC(CH3)3), 0.11 (6 
H, s, 2 x SiCH3) and 0.01 (6 H, s, 2 x SiCH3); 6C (125 MHz) 199.6 (C), 151.3 (CH), 127.2 
(CH), 71.5 (CH), 70.8 (CH), 70.2 (CH2), 52.6 (C), 49.9 (CH), 39.9 (CH2), 38.0 (CH2), 25.9 
(CH3), -4.7 (CH3) and -5.5 (CH3); m /z (TOF ES+) 428 (9), 427 (MH+, 100 %) and 295 (11).
(2/?S,3aSf?,4S/?,7/?S,7aRS)-2-(fe/t-Butyldimethylsilyloxy)-3a-(hydroxymethyl)- 
2,3,3a,4,7/7a-hexahydro-lH-indene-4,7-diol (189)
PTBDMS PTBDMSUH
TBDMSO
180 189
To a solution of peroxide 180 (379 mg, 0.89 mmol) in THF (10 mL) was added a 1 M 
solution of LiAlH4 in THF (2.0 mL, 2.0 mmol, 2.2 equiv.). After stirring for 90 min the 
reaction was quenched with 2 M NaOH, dried over Na2S04 and filtered. The solvent 
was removed in vacuo and the residue crystallised from Et20  and petroleum ether to 
give the title compound (191 mg, 72 %) as a colourless solid, m.p. 84 - 87 °C; (Found: 
MH+ 315.1996, Ci6H310 4Si requires M, 315.1992); vmax (CH2CI2) 3406, 2924, 2856, 1458, 
1260, 1089, 1022, 800 and 750 cm'1; 6H (500 MHz) 6.07 (1 H, dd, J 9.8, 3.7, one of
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alkene CH), 6.00 (1 H, br. dd, J 9.8, 4.9, one of alkene CH), 4 .29-4.23 (1 H, m, 
CHOTBDMS), 4.08 (1 H, br. s, one of HC=CHCHOH), 4.00-3.92 (2 H, m, one of 
HC=CHCHOH and one of CH2OH), 3.69 (1 H, br. d, J 10.9, one of Ctf2OH), 3.09 (1 H, br. s, 
OH), 3.01 (1 H, br. d, J 5.3, OH), 2.85 (1 H, d, J 8.2, OH), 2.41 (1 H, ddd, J 11.8, 7.9, 2.0, 
ring junction CH), 1.89 (1 H, app. ddt, J 13.4, 7.9, 1.5, one of CHCH2CHO), 1.86 (1 H, dd, 
J 13.8, 5.9, one of CCH2CHO), 1.58 -1 .49 (2 H, m, one of CHCH2CHO and one of 
CCH2CHO), 0.87 (9 H, s, SiC(CH3)3) and 0.04 (6 H, s, 2 x SiCH3); 6C (125 MHz) 134.2 (CH), 
130.5 (CH), 71.3 (CH), 70.5 (CH), 69.1 (CH2), 66.2 (CH), 48.7 (C), 47.9 (CH), 45.5 (CH2),
41.0 (CH2), 25.8 (CH3), 18.0 (C), -4.8 (CH3) and -4.8 (CH3); m /z (TOF ES+) 315 (MH+, 
29 %), 183 (4) and 165 (100).
(2Sfl,3aRS,7S/?,7aSfl)-2-(te/t-Butyldimethylsilyloxy)-3a-((te/t- 
butyldimethylsilyloxy)methyl)-7-hydroxyhexahydro-lH-inden-4(2H)-one (184)
PTBDMSTBDMSO
HO,
184
PTBDMSTBDMSO
HO,
182
10 % Pd/C (100 mg) and ammonium formate (560 mg, 8.9 mmol) were added to a 
solution of enone 182 (377 mg, 0.88 mmol) in EtOH (10 mL). This was heated to reflux 
for 2 h, allowed to cool and filtered through a pad of silica, washing with Et20. The 
filtrate was concentrated in vacuo and the residue partitioned between Et20  (20 mL) 
and brine (20 mL). The organic layer was separated and the aqueous phase extracted 
with Et20  (2 x 10 mL). The combined organic extracts were dried over Na2S04 and 
concentrated in vacuo to yield the title compound (341 mg, 91 %) as a pale yellow oil 
(Found: MH+, 429.2870. C22H45 0 4Si2 requires M, 429.2856); vmax (CH2CI2) 3446, 2942, 
2857, 1706, 1472, 1362, 1255, 1075, 837 and 776 cm'1; 6H (400 MHz) 4.53 (1 H, br. s, 
OH), 4.35 - 4.29 (1 H, m, CHOTBDMS), 4.00 (1 H, d, J 10.1, one of CH20), 3.91 - 3.85 (1 
H, m, CHOH), 3.77 (1 H, d, J 10.1, one of CH20), 2.77 (1 H, app. t, J 7.7, ring junction 
CH), 2.67 (1 H, ddd, J 16.5, 10.1, 7.2, one of Ctf2C=O), 2.29 (1 H, ddd, J 16.5, 6.3, 4.1, 
one of CH2C=O), 2.23 (1 H, ddd, J 13.2, 7.7, 5.4, one of CHCH2CHO), 2.13 -1.92 (2 H, m,
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CH2CH2CHOH), 1.83 -1 .75  (1 H, m, one of CHCH2CHO), 1.75 (1 H, dd, J 14.3, 6.0, one of 
CCH2CHO), 1.51 (1 H, br, d, J 14.3, one of CCH2CHO), 0.90 (9 H, s, SiC(CH3)3), 0.86 (9 H, 
s, SiC(CH3)3), 0.10 (3 H, s, SiCH3), 0.10 (3 H, s, SiCH3), 0.03 (3 H, s, SiCH3) and 0.03 (3 H, 
s, SiCHs); 6c (100 MHz) 213.3 (C), 72.8 (CH), 72.0 (CH), 69.6 (CH2), 52.8 (C), 51.8 (CH),
43.4 (CH2), 38.1 (CN2), 34.0 (CH2), 27.5 (CH2), 25.8 (CH3), 25.7 (CH3), 18.0 (C), 17.9 (C), 
-4.8 (CH3), -5.0 (CH3) and -5.7 (CH3).
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7.5 Experimental Data for Chapter 5
(/?S)-l-(l-((ferf-Butyldimethylsilyloxy)methyl)cyclohexa-2,5-dienyl)-3-chloropropan-2-
ol (190)
TBDMSO'HO
OHOH
113d 190
Imidazole (2.53 g, 40 mmol, 2.2 equiv.) and TBDMSCI (2.72 g, 18 mmol, 1.0 equiv.) 
were added to a solution of diol 113d (3.65 g, 18 mmol) in CH2CI2 (30 mL). After stirring 
for 1 h saturated aqueous NH4CI (30 mL) was added and the organic phase separated. 
The aqueous layer was extracted with CH2CI2 (2 x 10 mL), the combined organic phases 
were dried over Na2S04 and the residue purified by chromatography on silica (10 % 
Et20  in petroleum ether) to give the title compound (4.35 g, 76 %) as a colourless oil; 
(Found: MH+ 317.1710, Ci6H3o02SiCI requires M, 317.1724); vmax (neat) 3426, 2942, 
2855, 1471, 1409, 1361, 1255, 1107, 940, 837, 776, 723 and 698 cm'1; 6H (500 MHz) 
5.91 - 5.82 (2 H, m, 2 x alkene CH), 5.70 (1 H, app. dq, J 10.2, 2.0, one of alkene CH),
5.48 (1 H, app. dq, J 10.2, 2.0, one of alkene CH), 3.98 - 3.92 (1 H, m, CHOH), 3.53 (1 H, 
dd, J 11.0, 4.4, one of CH2CI), 3.48 (1 H, dd, J 11.0, 4.4, one of CH2CI), 3.41 (1 H, d, J 9.5, 
one of CH20), 3.40 (1 H, d, J 9.5, one of CH20), 2.99 (1 H, d, J 2.9, OH), 2.69 - 2.66 (2 H, 
m, CH=CH-CW2), 1.76 -1 .69  (2 H, m, CH2CHOH), 0.89 (9 H, s, SiC(CH3)s) and 0.03 (6 H, s, 
2 x SiCHs); 6C (125 MHz) 130.1 (CH), 130.0 (CH), 126.2 (CH), 125.6 (CH), 71.3 (CH2), 69.2 
(CH), 50.2 (CH2), 42.5 (CH2), 40.9 (C), 26.7 (CH2), 25.9 (CH3), 18.3 (C) and -5.4 (CH3); m/z 
(TOF ES+) 319 (5), 317 (MH+, 21 %), 187 (9) and 185 (100).
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(2/?S,3a/?S,7aflS)-7a-((te/t-Butyldimethylsilyloxy)methyl)-2,3#3a,4,5,7a-hexahydro-lH-
inden-2-ol (191) and (2Sf?,3afl5,7aflS)-7a-((tert-butyldimethylsilyloxy)methyl)- 
2,3,3a,4,5,7a-hexahydro-lH-inden-2-ol (192)
Chloride 190 (2.265 g, 7.16 mmol) was dissolved in benzene (30 mL) and the solution 
heated to reflux. Solutions of AIBN (235 mg, 1.43 mmol, 0.2 equiv.) and Bu3SnH (2.3 
ml, 8.59 mmol, 1.2 equiv.), each in 5 mL benzene, were added over 10 h by syringe 
pump. After a further 6 h at reflux the solvent was removed in vacuo and the residue 
chromatographed on silica containing approximately 10 % w/w NaF (7 -10  % EtOAc in 
petroleum ether).
191 (960 mg, 48 %): Found: MH+ 283.2091, Ci6H3i0 2Si requires M, 283.2093; vmax 
(neat) 3369, 2930, 2851, 1652, 1470, 1253, 1096, 838, 756, 709 and 677 cm"1; 6H (500 
MHz) 5.70 (1 H, ddd, J 10.0, 5.4, 2.4, CH2CH=CH), 5.36 (1 H, br. d, J 10.0, CH2CH=CH), 
4.14 - 4.09 (1 H, m, CHOH), 3.39 (1 H, d, J 9.5, one of CH20), 3.38 (1 H, d, J 9.5, one of 
CH20), 3.14 (1 H, d, J 9.0, OH), 2.41 (1 H, app. ddt, J 11.4, 7.5, 4,1, one of CH2CH=CH),
2.02 -1.93 (1 H, m, one of CH2CH=CH), 1.88 (1 H, app. dqd, J 17.6, 4.7, 1.2, one of 
CH2CH=CH), 1.84 (1 H, dt, J 14.1, 1.7), 1.75 - 1.56 (5 H, m), 0.92 (9 H, s, SiC(CH3)3) and 
0.09 (6 H, s, 2 x SiCH3); 6C (125 MHz) 132.3 (CH), 126.6 (CH), 71.1 (CH), 68.4 (CH2), 45.7 
(CH2), 45.7 (C), 39.7 (CH), 26.0 (CH3), 22.1 (CH2), 20.5 (CH2), 18.4 (C), -5.5 (CH3) and -5.5 
(CH3); m /z  (TOF ES+) 283 (MH*, 92 %), 189 (17) and 133 (100).
192 (385 mg, 19 %): vmax (neat) 3336, 2927, 2856, 1652, 1472, 1255, 1093, 837, 774, 
705 and 668 cm'1; 6H (500 MHz) 5.76 (1 H, ddd, J 10.0, 5.0, 2.5, CH2CH=CH), 5.52 (1 H, 
app. ddt, J 10.0, 2.6, 1.4, CH2CH=CH), 4.21 (1 H, app. tdd, J 7.0, 5.4,4.2, CHOH), 3.34 (1 
H, d, J 9.7, one of CH20), 3.32 (1 H, d, J 9.7, one of CH20), 2.20-2.03 (4 H, m, 
CHCH2CHOH, one of CCH2CHOH and one of HC=CHCH2), 1.95 (1 H, app. dtdd, J 18.1,
5.0, 3.0, 1.4, one of HC=CHCH2), 1.68 -1 .50  (3 H, m, HC=CHCH2CH2 and ring junction 
CH), 1.45 (1 H, dd, J 13.4, 4.2, one of CCH2CHO), 0.88 (9 H, s, SiC(CH3)3), 0.02 (3 H, s,
TBDMSO OTBDMS TBDMSO
190 191 192
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SiCH3) and 0.02 (3 H, s, SiCH3); 6C (125 MHz) 133.5 (CH), 127.4 (CH), 72.4 (CH), 68.2 
(CH2), 46.6 (C), 44.4 (CH2), 39.7 (CH2), 36.4 (CH), 25.9 (CH3), 22.2 (CH2), 20.7 (CH2), 18.3 
(C), -5.5 (CH3) and -5.5 (CH3).
(la5fl,3a/?S,5/?S,6aS/?,6b/?S)-6a-((tert-Butyldimethylsilyloxy)methyl)octahydro-laH- 
indeno(4,5-b)oxiren-5-ol (193)
TBDMSO
191 193
NaHC03 (0.84 g, 10 mmol, 1.5 equiv.) and mCPBA (77 %, 2.24 g, 10 mmol, 1.5 equiv.) 
were added to a solution of alkene 191 (1.88 g, 6.67 mmol) in CH2CI2 (40 mL). The 
resulting suspension was stirred for 3 h at room temperature before quenching with 
saturated aqueous Na2S20 3 (30 mL) and saturated aqueous NaHC03 (10 mL). After 
stirring vigorously for 10 min the organic layer was separated and the aqueous phase 
extracted with CH2CI2 (2 x 15 mL). The combined organic extracts were dried over 
Na2S04 and concentrated in vacuo. The residue was filtered through a column of silica, 
washing with Et20, to give the title compound as the major component of an approx. 
7:1 mixture of diastereoisomers (1.90 g, 96 %) as a colourless oil; (Found: MH+, 
299.2043. C16H310 3Si requires M, 299.2042); vmax (CH2CI2) 3438, 2932, 2856, 1471, 
1256, 1083, 1063, 838 and 779 cm'1; 6H (500 MHz) 4.13 (1 H, app. br. t, J 3.8, CHOH),
3.66 (1 H, d, J 9.5, one of CH20), 3.61 (1 H, d, J 9.5, one of CH20), 3.17 (1 H, app. br. t, J
3.3, CH2CH(0)CH), 2.75 (1 H, dd, J 4.1, 0.7, CH2CH(0)CH), 2.19 (1 H, app. tdd, J 13.1,
6.7, 4.6, ring junction CH), 1.94 (1 H, app. ddt, J 13.1, 4.6, 2.3, one of CCHCH2CH2), 1.85 
(1 H, dd, J 14.4, 2.7, one of CCH2CHOH), 1.84 (1 H, app. tdd, J 13.1, 4.6, 0.7, one of 
CCHCH2CH2), 1.78 (1 H, dd, J 14.4, 4.6, one of CCH2CHOH), 1.74 (1 H, app. tt, J 13.1, 4.6, 
one of CCHCH2CH2), 1.62 (1 H, ddd, J 12.9, 6.7, 2.2, one of CHCH2CHOH), 1.52 (1 H, td, J 
12.9, 3.5, one of CHCH2CHOH) 1.27 (1 H, app. ddt, J 13.1, 4.6, 2.3, one of CCHCH2CH2), 
0.92 (9 H, s, SiC(CH3)3), 0.14 (3 H, s, SiCH3) and 0.13 (3 H, s, SiCH3); 6C (125 MHz) 71.8 
(CH), 67.3 (CH2), 56.0 (CH), 51.3 (CH), 44.1 (CH2), 43.1 (C), 40.1 (CH2), 32.3 (CH), 25.9
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(CH3), 19.2 (CH2), 18.4 (C), 16.9 (CH2) -5.6 (CH3) and -5.6 (CH3); m /z (TOF ES+) 299 (MH+,
100 %), 281 (19), 167 (47) and 149 (21).
(2f?5,3a5/?,45/?,7aA5)-3a-((te/t-Butyldimethylsilyloxy)methyl)-2,3,3a,4,7,7a- 
hexahydro-lH-indene-2,4-diol (195)
pH PHTBDMSO TBDMSO
HO
195193 + 194
NaBH4 (291 mg, 7.66 mmol, 1.2 equiv.) was added in small portions to a suspension of 
(PhSe)2 (1.20 g, 3.83 mmol, 0.6 equiv.) in EtOH (30 mL). After hydrogen evolution had 
subsided, a mixture of epoxide diastereoisomers 193 and 194 (1.90 g, 6.38 mmol) were 
added as a solution in EtOH (10 mL). The solution was heated to reflux overnight, the 
solvent removed in vacuo and the residue re-dissolved in THF (30 mL). H20 2 (5 mL, 49 
mmol, 30 % aqueous solution) was added and the mixture was carefully warmed in an 
oil bath until a vigorous exothermic reaction began. The oil bath was removed until the 
reaction began to subside, and then replaced in order to maintain reflux for a total of 1 
h, resulting in a clear homogeneous solution. This was washed with brine (30 mL) and 
the aqueous phase extracted with Et20  (2 x 20 mL). The combined organic layers were 
washed with Na2S20 3 (30 mL) then dried over Na2S04 and concentrated in vacuo. The 
residue was purified by chromatography on silica (25 - 50 % EtOAc in petroleum ether) 
to give the title compound (1.46 g, 77 %) as a colourless waxy solid, m.p. 87 - 94 °C 
(Found: MH+, 299.2047. C16H3i0 3Si requires M, 299.2042); vmax (CH2CI2) 3394, 2934, 
1648, 1435 and 1049 cm'1; 6H (400 MHz) 5.89 - 5.79 (1 H, br. d, J 9.9, one of alkene CH),
5.75 - 5.68 (1 H, app. dtd, J 9.9, 4.6, 2.0, one of alkene CH), 4.41 (1 H, app. tdd, J 6.2,
2.8, 1.7, CH2CHOH), 3.96 (1 H, br. s, CH=CHCWOH), 3.93 (1 H, d, J 9.7, one of CH20),
3.48 (1 H, d, J 9.7, one of CH20), 2.38 (1 H, dd, J 14.2, 6.2, one of CCH2CHOH), 2.27 (1 H, 
ddd, J 17.1, 7.4, 4.6, one of CH2CH=CH), 2.05 (1 H, app. dtd, J 11.7, 7.4, 4.2, ring 
junction CH), 1.84 (1 H, app. ddt, J 13.5, 7.4, 1.4, one of CHCH2CHOH), 1.79 (1 H, ddd, J
17.1, 4.2, 2.0, one of CH2CH=CH), 1.68 (1 H, ddd, J 14.2, 2.8, 1.4, one of CCH2CHOH ),
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1.63 (1 H, ddd, J 13.5, 11.7, 6.2, one of CHCH2CHOH), 0.90 (9 H, s, SiC(CH3)3), 0.09 (3 H, 
s, SiCH3) and 0.08 (3 H, s, SiCH3); 6C (100 MHz) 132.2 (CH), 125.9 (CH), 73.1 (CH), 71.5 
(CH), 69.2 (CH2), 49.3 (C), 44.5 (CH2), 43.0 (CH2), 37.4 (CH), 26.8 (CH2), 25.8 (CH3), 18.1 
(C) and -5.7 (CH3); m /z  (TOF ES+) 300 (8), 299 (MH+, 100 %).
(2/?S,3a5/?,7a/?S)-3a-((tert-Butyldimethylsilyloxy)methyl)-2-hydroxy-3,3a,7,7a- 
tetrahydro-lH-inden-4(2H)-one (196)
PH PHTBDMSO TBDMSO
/H
195 196
M n02 (4.25 g, 49 mmol, 10 equiv.) was added to a solution of allylic alcohol 195 (1.46 
g, 4.9 mmol) in CH2CI2 (40 mL), and the resulting suspension stirred for 24 h. The 
mixture was filitered through a pad of silica, washing well with EtOAc, and the solvent 
removed in vacuo giving the title compound (1.40 g, 97 %) as a pale yellow oil (Found: 
MH+ 297.1880, Ci6H290 3Si requires 297.1886); vmax (CH2CI2) 3410, 2929, 2856, 1657, 
1471, 1393, 1253, 1089, 839 and 777 cm'1; 6H (400 MHz) 6.84 (1 H, dddd, J 10.1, 5.7,
2.4, 1.3, CH=CHC=0), 6.04 (1 H, ddd, J 10.1, 2.8, 1.2, CH=CHC=0), 4 .23-4.18 (1 H, m, 
CHO), 3.82 (1 H, d, J 9.3, one of CH20), 3.60 (1 H, d, J 9.3, one of CH20), 2.85 (1 H, app. 
dt, J 12.3, 7.0, ring junction CH), 2.78 (1 H, app. ddt, J 19.1, 7.0, 2.8, one of CH=CHCH2),
2.47 (1 H, dd, J 14.7, 6.3, one of CCH2CHOH), 2.33 (1 H, br. dd, J 19.1, 5.7, one of 
CHCHCW2), 183  (1 H, app. ddt, J 13.3, 7.0, 1.7, one of CHCH2CHOH), 1.75 (1 H, ddd, J
13.3, 12.3, 5.2, one of CHCH2CHOH), 1.62 (1 H, dt, J 14.7, 2.1, one of CCH2CHOH), 0.85 
(9 H, s, SiC(CH3)3), 0.03 (3 H, s, SiCH3) and 0.00 (3 H, s, SiCH3); 6C (100 MHz) 202.5 (C),
148.3 (CH), 129.3 (CH), 70.7 (CH), 68.8 (CH2), 56.9 (C), 43.6 (CH2), 42.3 (CH2), 37.4 (CH), 
26.9 (CH2), 25.8 (CH3), 18.2 (C), -5.7 (CH3) and -5.7 (CH3); m/z (TOF ES+) 297 (MH*, 
100 %).
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(ZflS^aSfljeSflfTaflSj-Sa- f^e/t-ButyldimethylsilyloxyJmethylJ-Z-hydroxy-e- 
methylhexahydro-lH-inden-4(2H)-one (197) and (2RS,3aSR,6RS,7aRS)-3a-[(tert- 
butyldimethylsilyloxy)methyl)-2-hydroxy-6-methylhexahydro-lH-inden-4(2H)-one 
(198)
PHP H TBDMSOTBDMSOPHTBDMSO
Me Me
196 197 198
Cu(OTf)2 (29 mg, 0.08 mmol, 0.1 equiv.) was added to a solution of enone 196 (235 mg, 
0.79 mmol) in toluene (10 mL) and the resulting suspension cooled to 0 °C. A 2 M 
solution of MesAI in hexanes (1.2 mL, 2.37 mmol, 3 equiv.) was added dropwise, the 
cooling bath was removed and the reaction stirred for 8 h before quenching carefully 
with saturated aqueous NaHC03  (20 mL). This was all filtered through a pad of silica, 
washing with Et20 , and the organic layer separated. The aqueous phase was extracted 
with Et20  (2 x 20 mL) and the combined organic layers were dried over Na2S04 and 
concentrated in vacuo. The residue was purified by chromatography on silica (20 - 25 % 
EtOAc in hexane) to give the title compounds, 197 and 198, approx. 3:1, as a pale 
yellow oil (200 mg, 81 %); vmax (CH2CI2) 3388, 2952, 1694,1455, 1344 and 1041 cm'1; 6H 
(400 MHz) 4.21 - 4.16 (1 H, m, CHOH), 3.68 (1 H, d, J 9.2, one of CH20), 3.62 (1 H, d, J
9.2, one of CH20), 2.79 - 2.75 (1 H, m, ring junction CH), 2.55 (1 H, dd, J 14.8, 5.8, one 
of CCH2CHOH), 2.38 (1 H, app. ddd, J 14.6, 3.5, 1.9, one of CH2C=0), 2.10 (1 H, dd, J
14.6, 12.6, one of CH2C=0), 2.05 -1 .90 (1 H, m, MeCH), 1.79 -1.66 (3 H, m, one of 
CHCH2CHOH and MeCHCH2CH), 1.60 (1 H, app. td, J 13.2, 4.8, one of CHCH2CHOH),
1.51 (1 H, app. dt, J 14.8, 2.1, one of CCH2CHOH), 1.00 (3 H, d, J 6.4, Me), 0.89 (9 H, s, 
SiC(CH3)3), 0.06 (3 H, s, Si(CH3)2), 0.04 (3 H, s, Si(CH3)2).
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tert-Butyl (2S/?,3aSff,6S/?,7a/?S)-3a-((tert-butyldimethylsilyloxy)methyl)-6-methyl-4-
oxooctahydro-lH-inden-2-yl(methoxycarbonyloxy)carbamate (212)
J -O M e
P H TBDMSO NBocTBDMSO
"H
MeMe
197 212
To a solution of alcohol 197 (220 mg, 0.74 mmol) in CH2CI2 (10 mL) was added PPh3 
(291 mg, 1.1 mmol, 1.5 equiv.) and BocNHOC02Me (283 mg, 1.5 mmol, 2.0 equiv.). 
DIAD (0.22 mL, 1.1 mmol, 1.5 equiv.) was added dropwise and stirring continued for 15 
min. The solvent was removed in vacuo and the residue purified by chromatography 
on silica (10 % EtOAc in petroleum ether) to give the title compound (280 mg, 78 %) as 
a viscous colourless oil. vmax (neat) 2953, 1794, 1713, 1455, 1393, 1371, 1337, 1259, 
1156,1102, 937, 839 and 772 cm 1.
±I ~T~
COro o> COo
(9H-Fluoren-9-yl)methyl-(2SK,3aSR,6S/?,7aRS)-3a-((tert-
butyldimethylsilyloxy)methyl)-6-methyl-4-oxooctahydro-lH-inden-2-
yl(methoxycarbonyloxy)carbamate (210)
O
OMe
P H TBDMSO NFmocTBDMSO
7H
Me Me
197 210
PPh3 (387 mg, 1.47 mmol, 1.2 equiv.) and FmocNHOC02Me (420 mg, 1.34 mmol, 1.1 
equiv.) were added to a stirred solution of alcohol 197 (390 mg, 1.25 mmol) in CH2CI2 
(10 mL). DIAD (0.29 mL, 1.47 mmol, 1.2 equiv.) was added dropwise and stirring 
continued for 1 h. The solvent was removed in vacuo and the residue purified by 
chromatography on silica (10 - 25 % EtOAc in petroleum ether), giving the title 
compound (200 mg, 27 %) as a colourless oil, followed by unreacted alcohol 197 (100
(9H-Fluoren-9-yl)methyl (2S/?,3aS/?,6S/?,7a/?S)-3a-((tert-
butyldimethylsilyloxy)methyl)-6-methyl-4-oxooctahydro-lH-inden-2
yl(phenoxycarbonyloxy)carbamate (211)
O
/-O P h
PH TBDMSO NFmocTBDMSO
/H
Me Me
197 211
To a solution of alcohol 197 (177 mg, 0.60 mmol) in CH2CI2 (10 mL) was added PPh3 
(255 mg, 0.97 mmol, 1.6 equiv.) and FmocNHOC02Ph (365 mg, 0.97 mmol, 1.6 equiv.). 
DIAD (0.19 mL, 0.97 mmol, 1.6 equiv.) was added dropwise and stirring continued for 
15 min. The solvent was removed in vacuo and the residue purified by 
chromatography on silica (10 % EtOAc in petroleum ether) to give the title compound 
(130 mg, 36 %) as a viscous colourless oil. vmax (CH2CI2) 3060, 2955, 2857, 1808, 1731, 
1714, 1593, 1454,1394, 1318, 1209, 1104, 840 and 742 cm'1
H i /_JL / /
W  V t V
po ro cn cd—* 
2 8 2 -2
co ro — to coto
ro cn co s  b oo  qd cn o  o
5 .0
"T~
2.0
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Carbonate 213
OPh
FmocN,
Me
OTBDMS
211
Me
OTBDMS
213
DBU (0.02 mL, 0.13 mmol, 2.8 equiv.) was added to a solution of ketone 211 (32 mg, 
0.05 mmol) in THF (2 mL). After stirring for 1 hr the solvent was concentrated in vocuo 
and the residue chromatographed on silica (5 -1 0  % EtOAc in petroleum ether) giving 
the title compound (6 mg, 35 %) as a colourless oil (Found: MH+, 354.2125. Ci8H32N04Si 
requires M, 354.2101); vmax (CH2CI2) 2928, 2855, 1808, 1704, 1471, 1257, 1097, 838 
and 777 cm'1; 6H (400 MHz) 3.86 (1 H, d, J 10.5, one of CH20), 3.78 (1 H, d, J 10.5, one 
of CH20), 3.73 - 3.70 (1 H, m, CHN), 2.37 (1 H, app. dq, J 11.5, 3.8, ring junction CH),
2.04 -1 .96 (3 H, m, MeCH, one of CCH2CHN and one of MeCHCH2C), 1.94 (1 H, ddd, J
13.6, 11.8, 4.1, one of CHOV2CHN), 1.64 (1 H, d, J 11.8, one of CCH2CHN), 1.54 (1 H, 
app. t, J 13.5, one of MeCHCH2C), 1.48 (1 H, br. d, J 14.1, one of MeCHCH2CH), 1.40 (1 
H, app. dt, J 13.6, 3.8, one of CHCH2CHN), 1.24 (1 H, ddd, J 14.1, 12.4, 3.8, one of 
MeCHC/72CH), 0.98 (3 H, d, J 6.4, CH3), 0.89 (9 H, s, SiC(CH3)3) and 0.06 (6 H, s, 2 x 
SiCH3); 6C (125 MHz) 154.1 (C), 106.6 (C), 65.4 (CH), 60.1 (CH2), 54.1 (C), 37.8 (CH2), 
37.1 (CH2), 34.3 (CH), 32.3 (CH2), 30.8 (CH2), 25.9 (CH3), 23.6 (CH), 21.3 (CH3), 18.3 (C), 
-5.5 (CH3), -5.5 (CH3); m /z  (TOF ES+) 395 (MH+.CH3CN, 100%), 354 (MH+, 15), 338 (5), 
310 (9), 262 (10), 234 (7) and 191 (3).
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(25/?,3a/?S,7aS/?)-3a-((terf-Butyldimethylsilyloxy)methyl)-2-hydroxyhexahydro-lH- 
inden-4(2H)-one (214)
PH
OTBDMS
214
PH
OTBDMS
196
Pd /  C (100 mg, 10 % w/w) was added to a solution of enone 196 (0.5 g, 1.7 mmol) in 
EtOAc /  EtOH (10 mL, 2:1) and the reaction placed under an atmosphere of H2. After 
stirring for 4 h, the mixture was filtered through a short pad of silica, washing well with 
EtOAc. The filtrate was concentrated under reduced pressure to afford the title 
compound (0.36 g, 71 %) as a pale yellow oil; 6H (400 MHz) 4.20 (1 H, app. tt, J 5.3, 1.8, 
CHOH), 3.72 (1 H, d, J 9.2, one of CH2OTBDMS), 3.64 (1 H, d, J 9.2, one of CH2OTBDMS), 
2.71 (1 H, app. dq, J 12.1, 5.8, ring junction CH), 2.48 (1 H, dd, J 14.7, 5.8, one of 
CHCH2CHOH), 2.41 - 2.35 (2 H, m), 2.07 -1 .76 (4 H, m), 1.65 -1.48 (3 H, m), 0.91 (9 H, s, 
SiC(CH3)3) and 0.09 (6 H, s, 2 x SiCH3).
(25/?/3aSf?/7aS/?)-4-(Allylimino)-3a-((tert-butyldimethylsilyloxy)methyl)octahydro-lH- 
inden-2-ol (215)
PHOH
OTBDMSOTBDMS
215
2 M Me3AI (2 mL, 4 mmol, 9 equiv.) was added to a solution of ketone 214 (140 mg, 
0.47 mmol) and allylamine (0.25 mL, 3.3 mmol, 7 equiv.) in DCM (10 mL). After stirring 
overnight, the reaction was quenched with saturated aqueous NaHC03 (20 mL). The 
organic layer was separated, the aqueous phase extracted with CH2CI2 (2 x 10 mL) and 
the combined organic layers dried over Na2S04. The solvent was removed under 
reduced pressure to give the title compound (approx 140 mg) as a pale yellow oil; 6H 
(400 MHz) 5.97 (1 H, app. ddt, J 17.2, 10.4, 5.2, CH2=CHCH2), 5.12 (1 H, app. dq, J 17.2,
1.9, one of CH2=CHCH2), 5.08 (1 H, app. dq, J 10.4, 1.9, one of CH2=CHCH2), 4.12 (1 H,
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br. t, J 4.8, CHOH), 4.05 - 3.99 (1 H, m, one of CH2=CHCH2), 3.97 - 3.91 (1 H, m, one of 
CH2=CHCH2), 3.64 (1 H, d, J 9.1, one of CH2OTBDMS), 3.51 (1 H, d, J 9.1, one of 
CH2OTBDMS), 2.69 (1 H, dd, J 14.7, 5.4, one of CCH2CHOH), 2.56 (1 H, app. dq, J 11.9,
7.0, ring junction CH), 2.49 - 2.41 (1 H, m), 2.14 - 2.06 (1 H, m), 1.99 - 1.86 (2 H, m),
1.76 (1 H, br. d, J 14.7, one of CCH2CHOH), 1.73 - 1.62 (1 H, m), 1.47 (1 H, ddd, J 12.6,
12.0, 4.5, one of CHCH2CHOH), 1.26 -1 .17  (1 H, m), 0.91 (9 H, s, SiC(CH3)3) and 0.09 (6 
H, s, 2 x SiCH3).
(2S/?,3aS/?,7a5/?)-3a-((tert-butyldimethylsilyloxy)methyl)-2-hydroxyhexahydro-lH- 
inden-4(2H)-one oxime (216)
OTBDMSHO
216
OTBDMS
214
A solution of ketone 214 (16 mg, 0.05 mmol), NH4OH.HCI (4.5 mg, 0.6 mmol, 1.2 
equiv.) and NaOAc (14.6 mg, 0.11 mmol, 2.0 equiv.) was refluxed for 16 h. The solvent 
was removed under reduced pressure and the residue partitioned between water (10 
mL) and Et20  (10 mL). The organic layer was separated, the aqueous phase extracted 
with Et20  (10 mL) and the combined organic layers dried over Na2S04. Concentration 
under reduced pressure gave the title compound (approx 15 mg) as a colourless oil; 6h 
(500 MHz) 4.13 (1 H, m, CHOH), 3.57 (1 H, d, J 9.3, one of CH2OTBDMS), 3.48 (1 H, d, J
9.3, one of CH2OTBDMS), 2.84 (1 H, ddd, J 18.0, 8.6, 6.9), 2.53 - 2.45 (2 H, m), 2.19 (1 H, 
app. dt, J 18.0, 5.8), 1.95 - 1.87 (2 H, m), 1.79 (1 H, br. d, J 14.5, one of CCH2CHOH),
1.74 - 1.66 (1 H, m), 1.57 - 1.45 (2 H, m), 1.20 - 1.12 (1 H, m), 0.91 (9 H, s, SiC(CH3)3), 
0.10 (3 H, s, SiCH3) and 0.09 (3 H, s, SiCH3); 6C (125 MHz) 163.0 (C), 71.4 (CH), 70.8 
(CH2), 51.9 (C), 44.4 (CH2), 43.3 (CH2), 38.0 (CH), 28.1 (CH2), 25.9 (CH3), 23.1 (CH2), 19.7 
(CH2), 18.4 (C), -5.5 (CH3) and -5.6 (CH3).
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7.6 Experimental Data for Chapter 6
l,4-c/s-l-(3-Chloro-2-hydroxypropyl)-l-hydroxymethyl-4-methylcyclohexa-2,5-diene 
(222) and l,4-trans-l-(3-chloro-2-hydroxypropyl)-l-hydroxymethyl-4- 
methylcyclohexa-2,5-diene (223)
H0‘HO'
OHOH
Me
220 221 222 223
To a solution of DPA (5.0 mL, 35.5 mmol, 1.1 equiv.) in THF (30 mL) at -78 °C was added 
/7-BuLi (22.2 mL, 1.6 M, 1.1 equiv.) and the resulting solution allowed to warm to room 
temperature. After re-cooling to -78 °C ester 220 (4.91 g, 32.3 mmol) was added 
dropwise. Stirring was continued for 30 min before the addition of epichlorohydrin (3.3 
mL, 42 mmol, 1.3 equiv.), the reaction was then allowed to warm to 5 °C over approx. 
3 h. Saturated aqueous NH4CI (75 mL) was added and after stirring for a few minutes 
the organic layer was separated and the aqueous layer extracted with Et20  (2 x 30 mL). 
The combined organic extracts were dried over Na2S04 and concentrated in vacuo to 
afford the crude intermediate lactone 221 (7.72 g) as an orange oil. This lactone was 
dissolved in ethanol (200 mL) and NaBH4 (2.45 g, 64.6 mmol, 2 equiv.) added in one 
portion. The exothermic reaction was allowed to subside and stirring continued for 1 h 
before quenching with glacial AcOH (approx. 3 mL). The solvent was removed in vacuo 
and the residue partitioned between saturated aqueous NaHC03 (200 mL) and EtOAc 
(100 mL). The organic layer was separated and the aqueous layer extracted with EtOAc 
(2 x 75 mL). The combined organic extracts were dried over Na2S04 and concentrated 
in vacuo. The residue was purified by chromatography on silica (50 % Et20  in 
petroleum ether) to give 222 (2.57 g, 37 %) and 223 (2.15, 31 %), both as a colourless 
oils.
Major diastereoisomer 222: Found: MH+ - CH3OH, 184.0667. C11H13CIO requires M, 
184.0655; vmax (neat) 3364, 2958, 2869, 1516, 1429, 1047, 803 and 743 cm 1; 6H (400
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MHz) 5.89 (1 H, ddd, J 10.2, 3.1, 1.9, one of alkene CH), 5.87 (1 H, ddd, J 10.2, 3.1, 1.9, 
one of alkene CH), 5.58 (1 H, app. dt, J 10.2, 2.1, one of alkene CH), 5.39 (1 H, app. dt, J
10.2, 2.1, one of alkene CH), 3.94 (1 H, app. ddt, J 10.4, 7.0, 3.4, CHOH), 3.53 (1 H, dd, J
11.1, 4.1, one of CH2CI), 3.45 (1 H, dd, J 11.1, 6.5, one of CH2CI), 3.36 (1 H, d, J 11.4, one 
of CH2OH), 3.34 (1 H, d, J 11.4, one of CH2OH), 2.83 (1 H, d, J 3.1, OH), 2.81 - 2.73 (1 H, 
m, MeCH), 1.64 (1 H, dd, J 14.3, 8.1, one of CH2CHOH), 1.55 (1 H, dd, J 14.3, 3.4, one of 
CH2CHOH) and 1.08 (3 H, d, J 7.3, CH3); 6C (100 MHz) 134.3 (CH), 134.0 (CH), 128.3 
(CH), 128.1 (CH), 69.9 (CH2), 69.0 (CH), 50.2 (CH2), 42.2 (C), 41.8 (CH2), 30.9 (CH) and
22.3 (CH3); m /z  (TOF ES+) 184 (M - CH3OH, 17 %) and 167 (100).
Minor diastereoisomer 223: Found: MH+-CH3OH, 184.0655. CuHi3CIO requires M, 
184.0655; vmax (neat) 3412, 2957, 1516, 1454, 1048, 805 and 748 cm'1; 6H (400MHz) 
5.94 -5.86 (2 H, m, two of alkene CH), 5.61 - 5.55 (1 H, m, one of alkene CH), 5.42 - 5.37 
(1 H, m, one of alkene CH), 3.94 (1 H, app. ddt, J 8.0, 6.4, 3.8, CHOH), 3.55 (1 H, dd, J
11.1, 4.1, one of CH2CI), 3.45 (1 H, dd, J 11.1, 6.4, one of CH2CI), 3.37 (2 H, app. s, 
CH2OH), 2.83 - 2.73 (1 H, m, MeCH), 2.70 (1 H, broad s, OH), 2.01 (1 H, broad s, OH),
1.64 (1 H, dd, J 14.3, 8.0, one of CH2CHOH), 1.54 (1 H, dd, J 14.3, 3.5, one of CH2CHOH) 
and 1.09 (3 H, d, J 7.3, CH3); 6C (100 MHz) 134.4 (CH), 134.0 (CH), 128.2 (CH), 128.1 
(CH), 70.2 (CH2), 69.0 (CH), 50.2 (CH2), 42.2 (CH2), 41.6 (C), 30.8 (CH) and 21.9 (CH3); 
m /z  (TOF ES+) 184 (M - CH3OH, 21 %) and 167 (100).
l-((15/?,45/?)-l-((te/t-Butyldiphenylsilyloxy)methyl)-4-methylcydohexa-2,5-dienyl)-3- 
chloropropan-2-ol (224)
HO' TBDPSO
OH OH
Me Me
222 224
To a solution of diol 222 (2.57 g, 11.9 mmol) in CH2CI2 (20 mL) was added imidazole 
(1.68 g, 26.2 mmol, 2.2 equiv) followed by TBDPSCI (3.4 mL, 13.1 mmol, 1.1 equiv.). 
After stirring overnight the reaction was quenched with saturated aqueous NH4CI (30 
mL) and the organic layer separated. The aqueous layer was extracted with CH2CI2 (2 x 
15 mL) and the combined organic extracts dried over Na2S04 and concentrated in
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vacuo. The residue was purified by chromatography on silica (10 % Et20  in petroleum 
ether) to give the title compound (4.35 g, 81 %) as a colourless viscous oil (Found: MH+, 
455.2190. C27H36CI02Si requires M, 455.2173); vmax (neat) 3420, 3072, 2931, 2858, 
1590, 1516, 1470, 1428, 1390, 1362, 1303, 1261 and 1111 cm'1; 6H (400 MHz)
7.66 - 7.63 (4 H, m, 4 x aromatic CH), 7.45 - 7.35 (6 H, m, 6 x aromatic CH), 5.83 - 5.77 
(2 H, m, 2 x alkene CH), 5.69 (1 H, app. dt, J 10.0,1.9, one of alkene CH), 5.49 (1 H, app. 
dt, J 10.0, 1.9, one of alkene CH), 3.97 - 3.91 (1 H, m, CHOH),3.55 (1 H, dd, J 11.0, 4.2, 
one of CH2CI), 3.48 (1 H, dd, J 11.0, 6.3, one of CH2CI), 3.44 (1 H, d, J 10.3, one of CH20), 
3.42 (1 H, d, J 10.3, one of CH20), 2.80 - 2.73 (1 H, m, MeCH), 2.60 - 2.50 (1 H, br. s, 
OH), 1.80 -1 .72 (2 H, m, CH2CHOH), 1.06 (9 H, s, SiC(CH3)3) and 1.02 (3 H, d, J 7.3, CH3); 
6C (125 MHz) 135.7 (3 x CH), 134.8 (CH), 133.3 (C), 132.7 (2 x CH), 132.4 (2 x CH), 129.7 
(2 x CH), 129.4 (CH), 128.6 (CH), 127.7 (C), 127.6 (3 x CH), 72.5 (CH2), 69.6 (CH), 53.4 
(C), 50.2 (CH2), 42.0 (CH2), 41.7 (C), 31.1 (CH), 26.9 (CH3), 22.0 (CH3) and 19.4 (C); m/z 
(TOF ES+) 457 (26 %), 455 (MH+, 100), 280 (12) and 199 (10).
(2RS,3aRS,5SR,7aRS)-7a-((tert-Buty\6\pheny\si\y\oxy)m ethy\)-5-m ethy\-2,3,3a,4,5t7a- 
hexahydro-lH-inden-2-ol (225) and (2SR,3aRS,5SR,7aRS)-7a-([tert- 
butyldiphenylsilyloxy)methyl)-5-methyl-2,3,3a,4,5,7a-hexahydro-lH-inden-2-ol (226)
TBDPSO'
+
Me
TBDPSO
Me
TBDPSO
OH
Me
224 225 226
A solution of chloride 224 (2.43 g, 5.35 mmol) in benzene (40 mL) was heated to reflux 
and solutions of AIBN (88 mg, 0.54 mmol, 0.1 equiv.) and Bu3SnH (1.7 mL, 6.42 mmol,
1.2 equiv.), each in 5 mL benzene, were added over 10 h by syringe pump. After a total 
of 18 h reflux the solution was concentrated and purified by silica gel chromatography 
(5 -10  % EtOAc in petroleum ether) to give compound 225 (1.16 g, 52 %) followed by 
compound 226 (0.51 g, 23 %), both as colourless oils.
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Major diastereoisomer 225: Found: MH+, 421.2605. C27H370 2Si requires M, 421.2563; 
vmax (neat) 3361, 3071, 2952, 1657, 1464, 1428, 1391, 1110, 822, 743 and 703 cm'1; 6 H 
(400 MHz) 7.70 - 7.65 (4 H, m, 4 x aromatic CH), 7.47 - 7.36 (6 H, m, 6 x aromatic CH),
5.45 (1 H, br. d, J 10.1, CHCH=CH), 5.26 (1 H, br. dd, J 10.1, 2.4, CHCH=CH), 4.19 (1 H, 
app. tt, J 4.6, 2.2, CHOH), 3.40 (2 H, app. s, CH20), 2.59 (1 H, app. tt, J 7.2, 3.5, ring 
junction CH), 2 .16-2 .08  (1 H, m, MeCH), 1.95 (1 H, app. dt, J 14.0, 2.1, one of 
CH2CHOH), 1.81 -1 .64  (4 H, m, one of MeCHCH2 and three of CH2CHOH), 1.18 (1 H, 
ddd, J 13.3, 1 1 .1, 4.6, one of MeCHCH2), 1.08 (9 H, s, SiC(CH3)3) and 0.93 (3 H, d, J 7.0, 
CH3); 6 c (100 MHz) 135.7 (2 x CH), 135.7 (2 x CH), 133.0 (C), 132.9 (C), 132.9 (CH), 131.5 
(CH), 129.8 (2 x CH), 127.7 (4 x CH), 71.4 (CH), 69.0 (CH2), 45.8 (C), 45.7 (CH2), 39.7 
(CH2), 35.4 (CH), 31.2 (CH2), 26.9 (CH3), 25.3 (CH), 21.5 (CH3) and 19.2 (C); m /z (TOF 
ES+) 422 (18) and 421 (MH+, 100 %).
Minor diastereoisomer 226: Found: MH+, 421.2570. C27H370 2Si requires M, 421.2563; 
Vmax (neat) 3360, 3030, 2943, 1649, 1590, 1461, 1425, 1390, 1108, 820, 744 and 697 
cm 1; 6 h (400 MHz) 7 .67 -7 .62  (4 H, m, 4 x aromatic CH), 7.45-7.35 (6 H, m, 6 x 
aromatic CH), 5.57 (1 H, br. d, J 10.1, CHCH=CH), 5.49 (1 H, dd, J 10.1, 1.8, CHCH=CH), 
4.22 (1 H, app. tt, J 6 .8 , 4.5, CHOH), 3.41 (1 H, d, J 9.8, one of CH20), 3.38 (1 H, d, J 9.8, 
one of CH20), 2.26 - 2.13 (4 H, m, MeCH, ring junction CH and two of CH2CHOH), 
1.70 - 1.55 (2 H, m, one of MeCHCH2 and one of CH2CHOH), 1.51 (1 H, dd, J 13.4, 4.5, 
one of CH2CHOH), 1.25 -1 .14  (1 H, m, one of MeCHCH2), 1.06 (9 H, s, SiC(CH3)3) and 
0.97 (3 H, d, J 7.0, CH3); 6 C (100 MHz) 135.7 (2 x CH), 135.6 (2 x CH), 133.7 (CH), 133.6 
(C), 133.6 (C), 132.8 (CH), 129.6 (CH), 129.6 (CH), 127.6 (4 x CH), 72.4 (CH), 69.0 (CH2),
46.6 (C), 44.6 (CH2), 40.0 (CH2), 36.8 (CH), 31.2 (CH2), 26.9 (CH3), 25.5 (CH), 21.3 (CH3) 
and 19.4 (C).
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2-((25/?,3aftS,55/?,7a/?S)-7a-((tert-Butyldiphenylsilyloxy)methyl)-5-methyl-
2,3,3a,4,5,7a-hexahydro-lH-inden-2-yl)isoindoline-l,3-dione (227)
TBDPSO TBDPSO
Me Me
225 227
To a solution of alcohol 225 (705 mg, 1.68 mmol) in CH2CI2 (15 mL) was added PPh3 
(660 mg, 2.52 mmol, 1.5 equiv.) and phthalimide (370 mg, 2.52 mmol, 1.5 equiv.). 
After the phosphine had dissolved DIAD (0.49 mL, 2.52 mmol, 1.5 equiv.) was added 
dropwise. The resulting yellow orange solution was stirred for 20 min, concentrated in 
vacuo and chromatographed on silica (10% Et20  in petroleum ether) to give the title 
compound (665 mg, 72 %) as a colourless oil; (Found: MH+, 550.2775. C3sH4oN0 3Si 
requires M, 550.2777); vmax (neat) 3071, 3011, 2954, 2855, 1770, 1713, 1614, 1590, 
1468, 1372, 1105, 910, 820, 703, 648 and 609 cm'1; 6 H (400 MHz) 7.81 (1 H, d, J 5.4, 
aromatic CH), 7.79 (1 H, d, J 5.4, aromatic CH), 7.71 - 7.66 (6 H, m, 6 x aromatic CH),
7.46 - 7.37 (6  H, m, 6 x aromatic CH), 5.60 (1 H, br. d, J 10.1, CHCH=CH), 5.48 (1 H, dd, J
10.1, 1.8, CHCH=CH), 4.71 - 4.60 (1 H, m, CHN), 3.45 (2 H, app. s, CH20), 2.53 (1 H, app. 
q, J 11.9, one of CHCH2CHN), 2.32 - 2.19 (3 H, m, MeCH, ring junction CH and one of 
CCH2CHN), 2.10 (1 H, dd, J 12.6, 10.3, one of CCH2CHN), 1.79 (1 H, app. dt, J 11.9, 6.2, 
one of CHCH2CHN), 1.71 (1 H, app. dt, J 13.4, 3.5, one of MeCHCH2), 1.27 - 1.22 (1 H, m, 
one of MeCHCH2), 1.10 (9 H, s, SiC(CH3)3) and 0.98 (3 H, d, J 7.0, CH3); 6 C (100 MHz)
168.4 (2 x C), 135.7 (2 x CH), 135.7 (2 x CH), 133.7 (2 x CH), 133.6 (2 x C), 132.1 (2 x C),
132.0 (CH), 131.9 (CH), 129.6 (2 x CH), 127.6 (2 x CH), 127.6 (2 x CH), 122.9 (2 x CH),
69.4 (CH2), 48.8 (CH), 45.6 (C), 37.5 (CH2), 37.4 (CH), 33.1 (CH2), 31.4 (CH2), 26.9 (CH3),
25.8 (CH), 21.4 (CH3) and 19.4 (C); m /z  (TOF ES+) 551 (20%), 550 (MH+, 100) and 294 
(14).
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(2S/?,3a/?S,5SR,7a/?S)-7a-((tert-Butyldiphenylsilyloxy)methyl)-5-methyl-2,3,3a,4,5,7a-
hexahydro-lH-inden-2-amine (228)
NHPhth NH2
TBDPSO^/
Me
TBDPSO'
Me
227 228
To a solution of phthalimide 227 (1.05 g, 1.91 mmol) in EtOH (15 mL) was added 
hydrazine hydrate (0.42 mL, 8.60 mmol, 4.5 equiv.) and the mixture bought up to 
reflux. After 20 min the suspension of hydrazide was cooled and diluted with Et20  (30 
mL) with good stirring. The precipitate was removed by filtration and the filter cake 
washed well with Et20. The filtrate was concentrated in vacuo to give the title 
compound (0.75 g, 94%) as an essentially-pure colourless oil (Found: MH+, 420.2733. 
C27H38NOSi requires M, 420.2723); vmax (CDCI3) 3364, 3070, 3002, 2930, 2856, 1643, 
1589, 1459,1428, 1390, 1110, 822, 741 and 703 cm'1; 6 H (400 MHz) 7.68 - 7.63 (4 H, m, 
4 x aromatic CH), 7.45 - 7.35 (6  H, m, 6 x aromatic CH), 5.47 (1 H, br. d, J 10.1, 
CHCH=CH), 5.41 (1 H, dd, J 10.1, 1.5, CHCH=CH), 3.39 (1 H, d, J 9.7, one of CH20), 3.37 
(1 H, d, J 9.7, one of CH20), 3.31 - 3.22 (1 H, m, CHN), 2.26 (1 H, dd, J 13.1, 8.1, one of 
CCH2CHN), 2.22 - 2.09 (2 H, m, MeCH and ring junction CH), 1.94 (1 H, app. dt, J 12.2,
6.5, one of CHCH2CHN), 1.64 -1 .57  (1 H, m, one of MeCHCH2), 1.37 (1 H, app. td, J 12.2,
9.5, one of CHCH2CHN), 1.28 -1.11 (2 H, m, one of MeCHCH2 and one of CCH2CHN),
1.05 (9 H, s, SiC(CH3)3) and 0.95 (3 H, d, J 7.0, CH3); 6C(100 MHz) 135.7 (2 x CH), 135.7 
(2 x CH), 133.7 (C), 133.7 (C), 132.8 (CH), 132.0 (CH), 129.5 (2 x CH), 127.6 (4 x CH), 69.5 
(CH2), 51.0 (CH), 46.2 (CH2), 45.8 (C), 40.9 (CH2), 37.9 (CH), 31.4 (CH2), 26.9 (CH3), 25.6 
(CH), 21.5 (CH3) and 19.4 (C); m /z  (TOF ES+) 461 (MH+.CH3CN, 36 %) and 420 (MH+, 
100).
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/V-((25R,3a/?S,5S/?,7a/?S)-7a-((tert-Butyldiphenylsilyloxy)methyl)-5-methyl-
2,3,3a,4,5,7a-hexahydro-lH-inden-2-yl)-4-nitrobenzenesulfonamide (230)
NH2 NHNs
TBDPSO TBDPSO
Me Me
228 230
To a solution of amine 228 (0.75 g, 1.79 mmol) in CH2CI2 (10 mL) was added Et3N (0.37 
mL, 2.69 mmol, 1.5 equiv.) followed by 4-nitrobenzenesulfonyl chloride (0.52 g, 2.33 
mmol, 1.3 equiv.). The resulting solution was stirred overnight, concentrated in vocuo 
and chromatographed on silica (1 0 -2 0 %  EtOAc in petroleum ether) to give the title 
compound (1.01 g, 93 %) as a pale yellow oil (Found MH+, 605.2538. C33H4iN20 5SSi 
requires M, 605.2505); vmax (CH2CI2) 3282, 3071, 2956, 2857, 1707, 1607, 1531, 1427, 
1349, 1310, 1265, 1165, 1093, 924, 855, 822, 738, 704 and 614 cm'1; 6 H (400 MHz) 8.32 
(2 H, d, J 8 .8 , 2 x aromatic CH), 8.02 (2 H, d, J 8 .8, 2 x aromatic CH), 7.61 - 7.55 (4 H, m, 
4 x aromatic CH), 7.47 - 7.33 (6  H, m, 6 x aromatic CH), 5.51 (1 H, br. d, J 10.0, 
CHCH=CH), 5.29 (1 H, dd, J 10.0, 1.6, CHCH=CH), 4.81 (1 H, d, J 8.9, NH), 3.80 - 3.69 (1 
H, m, CHN), 3.32 (1 H, d, J 9.9, one of CH20), 3.31 (1 H, d, J 9.9, one of CH20), 2.15 (2 H, 
m, ring junction CH and one of CH2CHN), 2 .10-1.98 (2 H, m, MeCH and one of 
072CHN), 1.56 (1 H, app. dt, J 13.6, 3.6, one of MeCHCtf2), 1.40 (1 H, app. dt, J 11.8,
8.4, one of CHCH2CHN), 1.19 (1 H, dd, J 13.3, 6.2, one of CCH2CHN), 1.13 -1.05 (1 H, m, 
one of MeCHCH2), 1.02 (9 H, s, SiC(CH3)3) and 0.93 (3 H, d, J 7.1, CH3); 6 C (100 MHz)
149.9 (C), 146.9 (C), 135.6 (2 x CH), 135.5 (2 x CH), 133.8 (CH), 133.3 (C), 133.2 (C),
131.6 (CH), 129.7 (2 x CH), 128.2 (2 x CH), 127.7 (4 x CH), 124.3 (2 x CH), 68.4 (CH2),
52.9 (CH), 46.1 (C), 42.5 (CH2), 37.8 (CH2), 36.7 (CH), 30.4 (CH2), 26.8 (CH3), 25.4 (CH),
21.2 (CH3), 19.3 (C); m /z  (TOF ES+) 606 (33%), 605 (MH+, 100), 418 (29) and 280 (63).
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(2/?5,3a5/?,4/?S,6fl5,7/?S,7aRS)-3a-(tert-Butyldimethylsilyloxymethyl)-7-iodo-6-methyl-
l-(4-nitrobenzenesulfonyl)-2,4-methanooctahydroindole (231)
NHNs
To a solution of sulfonamide 230 (400 mg, 0.66 mmol) in MeCN (10 mL) was added 
NaHC03 (167 mg, 1.98 mmol, 3 equiv.) and l2 (505 mg, 1.98 mmol, 3 equiv.). The 
reaction was stirred overnight before quenching with saturated aqueous Na2S03 (10 
mL). The organic layer was separated and the aqueous phase extracted with Et20  (2 x 
10 mL). The combined organic extracts were dried over Na2S04 and concentrated in 
vacuo. The residue was chromatographed on silica (10 % EtOAc in petroleum ether) to 
give the title compound (437 mg, 91 %) as a colourless oil that crystallised on standing, 
m.p. 173 - 175 °C (Found MH+, 731.1436. C33H4olN2OsSSi requires M, 731.1472); vmax 
(CH2CI2) 3071, 2959, 2857, 1605, 1533, 1470, 1428, 1351, 1312, 1263, 1155, 1109, 959, 
926, 856, 800, 740, 704, 632 and 601 cm4; 6 H (400 MHz) 8.18 (2 H, d, J 8 .8 , 2 x 
aromatic CH), 7.96 (2 H, d, J 8 .8 , 2 x aromatic CH), 7.52 - 7.47 (4 H, m, 4 x aromatic CH),
7.45 - 7.27 (6  H, m, 6 x aromatic CH), 4.92 (1 H, br. s, CHI), 4.19 (1 H, d, J 10.7, one of 
CH20), 3.99 (1 H, br. d, J 2.2, CHICHN), 3.92 (1 H, br. s, CH2CHN), 3.71 (1 H, d, J 10.7, 
one of CH20), 1.91 - 1.85 (2 H, m, ring junction CH and one of CH2CHN), 1.80 -1.71 (1 
H, m, one of CH2CHN), 1 .61-1 .50  (1 H, m, MeCH), 1.29-1.10 (2 H, m, MeCHCH2), 
0.99 - 0.94 (13 H, m, CH3, SiC(CH3)3 and one of CH2CHN) and 0.74 (1 H, br. d, J 10.3, one 
of CW2CHN); 6c (100 MHz) 150.0 (C), 143.2 (C), 135.8 (2 x CH), 135.6 (2 x CH), 133.3 (C),
132.9 (C), 129.8 (CH), 129.8 (CH), 128.8 (2 x CH), 127.6 (2 x CH), 127.5 (2 x CH), 124.5 (2 
x CH), 64.5 (CH2), 64.2 (CH), 59.6 (CH), 52.5 (C), 43.1 (CH2), 40.7 (CH), 37.0 (CH2), 34.1 
(CH), 29.3 (CH2), 26.9 (CH3), 24.1 (CH and CH3) and 19.3 (C).
TBDPSO'
OTBDPS
230 231
167
/V-((2Sff,3af?S,5Sfl,7a/?S)-7a-((fe/t-Butyldiphenylsilyloxy)methyl)>5-methyl-
2,3,3a,4,5,7a-hexahydro-lH-inden-2-yl)-toleuenesulfonamide (232)
TBDPSO TBDPSO
NHTs
Me Me
228 232
To a solution of amine 228 (230 mg, 0.55 mmol) in CH2CI2 (10 mL) was added Et3N 
(0.11 mL, 0.83 mmol, 1.5 equiv.) and TsCI (126 mg, 0.66 mmol, 1.2 equiv.). After 
stirring overnight the solution was concentrated and chromatographed on silica (20  % 
EtOAc in petroleum ether) to give the title compound as a colourless oil (265 mg, 
84%). (Found: MNH4+, 591.3063. C34H47N20 3SSi requires M, 591.3077); vmax (CDCI3) 
3271, 3071, 2955, 2857, 1598, 1428, 1325, 1160, 1094, 910, 815, 735, 704, 665 cm'1; 
6 h (400 MHz) 7.66 (2 H, d, J 8.3, aromatic CH), 7.53 - 7.49 (4 H, m, aromatic CH), 7.38 - 
7.27 (6  H, m, aromatic CH), 7.19 (2 H, d, J 8.3, aromatic CH), 5.40 (1 H, br. d, J 10.1, 
CHCH=CH), 5.22 (1 H, dd, J 10.1, 1.7, CHCH=CH), 4.62 (1 H, d, J 8.7, NH), 3.57 (1 H, m, 
CHN), 3.23 (1 H, d, J 9.8, one of CH20), 3.20 (1 H, d, J 9.8, one of CH20), 2.33 (3 H, s, 
ArCH3), 2.05 1.94 (2 H, m, ring junction CH and MeCH), 2.03 (1 H, dd, J 13.3, 8.2, one of 
COV2CHN), 1.92 (1 H, app. dt, J 12.3, 7.3, one of CHCH2CHN), 1.46 (1H, app. dt, J 13.5, 
3.7, one of MeCHCH2), 1.37-1.27 (1 H, ddd, J 12.3,11.5, 8.3, one of CHCH2CHN), 1.11 
(1 H, dd, J 13.3, 6.3, one of CCH2CHN), 1.00 (1 H, ddd, J 13.5, 10.8, 4.1, one of 
MeCHCH2), 0.93 (9 H, s, SiC(CH3)3) and 0.84 (3 H, d, J 7.0, CH3CH); 6C (125 MHz) 143.1 
(C), 138.0 (C), 135.6 (2 x CH), 135.6 (2 x CH), 133.5 (C), 133.4 (C), 133.3 (CH), 131.9 
(CH), 129.6 (2 x CH), 127.6 (4 x CH), 127.1 (2 x CH), 68 .8  (CH2), 52.6 (CH), 46.0 (C), 42.5 
(CH2), 37.8 (CH2), 36.8 (CH), 30.7 (CH2), 26.9 (CH3), 25.4 (CH), 21.5 (CH3), 21.2 (CH3) and
19.3 (C); m /z  (TOF ES+) 593 (19%), 592 (53) and 591 (M.NH4+, 100).
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(2/?5,3aS/?,4/?S,6f?S,7/?S,7aRS)-3a-(tert-Butyldimethylsilyloxymethyl)-7-iodo-6-methyl-
l-(4-toluenesulfonyl)-2,4methanooctahydroindole (233)
NHTs
TBDPSO'
Me
TsN.
Me
OTBDPS
233
To a solution of sulfonamide 232 (250 mg, 0.44 mmol) in MeCN (5 mL) was added 
NaHC03 (110 mg, 1.31 mmol, 3 equiv.) and b (332 mg, 1.31 mmol, 3 equiv.). After 
stirring overnight the reaction was quenched by the addition of saturated aqueous 
Na2S03  (10 mL), the organic layer separated and the aqueous phase extracted with 
Et20  (2 x 10 mL). The combined organic extracts were dried over Na2S04  and 
concentrated in vacuo. The residue was purified by chromatography on silica (10 % 
EtOAc in petroleum ether) to give the title compound (210 mg, 69 %) as a colourless oil 
that crystallised on standing, m.p. 150-152 °C (Found: MH+, 700.1765. C34H43lN0 3SSi 
requires M, 700.1778); vmax (CH2CI2) 3070, 2958, 2857, 1597, 1469, 1428, 1346, 1260, 
1153, 1110, 958, 926, 802, 740, 704 and 665 cm'1; 6 H (500 MHz) 7.68 (2 H, d, J 8.3, 2 x 
aromatic CH), 7.54 - 7.51 (4 H, m, 4 x aromatic CH), 7.45 - 7.29 (6 H, m, 6 x aromatic 
CH), 7.14 (2 H, d, J 8.3, 2 x aromatic CH), 4.94 (1 H, br. t, J 3.1, CHI), 4.15 (1 H, d, J 10.6, 
one of CH20), 4.01 (1 H, br. d, J 2.3, CHICtfN), 3.88 (1 H, br. s, CH2CHN), 3.69 (1 H, d, J 
10.6, one of CH20), 2.36 (3 H, s, ArCH3), 1.87 -1 .80  (2 H, m, ring junction CH and one of 
CH2CHN), 1.76 -1 .70  (1 H, m, one of CH2CHN), 1.65 -1.50 (1H, m, MeCH), 1.28 -1.11 (2 
H, m, MeCHC/V2), 0.99 (9 H, s, SiC(CH3)3), 0.95 (3 H, d, J 6.4, CH3CH), 0.95 - 0.91 (1 H, m, 
one of CH2CHN) and 0.85 (1 H, app. dt, J 10.1, 2.2, one of CHCH2CHN); 6C 143.5 (C),
135.9 (2 x CH), 135.7 (2 x CH), 133.7 (C), 133.3 (C), 129.9 (2 x CH), 129.7 (CH), 129.6 
(CH), 127.7 (2 x CH), 127.5 (2 x CH),127.4 (2 x CH), 64.7 (CH2), 64.0 (CH), 59.3 (CH),
52.3 (C), 42.9 (CH2), 42.1 (CH), 37.1 (CH2), 34.2 (CH), 29.5 (CH2), 27.0 (CH3), 24.2 (CH3), 
24.1 (CH), 21.5 (CH3) and 19.3 (C); m /z  (TOF ES+) 701 (25%), 700 (MH+, 100) and 572 
(14).
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(2/?S,3aS/?,4RS,6/?S,7/?S,7a/?S)-3a-(tert-Butyldimethylsilyloxymethyl)-6-methyl-l-(4-
toluenesulfonyl)-2,4-methanooctahydroindole (234)
Me
OTBDPS
233
Me
OTBDPS
234
To a solution of iodide 233 (40 mg, 0.06 mmol) in benzene (10 mL) was added Bu3SnH 
(0.15 mL, 0.57 mmol, 10 equiv.) and AIBN (25 mg, 0.15 mmol, 2.7 equiv.). The solution 
was heated to reflux overnight, concentrated and chromatographed on silica 
containing approx. 10 % w /w  NaF (10 % EtOAc in petroleum ether) to give the title 
compound (33 mg, 100%) as a yellow oil (Found: MH+, 574.2834. C34H44N0 3SSi 
requires M, 574.2811); vmax (CH2CI2) 3071, 2956, 2855, 1599, 1457, 1428, 1341, 1156, 
1111, 957, 934, 898, 802, 739 and 705 cm'1; 6 H (500 MHz) 7.71 (2 H, d, J 8.3, 2 x 
aromatic CH), 7.56 - 7.50 (4 H, m, 4 x aromatic CH), 7.45 - 7.33 (6 H, m, 6 x aromatic 
CH), 7.24 (2 H, d, J 8.3, 2 x aromatic CH), 4.04 (1 H, br. s, CCH2CHN), 3.62 - 3.58 (2 H, m, 
MeCH2CWN and one of CH20), 3.49 (1 H, d, J 10.6, one of CH20), 2.39 (3 H, s, ArCH3), 
2.12 (1 H, br. d, J 13.9, one of MeCHCH2CHN), 2.07 -1.95 (1 H, m, MeCH), 1.88 -1.78 (2 
H, m, ring junction CH and one of CCHCH2CHN), 1.72 -1.62 (1 H, m, one of 
CCHCH2CHN), 1.44 (1 H, br. d, J 13.8, one of MeCHCH2CH), 1.02 (1 H, app. d, J 9.8, one 
of CCH2CHN), 0.98 - 0.89 (11 H, m, one of CQy2CHN, one of MeCHCtf2CHN and 
SiC(CH3)3), 0.88 - 0.83 (1 H, m, one of MeCHCH2CH) and 0.86 (3 H, d, J 6 .6 , CH3); 6C (125 
MHz) 142.9 (C), 135.6 (2 x CH), 135.5 (2 x CH2), 133.1 (C), 133.1 (C), 129.8 (CH), 129.8 
(CH), 129.7 (2 x CH), 127.7 (2 x CH), 127.7 (2 x CH), 127.6 (2 x CH), 62.8 (CH2), 59.8 
(CH), 59.7 (CH), 51.3 (C), 41.2 (CH2), 37.2 (CH2), 34.9 (CH), 33.7 (CH2), 33.5 (CH2), 26.8 
(CH3), 21.6 (CH3), 21.5 (CH3), 20.2 (CH) and 19.2 (C); m /z (TOF ES+) 575 (22%) and 574 
(MH+, 100).
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(2/?S,3aS/?,4/?S,6/?S,7RS,7a/?S)-3a-(tert-Butyldimethylsilyloxymethyl)-6-methyl-2,4-
methanooctahydroindole (229).
TsNj
Me
OTBDPS
234
HNj
Me'
OTBDPS
229
To a solution of naphthalene (125 mg, 0.98 mmol) in THF (2 mL) was added sodium (22 
mg, 0.96 mmol) and the metal crushed with a spatula. After stirring for 30 min a 1 mL 
aliquot of the resulting green solution was added dropwise to a -78 °C solution of 
tosylate 234 (25 mg, 0.04 mmol) in THF (3 mL), giving a permanent green colour. After 
stirring for 15 min the reaction was quenched by addition of 2 M NaOH (10 mL) and 
allowed to warm to room temperature. The organic layer was separated and the 
aqueous phase extracted with Et20 (2 x 10 mL). The combined organic layers were 
dried over Na2S04 and concentrated in vacuo. The residue was chromatographed on 
silica (10 % EtOAc in petroleum ether followed by 1 % Et3N in MeOH) to give a yellow 
oil which proved to be a salt by 1H NMR. This was dissolved in CH2CI2 (10 mL) and 
washed with 2 M NaOH (10 mL). The aqueous phase was extracted with CH2CI2 (10 mL) 
and the combined organic phases dried over NaOH and concentrated in vacuo to give 
the title compound (15 mg, 82 %) as a yellow oil (Found MH+, 420.2731. C27H38NOSi 
requires M, 420.2723); vmax (neat) 3398, 3072, 2929, 2861, 1587, 1428, 1111, 1097, 
823, 737 and 703 cm'1; 6 H (500 MHz) 7.66 (4 H, app. br. d, J 7.1, 4 x aromatic CH),
7.45 - 7.36 (6  H, m, 6 x aromatic CH), 3.70 (1 H, d, J 10.5, one of CH20), 3.69 (1 H, d, J
10.5, one of CH20), 3.29 (1 H, br. s, CCH2CHN), 3.22 (1 H, br. s, CCHN), 2.07 (1 H, m, ring 
junction CH), 1.85 (1 H, app. td, J 12.3, 2.8, one of CHCH2CHN), 1.86-1.75 (1 H, m, 
MeCH), 1.71 (1 H, app. dt, J 9.3, 2.2, one of CCH2CHN), 1.62 (1 H, br. d, J 14.3, one of 
MeCHCH2CHN), 1.55 (1 H, d, J 9.3, one of CCF/2CHN), 1.45 (1 H, br. d, J 13.7, one of 
MeCHCH2CH), 1.35 (1 H, app. dt, J 12.3, 3.4, one of CCHCF/2CHN), 1.05 (9 H, s, 
SiC(CH3)3), 0.98 - 0.88 (2 H, m, one of MeCHCF/2CH and one of MeCHCF/2CHN) and 0.85 
(3 H, d, J 6.5, CH3); 6 c (125 MHz) 135.7 (4 x CH), 133.8 (2 x C), 129.6 (2 x CH), 127.6 (4 x 
CH), 63.8 (CH2), 56.0 (CH), 55.2 (CH), 49.8 (C), 44.9 (CH2), 38.2 (CH2), 34.6 (CH2), 34.2
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(CH), 33.6 (CH2), 26.9 (CH3), 21.9 (CH3), 19.7 (CH) and 19.4 (C); m/z (TOF ES+) 422
(10%), 421 (35) and 420 (MH+, 100).
(3a/?S,7a/?S)-3a-((tert-ButYldimethylsilyloxy)methyl)-3,3a,7,7a-tetrahydro-lH-inden- 
2(6H)-one (235)
TBDMSO TBDMSO
/H
191 235
PDC (500 mg, 1.3 mmol, 1.5 equiv.) was added to a solution of alcohol 191 (250 mg, 
0.89 mmol) in CH2CI2. After stirring for 16 h, the mixture was filtered through a short 
column of silica gel, washing well with CH2CI2. Removal of the solvent in vacuo 
afforded the title compound (200 mg, 81 %) as a pale yellow oil. 6 H (500 MHz) 5.81 (1 
H, app. dt, J 10.1, 3.8, one of alkene CH), 5.38 (1 H, app. dt, J 10.1, 1.9, one of alkene 
CH), 3.50 (1 H, d, J 9.9, one of CH2OTBS), 3.43 (1 H, d, J 9.9, one of CH2OTBS), 2.52 (1 H, 
d, J 18.2, one of CCtf2C=0), 2.47 - 2.39 (2 H, m), 2.12 - 2.02 (3 H, m), 2.05 (1 H, d, J 18.2, 
one of CCH2C=0), 1.77 (1 H, dddd, J 13.8, 7.7, 6.2, 3.5), 1.55 (1 H, app. dq, J 13.7, 5.9), 
0.89 (9 H, s, SiC(CH3)3) and 0.04 (6  H, s, 2 x SiCH3).
(3aS/?,7a/?S)-l-Allyl-3a-((tert-butyldimethylsilyloxy)methyl)-3,3a,7f7a-tetrahydro-lH- 
inden-2(6H)-one (236)
0 TBDMSOTBDMSO
236235
A solution of ketone 235 (0.5 g, 1.8 mmol) in THF (2 mL) was added to a solution of 2M 
LDA (1.1 mL, 2.2 mmol, 1.2 equiv.) in THF (10 mL) at -78 °C. After stirring for 30 min, 
allyl iodide (0.21 mL, 2.3 mmol, 1.3 equiv.) was added dropwise and the reaction 
allowed to warm to room temperature while stirring overnight. Saturated aqueous
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NH4CI (20 mL) was added, the organic layer separated and the aqueous phase 
extracted with Et20  (2 x 10 mL). The combined organic extracts were dried over 
Na2S04 and concentrated in vacuo. The residue was purified by chromatography on 
silica gel (2 % Et20  in petroleum ether) giving the title compound (300 mg, 76 %) as a 
yellow oil. 6 H (500 MHz) 5.85 - 5.69 (2 H, m, 2 x alkene CH), 5.40 - 5.28 (1 H, m, alkene 
CH), 5.11 - 4.97 (2 H, m, 2 x alkene CH), 3.50 (1 H, d, J 10.1, one of CH2OTBS), 3.39 (1 H, 
d, J 10.1, one of CH2OTBS), 2.57 (1 H, d, J 18.3, one of CCtf2C=0), 2.38 - 2.27 (2 H, m), 
2.18 (1 H, app. dtd, J 11.3, 5.8, 1.5), 2.10 -1 .99 (3 H, m), 1.82 - 1.67 (2 H, m), 1.55 (1 H, 
app. dq, J 13.7, 5.6), 0 .88  (9 H, s, SiC(CH3)3) and 0.03 (6 H, s, 2 x SiCH3); 6C (100  MHz)
135.3 (CH), 130.5 (CH), 129.0 (CH), 116.6 (CH2), 65.0 (CH2), 48.6 (CH), 45.7 (CH2), 43.0 
(C), 37.7 (CH), 32.8 (CH2), 25.6 (CH3), 19.9 (CH2), 18.7 (CH2), 17.9 (C), -5.8 (C) and -5.8 
(C).
(3a/?5,7a/?5)-3a-((Methoxymethoxy)methyl)-3,3a,7,7a-tetrahydro-lH-inden-2(6H)-one
(237)
TBDMSO
235
MOMO
237
A I M  THF solution of TBAF (3 mL, 3 mmol, 1.5 equiv.) was added to a solution of 
ketone 235 (0.6 g, 2.1 mmol) in THF (10 mL). After stirring for 30 min, the reaction was 
quenched with water (20 mL), the organic layer separated and the aqueous phase 
extracted with Et20  (2 x 10 mL). The combined organic extracts were washed with 
water (20 mL) and brine (20 mL) then dried over Na2S04. The solvent was removed in 
vacuo and the residual orange oil (364 mg) dissolved in DCM (20 mL). DIPEA (1.74 mL, 
5 mmol, 2.5 equiv.) was added, followed by an approximately 1 M solution of MOM-CI 
in CH2CI2. After stirring for 16 h, the reaction was quenched with 2 M HCI (20 mL), the 
organic layer separated and the aqueous phase extracted with CH2CI2 (2 x 10 mL). The 
combined organic layers were dried over Na2S04, concentrated under reduced
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pressure, and the resulting residue purified by chromatography on silica (15 % EtOAc in 
petroleum ether) to yield the title compound (0.29 g, 67 %) as a colourless oil.
(3aS/?,7aflS)-l-Allyl-3a-((methoxymethoxy)methyl)-3,3a,7,7a-tetrahydro-lH-inden- 
2(6H)-one (238)
MOMO
237
MOMO
238
A solution of ketone 237 (0.29 g, 1.4 mmol) in THF (2 mL) was added to a solution of 
2M LDA (0.84 mL, 1.7 mmol, 1.2 equiv.) in THF (10 mL) at -78 °C. After stirring for 30 
min, allyl bromide (0.24 mL, 2.8 mmol, 2.0 equiv.) was added dropwise and the 
reaction allowed to warm to room temperature while stirring overnight. Saturated 
aqueous NH4CI (20 mL) was added, the organic layer separated and the aqueous phase 
extracted with Et20  (2 x 10 mL). The combined organic extracts were dried over 
Na2S0 4, concentrated under reduced pressure, and the residue purified by 
chromatography on silica gel (8  % EtOAc in petroleum ether) giving the title compound 
(165 mg, 47 %) as a yellow oil; 6 H (500 MHz) 5.88 - 5.66 (2 H, m, 2 x alkene CH), 5.40 - 
5.35 (1 H, m, one of alkene CH), 5.13 - 4.98 (2 H, m, 2 x alkene CH), 4.62 (3 H, s, OCH3),
3.47 (1 H, d, J 9.6, one of CH2OMOM), 3.42 (1 H, d, J 9.6, one of CH2OMOM), 3.49 (2 H, 
s, OCH20), 2.48 (1 H, d, J 18.4, one of CCH2C=0), 2.46 - 2.38 (1 H, m, one of C=CHCH2), 
2.33 - 2.19 (3 H, m), 2.16 (1 H, d, J 18.4, one of CCH2C=0), 2.06 -1.99 (2 H, m), 1.83 (1 
H, dddd,7 13.8,10.2, 6 .8 , 3.5) and 1.75 (1 H, app. ddt,7 14.1, 5.8, 2.7).
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Methyl 2-(l-allylcyclohexa-2,5-dienyl)acetate (240)
COoMe
239 240
Methyl chloroformate (1.32 mL, 16.7 mmol, 1.1 equiv.) was added dropwise to an ice- 
cold solution of acid 239 (2.5 g, 15.2 mmol) and Et3N (2.32 mL, 16.7 mmol, 1.1 equiv.) 
in Et20  (50 mL). The resulting suspension was stirred for 30 min, while a suspension of 
Diazald (4.9 g, 22.8 mmol, 1.5 equiv.) in EtOH (10 mL) was prepared and warmed to 
approx. 50 °C in a separate flask. A solution of KOH (5 g) in H20  (8  mL) was added 
dropwise to the well stirred Diazald suspension and the gas generated was passed into 
the flask containing the mixed anhydride.
Stirring was continued for 30 min before the crude diazoketone solution was filtered 
through a short column of silica, washing well with Et20. Removal of the solvent under 
reduced pressure gave a residue which was redissolved in MeOH (50 mL) and treated 
with a solution of freshly prepared silver (I) benzoate (100 mg) in Et3N (10 mL). This 
was heated cautiously to reflux, resulting in vigorous gas evolution. After 4 h at reflux, 
the mixture was again filtered through a short column of silica, washing with Et20, and 
the filtrate concentrated under reduced pressure. The residue was purified by 
chromatography on silica (2 - 10 % EtOAc in petroleum ether) to afford the title 
compound (1.24 g, 42 %) as a colourless oil; 6 h (500 MHz) 5.82 - 5.78 (2 H, m, 2 x 
alkene CH), 5.71 (1 H, app. ddt, J 17.6, 10.4, 7.2, alkene CH), 5.56 - 5.52 (2 H, m, 2 x 
alkene CH), 5.07 - 4.98 (2 H, m, 2 x alkene CH), 3.62 (3 H, s, OMe), 2.56 (2 H, app. tdd, J
5.4, 3.3, 2.1, CHCH2CH), 2.36 (2 H, s, CH2C02Me) and 2.20 (2 H, br. d, J 7.2, 
CH2=CHCH2).
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Compound Lists
Appendix A -l. Compound List for Chapter 2
73at R = Me 
73b, R = 2-BrC6H4 
73c, R = Ph
74a, R = Me 
74b, R = 2-BrC6H4 
74c, R = Ph
61a, R = Me 
61b, R = n-Bu 
61c, R = /-Bu 
61d, R = f-Bu 
61e, R = Ph
Me
OH
62a, R = Me 
62c, R = /-Bu 
62e, R = Ph
60a, R = Me 
60b, R = n-Bu 
60c, R = /-Bu 
60d, R = f-Bu 
60e, R = Ph
60f, R = Me 
60g, R = /-Bu 
60h, R = Ph
61f, R = Me 
61 g, R = /-Bu 
61h, R = Ph
62f, R = Me 
62g, R = /-Bu 
62h, R = Ph
86a, R = Me 
86b, R = n-Bu 
86c, R = /-Bu 
86e, R = Ph
85a, R = Me 
85b, R = n-Bu 
85c, R = /-Bu 
85e, R = Ph
PhMe
87a, R = Me 
87b, R = n-Bu
Cl
HO.
Me
Cl
HO.
63a, R = Me 
63c, R = /-Bu 
63e, R = Ph
63f, R = Me 
63g, R = /-Bu 
63h, R = Ph
MeHO.HO.
Me
HO' Ph
/-Bu
75c 75f, R = Me 
75g, R = /-Bu
78 84a, R = Me 
84b, R = n-Bu 
84c, R = /-Bu 
84e, R = Ph
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Appendix A-2. Compound List for Chapter 3
121a, R = Me 
121b, R = n-Bu 
121c, R = f-Bu 
121d, R = CH2CI 
121e, R = CH2OH 
121f, R — c-CgH'j'j 
121g, R = Ph
113a, R = Me 
113b, R = n-Bu 
113c, R = f-Bu 
113d, R = CH2CI 
113e, R = CH2OH 
113f, R = c-CgHn 
113g, R = Ph
121h 121 i
Ph
HO'HO'
OH OH
113h 113i
R
114a, R = 
114b, R = 
114c, R = 
114d, R = 
114e, R = 
114f, R = 
114g, R =
Me 
n-Bu 
t- Bu 
CH2CI
ch2oh
c-CgH i^
Ph
HO
HO'
^  ^  ,0 
H
115a, R = Me 
115b, R = n-Bu 
115g, R = Ph
Br OH
Ph
HO'
114h
115h
HO'
114i
HO
115i
OHMe
HO' Me'
116b 117b 116a 117a
H,C
126
OH
HO OH
127 118
0 HO
119 120
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Appendix A-3. Compound List for Chapter 4
PTBDMSTBDMSOTBDMSO
174 180
TBDMSO
TBDMSO OTBDMS TBDMSO
HO,,.
OTBDMS TBDMSO
ho*.
175 182 183
PTBDMSTBDMSO OTBDMS
189 189
pTBDMS
'H
OTBDMS
''H
"o
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Appendix A-4. Compound List for Chapter 5
OH
r  TBDMSO OHTBDMSOTBDMSO
•'/
190 191 192
TBDMSO
193 and 
194
PH PHTBDMSO TBDMSO
PH PHTBDMSO TBDMSO
HO
Me Me
195 196 197 198
O
^—OMe
O
NBocTBDMSO
Me
212
OR
O
NFmocTBDMSO
Me
210, R = Me
211, R = Ph
OTBDMS
213
PH
OTBDMS OTBDMS OTBDMSHO
214 215 216
180
Appendix A-5. Compound List for Chapter 6
TBDPSO
TBDPSO'TBDPSO'TBDPSO'
NHNs NHTs
TBDPSO TBDPSO' TBDPSO'
OTBDPS
TBDMSO
MeMeMe
OTBDPS OTBDPSOTBDPS
233 234 229 235
MOMOMOMOTBDMSO
236 237 238 240
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